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Preface
This dissertation is the result of my own work and includes nothing which is the out-
come of work done in collaboration except as declared in the Preface and specified in
the text. It is not substantially the same as any that I have submitted, or, is being
concurrently submitted for a degree or diploma or other qualification at the Univer-
sity of Cambridge or any other University or similar institution except as declared in
the Preface and specified in the text. I further state that no substantial part of my
dissertation has already been submitted, or, is being concurrently submitted for any
such degree, diploma or other qualification at the University of Cambridge or any
other University or similar institution except as declared in the Preface and specified
in the text. It does not exceed the prescribed word limit of 60,000 words.
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Summary
We know little about how isoform choice is regulated in individual cells for most
spliced genes. In theory, single-cell RNA-sequencing (scRNA-seq) could enable us
to investigate isoform choice at cellular resolution. Therefore, scRNA-seq could give
insight into the fundamental molecular biology process of how alternative splicing
is regulated within cells. However, scRNA-seq is a relatively new technology, and
at the start of my PhD it was not clear whether existing bioinformatics approaches
would enable accurate splicing analyses. In my PhD I consider what the limitations
are when attempting to study alternative splicing using scRNA-seq and what can be
done to overcome them.
Alternative splicing is commonly analysed using bulk RNA sequencing (bulk
RNA-seq) data with isoform quantification software. It was not clear whether iso-
form quantification software designed for bulk RNA-seq would perform well when
run on scRNA-seq data. To address this, I performed a simulation-based benchmark
of isoform quantification software developed for bulk RNA-seq when run on scRNA-
seq. I made two important findings. Firstly, I found that isoform quantification
software performs poorly when run on Drop-seq data, but performs better when run
on scRNA-seq data generated using full-length transcript protocols (eg. SMART-seq
and SMART-seq2). Secondly, I found that for the most part, isoform quantifica-
tion software performs almost as well when run on full-length scRNA-seq as it does
when run on bulk RNA-seq. Based on these findings, I concluded that software
tools to accurately quantify the reads from full-length scRNA-seq experiments exist,
theoretically enabling alternative splicing to be analysed using scRNA-seq.
Encouraged by this result, I embarked on a series of experiments designed to
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answer questions such as ‘How many isoforms does a gene typically produce per
cell?’. This is a key basic biology question that could in theory be answered using
scRNA-seq. Unfortunately, I found that the results of these experiments were largely
impossible to interpret because I was unable to distinguish between biological signal
and technical noise. I realised that without a solid understanding of the technical
noise and confounding factors associated with scRNA-seq, distinguishing biological
signal from technical noise would be challenging and might not be possible. To
address this, I embarked on a second simulation-based study, this time investigat-
ing the impact of technical noise on our ability to study alternative splicing using
scRNA-seq. I simulated four situations: a situation where every gene expressed one
isoform per cell, a situation where all genes expressed two isoforms per cell, a sit-
uation where all genes expressed three isoforms per cell and a situation where all
genes expressed four isoforms per cell. Importantly, I explicitly simulated isoform
choice, dropouts and quantification errors. The results of the four simulated situ-
ations were not trivial to distinguish from each other, raising concerns about the
feasibility of resolving the more complex splicing patterns that probably exist in re-
ality using scRNA-seq data. I concluded that attempts to study alternative splicing
using scRNA-seq are currently substantially confounded by a high rate of dropouts
and a lack of understanding about the mechanism of isoform choice. Importantly,
improvements to isoform quantification software accuracy alone were insufficient to
correct for confounding effects caused by dropouts. I propose that to enable accu-
rate alternative splicing analyses using scRNA-seq, further research into accurately
modelling dropouts is required, or alternatively, scRNA-seq technologies should be
improved to increase their capture efficiency. Additionally, research into how isoform
choice is regulated at a cellular level is necessary to enable accurate analyses. Over-
all, I find that it is not currently possible to accurately perform alternative splicing
analyses using scRNA-seq. However, I am optimistic that with further research, it
may become possible in the future.
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1Introduction
I never am really satisfied that I understand anything; because, understand
it well as I may, my comprehension can only be an infinitesimal fraction of
all I want to understand...
– Ada Lovelace, quoted by (Henderson, 1995).
1.1 Motivation
Alternative splicing is a fundamental process in molecular biology which enables
multiple proteins to be generated from single genes. Alternative splicing is implicated
in many biological processes, including the activation of pluripotency genes (Gabut
et al., 2011), cell fate decisions (Yamazaki et al., 2018) and transcriptional regulation
(Li et al., 2017). In addition, errors in alternative splicing have been implicated in
numerous human diseases, including cancer (David and Manley, 2010) and genetic
diseases such as Duchenne Muscular Dystrophy (Muntoni et al., 2003). Therefore,
furthering our understanding of alternative splicing would be highly beneficial to our
understanding of basic biology and human disease.
When bulk RNA-seq was first developed over a decade ago (Emrich et al., 2007;
Lister et al., 2008), it enabled researchers to quantitatively measure transcript abun-
dance on a genome wide scale. For the first time, researchers were able to study
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alternative splicing across the entire transcriptome in a quantitative manner. How-
ever, although bulk RNA-seq enabled researchers to study more genes in a single
experiment than had previously been possible using array based technologies, in one
sense the resolution of bulk RNA-seq experiments remains poor. Consider Figure
1.1.
Figure 1.1: An imaginary bulk RNA-seq experiment in the liver and brain.
In Figure 1.1, we imagine an experiment in which we perform bulk RNA-seq on a
mouse liver and brain. We find that for our gene of interest, ‘Gene1’, only one isoform
(‘Isoform1’) is detected in the liver, whereas two isoforms (‘Isoform1’ and ‘Isoform2’)
are detected in the brain. This is an informative result which indicates that there
is differential splicing of Gene1 in the brain and the liver. However, because bulk
RNA-seq is performed on a population of cells, based on this result there is very
little that we can infer about how this differential splicing is regulated at a cellular
level. For example, based on our bulk RNA-seq results, it would be challenging or
impossible to answer the following questions:
1. Does Gene1 expresses two isoforms in every cell in the brain, or do some brain
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cells exclusively express Isoform1 and others exclusively express Isoform2, or is
there is some intermediate situation between these two extremes?
2. If there is heterogeneity in isoform expression between cells, does the hetero-
geneity correlate with cell type?
3. Do all cells express Gene1 in the brain or the liver?
At first sight, these questions appear deceptively simple. However, they are
fundamental questions in molecular biology. If we are unable to answer them, we are
severely limited in our understanding both of how alternative splicing is regulated in
individual cells and of how splicing is regulated across complex tissues and organs.
In theory, single-cell RNA-seq (scRNA-seq) could enable us to answer all of the
questions posed above, and more, by allowing us to study alternative splicing at a
cellular resolution. That is, of course, if it is possible to study alternative splicing
using scRNA-seq.
1.2 What is alternative splicing?
Alternative splicing is the process by which more than one mRNA transcript can be
produced from a single gene. An example is illustrated in Figure 1.2.
Figure 1.2 illustrates a gene with a promoter, two exons and an intron. The
promoter is the region where transcription begins, the exons are coding regions of
the gene and the intron is non coding sequence. The gene in Figure 1.2 is transcribed
and spliced to produce two mRNA isoforms, one consisting of only the first exon,
and one consisting of the first and the second exon with the intron removed. The
process by which two distinct isoforms can be produced from a single gene is known
as alternative splicing.
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Figure 1.2: An example of an alternatively spliced gene.
1.3 Molecular mechanisms of alternative splicing
The previous section described the outcome of alternative splicing. In this section I
will briefly explain how alternative splicing takes place at a molecular level.
Alternative splicing is catalysed by the spliceosome. The spliceosome is a ribonu-
cleoprotein (RNP) complex made up of five spliceosomal RNP subunits and many
more protein cofactors. snRNAs, the RNA molecules that form part of the spliceo-
somal subunits, are thought to provide the catalytic activity required for alternative
splicing (Matera and Wang, 2014). This hypothesis is supported by experiments in
which splicing-like reactions have been catalysed in protein free systems (Valadkhan
et al., 2007, 2009).
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Figure 1.3: A schematic of the alternative splicing process. Adapted from Matera et
al. (Matera and Wang, 2014)
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Figure 1.3 illustrates the splicing process from start to end. The catalytic process
of alternative splicing can be considered to take place in two steps, however prior
to catalysis the spliceosome must assemble. This begins with two of the spliceoso-
mal subunits, U1 and U2, assembling onto the pre-mRNA co-transcriptionally. The
Carboxy-Terminal Domain (CTD) of RNA polymerase II possibly mediates this pro-
cess (Go¨rnemann et al., 2011; Wiesner et al., 2002; Morris and Greenleaf, 2000).
Next, U1 and U2 interact to form the pre-spliceosome, also known as Complex A.
The U4-U6.U5 tri-snRNP complex is then recruited to Complex A, leading to the
formation of Complex B. Complex B releases two spliceosomal subunits, U1 and U4
(Raghunathan and Guthrie, 1998), and undergoes rearrangements to form catalyti-
cally active Complex B*. The spliceosome is now finally ready to begin catalysing
a splicing reaction. The first step of the splicing reaction (Step I or ‘branching’)
generates Complex C. Complex C contains free exon1 and the intron-exon2 lariat
intermediate. Complex C then undergoes rearrangements and carries out Step II,
leading to the formation of the post spliceosomal complex. The post spliceosomal
complex contains the lariat intron and the spliced together exons. The post spliceo-
somal complex then dissembles, releasing the spliced product.
A question that is likely to arise from this description is how the spliceosome
is able to recognise where it should assemble on the pre-mRNA and thus which
sequences it should splice out and which sequences should be retained in the final
mature mRNA. The DNA sequence at splice sites (the locations on the pre-mRNA
where the splicesome assembles) is not random. In the nucleus, introns typically
begin with a GT and end with an AG (Breathnach et al., 1978). As the number of
splice sites studied increased, it was recognised that there were a number of consensus
splice site sequences, although the consensus sequences are not universal and vari-
ations have been observed (Mount, 1982). With the advent of genomic sequencing,
software to predict splice sites based on genomic sequence was developed. Whilst
this has been extremely useful in terms of enabling scientists to study alternative
splicing on a genome wide scale, predicting splice sites based on sequence is not
trivial and is likely to be error prone (Mount, 2000). However, although predicting
splice sites based on sequence is challenging for humans and computers, the sequence
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at splice sites is recognised by components of the spliceosome and thus determines
where alternative splicing should take place. The 5’ splice site, located at the start of
the intron, is recognised by the U1 snRNP, both by base pairing with the U1 snRNA
and in a base pairing independent manner by the U1C subunit of U1 snRNP (Du
and Rosbash, 2002). The 3’ splice site, located at the end of the intron, is recognised
by the U2 snRNP and other associated splicing factors (Matera and Wang, 2014).
1.4 History of alternative splicing
Alternative splicing was independently discovered in 1977 by Berget et al. and
Chow et al. (Berget et al., 1977; Chow et al., 1977). The discovery was made
by studying hybridisation reactions between single stranded adenovirus DNA and
its complementary RNA. The formation of single stranded DNA loops, interspersed
between lengths of RNA-DNA hybridisation, were observed by electron microscopy.
These loops corresponded to introns. Based on these observations, a mechanism in
which lengths of RNA were ‘spliced’ out of mature mRNAs was proposed to explain
the observation that the length of DNA sequence corresponding to a gene is often
much longer than the length of the transcribed mRNA (Berget et al., 1977).
Two years later, a study by Lerner et al. into two antibodies produced by sys-
temic Lupus patients found that the antibodies pulled down six snRNPs (Lerner
and Steitz, 1979). Lerner et al. identified that the six snRNPs formed a complex
with one another, likely making this the first time that the spliceosome was exper-
imentally isolated. The observation that one of the six snRNP’s (U1’s) RNA has
a complementary nucleotide sequence to many splice sites led some to suggest that
the isolated snRNP complex might play a role in alternative splicing (Lerner et al.,
1980). In the years that followed, further studies confirmed that the other snRNPs
in the complex played a role in splicing (Black et al., 1985; Krainer and Maniatis,
1985; Berget and Robberson, 1986; Grabowski and Sharp, 1986).
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Figure 1.4: A timeline of the major events in splicing research.
Development of in vitro splicing assays enabled further biochemical insights into
the process of alternative splicing (Shi, 2017). In vitro assays identified that ATP and
Mg2+ were necessary for alternative splicing (Hernandez and Keller, 1983; Hardy
et al., 1984) and confirmed the existence of an intron lariat intermediate (Grabowski
et al., 1984; Padgett et al., 1984; Ruskin et al., 1984). Non-denaturing gel elec-
trophoresis experiments identified that the spliceosome formed several distinct com-
plexes throughout the splicing reaction (Lamond et al., 1987; Konarska and Sharp,
1986, 1987; Pikielny et al., 1986; Cheng and Abelson, 1987; Bindereif and Green,
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1987).
Further biochemical experiments studying the interactions and spatial location of
spliceosome components enabled researchers to build a simple ‘map’ of the spliceo-
some and furthered the field’s mechanistic understanding of the chemical processes
behind alternative splicing (Shi, 2017; Newman and Norman, 1991; Madhani and
Guthrie, 1992; Wassarman and Steitz, 1992; Wyatt et al., 1992; Lesser and Guthrie,
1993; Sontheimer and Steitz, 1993; Anokhina et al., 2013; Newman et al., 1995).
Microscopy based approaches were also used to study the structure of the spliceo-
some. Due to the highly dynamic nature of the spliceosome, it is almost impossible
to crystallise spliceosome complexes (Shi, 2017). Consequently, X-ray crystallogra-
phy based approaches have had some success in studying some of the subcomplexes
and components of the spliceosome (Sickmier et al., 2006; Lin and Xu, 2012; Jenkins
et al., 2013; Yoshida et al., 2015; Leung et al., 2011; Zhou et al., 2014; Montemayor
et al., 2014; Weber et al., 2010; Pomeranz Krummel et al., 2009; Kondo et al., 2015;
Price et al., 1998), but a fully assembled spliceosome has never been successfully
crystalised. Electron microscopy approaches have had more success, and have been
used to successfully study the structure of many of the spliceosomal complexes (Be-
hzadnia et al., 2007; Furman and Glitz, 1995; Boehringer et al., 2004; Wolf et al.,
2009; Deckert et al., 2006; Bessonov et al., 2010; Golas et al., 2010; Jurica et al.,
2004; Ilagan et al., 2013; Fabrizio et al., 2009; Ohi et al., 2007; Chen et al., 2014).
However, these studies only had moderate resolutions, meaning the structural insight
that could be gained from them was limited. A real breakthrough came in 2015, when
cryo-EM studies of the spliceosome enabled structural study of the spliceosome at
atomic level resolutions (Yan et al., 2015; Hang et al., 2015). The cryo-EM studies
of 2015 and after have given researchers a new level of mechanistic insight into the
biochemical splicing reaction (Yan et al., 2015; Hang et al., 2015; Agafonov et al.,
2016; Yan et al., 2016; Wan et al., 2016b,a; Galej et al., 2016; Yan et al., 2017; Fica
et al., 2017; Rauhut et al., 2016; Bertram et al., 2017; Nguyen et al., 2016; Zhang
et al., 2018; Haselbach et al., 2018; Zhang et al., 2019).
In parallel to the biochemical study of the mechanistic process of alternative
splicing, since the advent of whole genome sequencing alternative splicing has also
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been studied at a genomic level. Initially, DNA sequence was annotated using gene
annotation software, which made predictions about gene structure including splice
sites and promoters (Mount, 2000; Reese et al., 2000). Later, reads from RNA-seq
experiments enabled researchers to verify gene and isoform structure predictions,
make new predictions, and to quantify the relative abundance of each splice isoform
(Weber, 2015). Whilst methods for quantifying isoform abundance or predicting
gene structure based on sequencing reads remain far from perfect (Ho¨lzer and Marz,
2019; Everaert et al., 2017), it is fair to say that sequencing technologies have given
us a level of insight into splicing which was previously unimaginable.
1.5 Alternative splicing and disease
Alternative splicing defects have been linked to many human diseases, including
Duchenne Muscular Dystrophy (Muntoni et al., 2003), Early Onset Parkinson Disease
(Samaranch et al., 2010), Retinitis pigmentosa (Tanackovic et al., 2011; Cvacˇkova´
et al., 2014) and cancer (David and Manley, 2010). Furthering our understanding of
how splicing is regulated at a cellular level is likely to be relevant to the therapeutic
treatment of many diseases in which splicing errors play a role.
It is perhaps unsurprising that splicing has been implicated in such a wide range
of diseases given that a study by Lopez-Bigas et al. suggests that in humans, up to
60% of disease causing mutations affect splicing (Lo´pez-Bigas et al., 2005). Related
studies suggested that one third of all mutations (Lim et al., 2011), and one quarter
of all coding mutations (Sterne-Weiler et al., 2011) impact splicing. Clearly these
numbers can differ quite substantially depending on the type of mutation investigated
and the methodology used, however they do all support the hypothesis that a high
proportion of mutations alter splicing. An additional hypothesis for why splicing
is implicated in so many human diseases is that mutations which alter splice sites
can dramatically change the protein produced from the parent gene. In contrast,
non-splice site mutations have a moderate likelihood of having a small or no impact
on the protein structure produced. Such mutations are unlikely to produce a disease
phenotype.
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1.6 What is scRNA-seq?
scRNA-seq is a relatively new sequencing technology in which RNA molecules are
captured from individual cells and sequenced. scRNA-seq has the potential to give
deep insight into how alternative splicing is regulated in individual cells across the
entire transcriptome. However, this is only possible if splicing analyses are not con-
founded by the high degree of technical noise in scRNA-seq data. I will begin my
discussion of the current state of scRNA-seq based approaches by considering the
history of scRNA-seq.
1.7 History of scRNA-seq
Figure 1.5 is a timeline of some of the major events in the scRNA-seq’s short history.
Our timeline begins with the first published scRNA-seq experiment in 2009, when
Tang et al. performed scRNA-seq on a handful of mouse blastomeres and oocytes
(Tang et al., 2009). In their study, Tang et al. noted that 8-19% of known genes with
two or more isoforms expressed at least two isoforms in individual cells, showing that
there has been an interest in studying alternative splicing in individual cells from
the first scRNA-seq experiments.
Our next major event comes a year later, when Guo et al. took an array based
approach to profile the expression of 48 genes in approximately 500 cells (Guo et al.,
2010). Although this was not an scRNA-seq experiment, it had an important impact
on the single cell community. Guo et al. demonstrated that they could use the
expression of their 48 profiled genes to identify each cell’s cell type. The idea that a
cell’s identity can be determined by the expression of a selection of its genes is a key
part of the philosophy of modern scRNA-seq clustering algorithms.
In 2011, Islam et al. developed STRT-seq, a multiplexed scRNA-seq protocol
(Islam et al., 2011). This was revolutionary because it enabled researchers to se-
quence hundreds or thousands of cells in a single experiment, whereas previously most
scRNA-seq experiments sequenced tens of cells, if not fewer (Tang et al., 2009, 2010).
A year later, an scRNA-seq protocol called SMART-seq was published (Ramsko¨ld
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Figure 1.5: Timeline of selected events in the history of scRNA-seq.
et al., 2012). SMART-seq was the first ‘full-length’ scRNA-seq protocol, so called
because the protocol attempted to sample reads across the full length of transcripts
and thus reduce the 3’ bias observed in previous protocols. In practice, SMART-seq
is not entirely free from 3’ bias although it is reduced (Picelli, 2017). A newer pro-
tocol called SMART-seq2 has further reduced coverage bias, although again the bias
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is not fully eliminated (Picelli et al., 2014). The development of ‘full-length’ proto-
cols is important for studying alternative splicing using scRNA-seq. Protocols which
only sequence one end of each transcript are unable to distinguish between isoforms
whose exon usage differs only at the other end of the transcript. Such protocols are
therefore of limited use for alternative splicing studies.
It is challenging to obtain intact isolated cells from some tissues, such as neural
progenitor cells and dental gyrate. Consequently, scRNA-seq can be difficult in these
tissues. This problem was overcome in 2013 by Grindberg et al., who developed an
scRNA-seq protocol in which nuclei rather than whole cells were sequenced (Grind-
berg et al., 2013). This enabled neurobiologists to apply scRNA-seq to their studies
in a widespread manner. It was also exciting news for those interested in studying
alternative splicing, as alternative splicing is known to be widespread in the human
brain and to correlate with brain development and neuronal differentiation (Su et al.,
2018).
2013 could be regarded as a turning point in scRNA-seq’s history. Following tech-
nological advances in 2013 and in previous years, scRNA-seq was crowned Nature
Method of The Year 2013 (NatMethods, 2014). By the start of 2014, scRNA-seq had
advanced to a point where a sufficiently large number of cells could be sequenced
to perform meaningful statistical analyses (ie. over one hundred cells) and the ex-
perimental protocols were reasonably accessible for many labs. This heralded the
beginning of an explosion in the number of scRNA-seq publications.
The next major event on our timeline is the development of droplet based scRNA-
seq methods. Droplet based scRNA-seq methods capture cells for sequencing in
droplets and changed the field by enabling hundreds of thousands and eventually
millions of cells to be sequenced in a single experiment. The first two droplet based
methods were Drop-seq and InDrop, which were published in the same issue of Cell
in 2015 (Klein et al., 2015; Macosko et al., 2015). Two years later, 10X Genomics
released their droplet based protocol (Zheng et al., 2017). Due to the low cost
and user friendly nature of 10X’s platform, 10X is currently the dominant player in
scRNA-seq.
Whilst this thesis was being written, a new scRNA-seq library preparation proto-
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col called SMART-seq3 was released (Hagemann-Jensen et al., 2019). SMART-seq3
is the first technology to combine full length reads and reads containing Unique
Molecular Identifiers (UMIs) and has therefore been greeted with excitement by the
scRNA-seq community.
At the time of writing, a range of scRNA-seq protocols are widely in use and new
protocols are still being developed. Identifying which of these protocols are likely to
be applicable to studying alternative splicing is an important goal of my thesis.
1.8 A generalised scRNA-seq protocol
Figure 1.6 is a flowchart for a generalised scRNA-seq protocol. In this section I
will discuss each step of the generalised protocol and how some steps differ between
protocols.
The first step of our generalised protocol is cell capture and lysis. Broadly speak-
ing, scRNA-seq protocols can be split into three groups depending on their mecha-
nism of cell capture:
1. Microwell based capture methods. In these methods, cells are captured in wells
using lasers, pipettes or Fluorescent Activated Cell Sorting (FACS) (Lafzi et al.,
2018; Svensson et al., 2018). Using FACS for sorting has two major advantages
- firstly FACS methods often lend themselves well to automation and secondly,
FACS based methods allow researchers to enrich for cells of a particular cell
type.
2. Microfluidics based capture methods. These technologies capture cells in nano-
liter reaction volumes in an automated fashion, lending themselves well to
medium sized experiments (order of 1000 cells) (Lafzi et al., 2018; Svensson
et al., 2018).
3. Droplet based capture methods. These are the newest methods in which cells
are captured in nanoliter droplet emulsions (Svensson et al., 2018). Very large
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Figure 1.6: Flowchart of a generalised scRNA-seq protocol.
numbers of cells can be captured in these experiments (order of 10,000 cells
and greater), making them best suited to large scale experiments.
Once they have been captured, cells are lysed in their wells/reaction volumes/droplets.
In the next step of our protocol RNA is captured from each cell. All of the scRNA-
seq protocols I will consider in my thesis capture poly(A) tailed mRNAs, typically
using poly(T) oligonucleotides (Lafzi et al., 2018). The captured RNA is converted
to cDNA prior to amplification in Step 3. All of the protocols considered in my the-
sis use PCR to amplify the harvested cDNA although protocols which use in vitro
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transcription as their amplification method also exist (Svensson et al., 2018). Any
final library preparation steps take place and the libraries are sequenced in Step 4. In
Step 5, the obtained sequences can be computationally analysed. Typically this will
involve some form of reads alignment and gene or isoform quantification, followed
by a single cell specific analysis. Some typical analyses are considered in the next
section.
1.9 Typical applications of scRNA-seq
In this section, I give a brief overview of a selection of popular scRNA-seq applica-
tions. All of the applications below are typically run using gene rather than isoform
level expression estimates. In theory, these applications could be used with isoform
level expression estimates. Uncertainty over the feasibility of isoform quantification
in scRNA-seq and ability to detect isoforms in scRNA-seq data are two likely rea-
sons that these applications are usually run with gene level expression estimates.
In addition, gene level quantification is sufficient for many scRNA-seq experiments.
For example, if the goal of an scRNA-seq experiment is to identify cell types in a
blood sample, gene level quantification estimates are likely to enable accurate cell
type identification.
1.9.1 Clustering
Guo et al.’s pioneering experiments identifying cells based on their gene expression
gave rise to perhaps the most popular application of scRNA-seq (Guo et al., 2010).
Clustering is now considered to be an essential step of many scRNA-seq experiments
and is typically used to attempt to infer cell identities based on gene expression
(Luecken and Theis, 2019; Petegrosso et al., 2019). This is not trivial. Technical
noise is a major issue in scRNA-seq, and if not appropriately corrected for, technical
noise rather than biological signal can dominate clusters (Luecken and Theis, 2019).
Clustering approaches and ideas about cell types have played a role in motivating
large scale scRNA-seq projects such as the Human Cell Atlas. The goal of the Human
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Cell Atlas project is to provide a catalogue of the cell types present in the human
body and a map of the relationships between them (Regev et al., 2017). Projects
such as the Human Cell Atlas are likely to lead to an increased understanding of what
a typical human looks like at a cellular level, and may help answer questions such
as: ‘How many cell types are there in a typical human?’. In addition, the Human
Cell Atlas will provide a valuable resource to the scientific community.
1.9.2 Pseudotime
It may not always be possible to separate a population of cells into discrete types.
For example, a differentiating population of cells may lie along a continuum between
two cell types, rather every cell being entirely one cell type or the other. Unlike clus-
tering algorithms, which attempt to cluster cells into discrete cell types, pseudotime
algorithms attempt to order cells along a linear or branching topological continuum
based on similarity of expression (Saelens et al., 2019).
1.9.3 Differential expression
Identifying differences in gene expression between two populations of cells is a pop-
ular application of scRNA-seq. Differential expression analyses pre-existed scRNA-
seq and a number of software tools for differential expression in bulk RNA-seq exist
(Costa-Silva et al., 2017). However, there are substantial differences between bulk
and scRNA-seq, most notably the much higher degree of technical noise present
in scRNA-seq relative to bulk. Therefore it was not clear whether differential ex-
pression software designed for bulk RNA-seq would give accurate results when run
on scRNA-seq (Luecken and Theis, 2019; Soneson and Robinson, 2018b). A recent
benchmark found that bulk RNA-seq differential expression software did not per-
form more poorly on scRNA-seq than differential expression software that had been
designed for scRNA-seq (Soneson and Robinson, 2018b). However, some bulk RNA-
seq differential expression softwares were more sensitive to pre-filtering of genes than
scRNA-seq softwares (Soneson and Robinson, 2018b).
27
1.9.4 Network modelling
Network modelling approaches represent biological systems as nodes and edges, where
nodes can represent genes, proteins or other biological molecules, and edges can
represent binding, enzymatic reactions, or other types of interaction (Blencowe et al.,
2019). Network modelling is a classic systems biology approach that attempts to
understand a complex system. Traditionally, network modelling has relied on bulk
genomic data, and attempts to apply network modelling approaches to scRNA-seq
data are relatively recent. A benchmark study found that network methods designed
for bulk RNA-seq performed extremely poorly when run on scRNA-seq data (Chen
and Mar, 2018). This is likely to reflect the substantial differences between bulk
and scRNA-seq data. The high rate of technical dropouts, more dramatic batch
effects and much larger dimensionality of scRNA-seq compared with bulk RNA-seq
are possible reasons that bulk methods performed poorly on scRNA-seq (Blencowe
et al., 2019). Despite these challenges, a large number of scRNA-seq methods for
network analysis have been developed. However, in the benchmark above three
scRNA-seq network analyses were considered in addition to the bulk approaches,
and the performance of the scRNA-seq approaches was also generally poor (Chen
and Mar, 2018). This indicates a need for further, larger benchmarks to establish
whether scRNA-seq network methods with good performance exist. If they do not,
research into which features of scRNA-seq data make network analyses so challenging
would be informative.
1.10 Technical noise in scRNA-seq
A major issue when analysing scRNA-seq data is the high degree of technical noise
relative to bulk RNA-seq. In this section I will discuss some of the main types of
technical noise that are commonly seen in scRNA-seq. An understanding of the tech-
nical noise present in scRNA-seq data is crucial when analysing scRNA-seq data, as
failing to recognise and correct for technical noise can lead to inappropriate analyses
being performed, generating misleading results.
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1.10.1 Read quality
As in any sequencing technology, issues relating to read quality are a source of
technical noise in scRNA-seq. Tools such as FastQC can be used to investigate a
variety of read quality metrics and establish the degree to which read quality is
likely to be a significant source of technical noise (Andrews, 2015). Tools such as
cutadapt can be used to trim unwanted sequencing adapters from reads, improving
the accuracy of alignment (Martin, 2011).
1.10.2 Multiplets and empty wells
The goal of scRNA-seq is to sequence individual cells. However, the cell capture and
isolation process is not perfect for any protocol. A common problem is that cells
will sometimes clump together, so that multiple cells (’multiplets’) end up in one
well or droplet, depending on the sequencing protocol. Another common problem is
that some wells or droplets contain no cells. These empty wells or droplets do still
typically contain RNA, originating cells that lysed prematurely before capture.
As the goal of scRNA-seq is to sequence individual cells, multiplets and empty
wells or droplets should be removed prior to analysing the data, leaving only ’singlets’
(wells or droplets containing only one cell). There are a variety of methods for
removing multiplets and empty wells or droplets from scRNA-seq datasets (Zappia
et al., 2018). Perhaps the simplest method is to plot the dataset’s distribution
of library size and use the distribution to determine which cells are singlets and
should be kept. If the dataset contains a large number of multiplets and empty cells,
typically multiple peaks can be seen in the library size distribution. The first peak
lies close to zero and corresponds to wells or droplets which didn’t capture any cells.
These empty cells should be removed. The second peak corresponds to the average
library size of a singlet. These cells should be kept. Typically, the multiplet peaks
will appear at multiples of the average library size of singlet. These multiplets should
be removed.
More sophisticated tools for identifying multiplets and empty wells and droplets
also exist (Ilicic et al., 2016; DePasquale et al., 2018; Wolock et al., 2019). If the
29
dataset under consideration contains genetically heterogeneous cells, genetic infor-
mation can be used to resolve between singlets and multiplets (Kang et al., 2018).
A new technology called Cell Hashing, in which oligo-tagged antibodies are used
to label distinct cell populations, enables oligo information to be used to facilitate
multiplet identification (Stoeckius et al., 2018).
1.10.3 Unwanted Biological Noise
Usually the aim of a scRNA-seq experiment is to detect biological signal. However,
sometimes some of the biological noise present can confound the biological signal we
are trying to detect. For example, during cell isolation and lysis, some cells become
stressed and die. The stressed cells activate apoptosis pathways, altering their tran-
scriptional profile. This is a strong biological signal with the potential to confound
downstream analyses. Therefore, these cells should normally be removed. When
dying cells lyse, cytoplasmic RNA leaks out of the cells, whereas mitochondrial RNA
is relatively protected because it is encapsulated by the mitochondrial memberanes.
Therefore, stressed and dying cells are commonly identified based on the proportion
of each cell’s sequencing library made up of mitochondrial reads (Luecken and Theis,
2019).
If an scRNA-seq dataset is made up of cells in a variety of cell cycle stages, it is
common for clustering algorithms to cluster cells by their cell cycle stage, potentially
hiding undetected subpopulations of cells. Buettner et al developed software that
attempts to correct gene expression based on cell cycle stage, thus removing this
confounder (Buettner et al., 2015).
1.10.4 Dropouts
Dropouts are a phenomenon where genes or isoforms for which high expression is
detected in some cells are not detected as expressed at all in other cells (Kharchenko
et al., 2014). This can occur for biological reasons. For example, if a mixture of cell
types is sequenced, and a gene of interest is expressed in some cell types but not
others, there will be biological dropouts in the scRNA-seq data. Alternatively, if a
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gene has ‘bursty’ expression, so each cell sometimes switches that gene’s transcription
‘ON’ and at other times does not express the gene at all, it is likely that the gene
will exhibit biological dropouts in scRNA-seq data.
However, it is now known that a substantial proportion of dropouts in a typical
scRNA-seq experiment are technical in origin. In this thesis, I will define the cap-
ture efficiency of an scRNA-seq experiment as the proportion of expressed genes (or
isoforms) in a cell that are detected as expressed by scRNA-seq, ie.:
CaptureEfficiency =
NumberOfGenesDetected
NumberOfGenesExpressed
It has been shown that the capture efficiency of scRNA-seq can be 10% or less
(Marinov et al., 2014; Svensson et al., 2017; Islam et al., 2014). In an scRNA-seq
experiment with a capture efficiency of 10%, only about 10% of transcripts in a cell
generate sequencing reads. Consequently, a high percentage of expressed genes and
isoforms will not be detected as expressed. Dropouts that occur due to a failure
to capture reads from expressed transcripts are known as technical dropouts, and
are a major source of technical noise. In addition to the low capture efficiency of
scRNA-seq, technical dropouts can also occur if cells are very shallowly sequenced.
Sequencing cells at low read depths is more common in droplet based protocols, and
sometimes occurs due to financial considerations.
How best to correct for technical dropouts is an area of ongoing research. A
common approach for attempting to correct for technical dropouts is imputation.
Imputation approaches use mathematical modelling approaches to attempt to predict
which dropouts are technical, and convert these zero values to their predicted ‘true’
values. A recent benchmark found that many imputation methods introduce false
positives, illustrating that the problem of correcting for technical dropouts is not yet
fully solved (Andrews and Hemberg, 2018b).
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1.10.5 Batch effects
Batch effects occur due to technical variability between samples. Batch effects are not
exclusive to scRNA-seq, they are also commonly corrected for in bulk RNA-seq (Fei
et al., 2018). However batch effects are more complex and thus more challenging to
correct for in scRNA-seq, where each cell can be regarded as a sample and therefore
a batch (Tung et al., 2017).
Methods to correct for batch effects in scRNA-seq experiments exist, however they
are only effective if the experiment has been appropriately designed. Importantly,
if the different biological conditions being tested entirely overlap with batch effects,
the experiment is confounded and it will be impossible to correct for batch effects.
For example, if an experiment with two conditions, A and B, is performed, and cells
in condition A are sequenced in one lab and cells in condition B are sequenced in
another lab, it is impossible to determine whether differences between A and B are
due to the condition or the lab. The experiment is therefore completely confounded
by batch effects. If cells in each condition had been split between the two labs, batch
correction would have been possible.
Reasons batch effects can occur in scRNA-seq include:
1. Samples were prepared in different facilities
2. Samples were prepared at different times
3. Samples were prepared by different people
4. Samples were sequenced at different depths
5. Samples were prepared using different reagents
6. Samples were sequenced in different lanes
7. Samples were prepared on different plates
8. Samples were prepared in different wells
9. Pipetting errors during library preparation
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Reasons 1-7 can sometimes (though not always) be avoided with good experi-
mental design. Reasons 8 and 9 can lead to batch effects between cells sequenced in
the same run and are almost impossible to fully avoid.
Some of the reasons above generate more technical noise than others and are thus
more important to correct for. For example, plate based and well based effects tend
to be very minor, whereas having different people prepare samples can lead to more
substantial noise, especially if their interpretation of how to follow the experimental
protocol differs. Unfortunately, it is usually impossible to design a perfect experi-
ment entirely unconfounded by batch effects, especially when dealing with rare or
perishable samples. The goal should therefore be to minimise confounding factors as
far as possible, and to recognise what confounders are likely to remain when inter-
preting results. A number of batch correction methods exist and should be used to
correct for batch effects where possible. Based on a benchmark comparing scRNA-
seq pipelines, Tian et al. recommended MNNs as a good general method (Tian et al.,
2019; Haghverdi et al., 2018).
1.10.6 PCR amplification bias
Like batch effects, PCR amplification bias is not unique to scRNA-seq. PCR amplifi-
cation bias exists in any protocol which involves a PCR amplification step. However,
due to the small amount of starting material in scRNA-seq experiments, PCR ampli-
fication bias is more dramatic in scRNA-seq compared to eg. bulk RNA-seq (Smith
et al., 2017).
Unique Molecular Identifiers (UMIs) have largely corrected for PCR amplification
bias in some scRNA-seq protocols. UMIs are unique barcodes that are added to
cDNA molecules prior to PCR amplification (see Figure 1.7) (Islam et al., 2014).
After sequencing, the combination of the transcript identity and the UMI can be
used to estimate how many copies of the transcript were originally captured.
Errors can occur during UMI deduplication, especially if there is a sequencing
error in the UMI barcode or if the same UMI sequence binds to more than one
cDNA molecule originating from the same gene. However, provided that the UMIs
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Figure 1.7: Schematic illustrating how addition of UMIs enables us to correct for
PCR amplification bias.
are 8 bases or longer (Islam et al., 2014), these errors are usually relatively minor
compared to the bias that would be introduced by not correcting for PCR amplifica-
tion. Methods exist that attempt to correct for UMI errors (Petukhov et al., 2018;
Smith et al., 2017). Unfortunately, UMIs are not compatible with all scRNA-seq
protocols, and in particular are not compatible with full-length protocols such as
SMART-seq2. Given full-length protocols are likely to be best suited to studying
alternative splicing, that we are unable to effectively correct for PCR amplification
bias in these protocols is concerning.
1.11 Previous attempts to study alternative splic-
ing using scRNA-seq
In the first published scRNA-seq study, Tang et al. noted that 8-19% of known genes
with two or more isoforms expressed at least two isoforms in individual cells (Tang
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et al., 2009). There has therefore been an interest in studying alternative splicing in
individual cells since the first days of scRNA-seq. A common approach taken in later
studies was to identify genes expressing multiple isoforms in bulk RNA-seq data and
to ask how many isoforms were detected from these genes in individual cells using
matched scRNA-seq data. These studies found that typically, only one or a few
isoforms were detected in individual cells using scRNA-seq, even if multiple isoforms
were detected using bulk RNA-seq (Shalek et al., 2013; Zhao et al., 2016; Marinov
et al., 2014; Song et al., 2017). However, these studies typically did not consider
dropouts, or if they did attempt to correct for dropouts used approximations that
now seem inappropriate, given the field’s greater understanding of dropout modelling
(Marinov et al., 2014). As dropouts impair our ability to detect expressed isoforms
and the goal was to count the number of expressed isoforms in each cell, this raises
questions about the accuracy of these studies’ findings. In addition, the bioinfor-
matic methods to detect isoforms used in these studies had not been independently
benchmarked for their performance on scRNA-seq data, raising another potential
confounder in these analyses.
In addition to scRNA-seq studies attempting to answer fundamental molecular
biology questions about alternative splicing, there have been a small number of stud-
ies where scRNA-seq has been used to study alternative splicing to answer questions
from other areas of biology. For example, a recent study of a neuronal scRNA-seq
dataset investigated the splicing patterns of neurexins, synaptic organisers which
have thousands of isoforms, and found that developmentally related cell types had
shared patterns of neurexin isoform expression (Lukacsovich et al., 2019). However,
the overall number of publications investigating alternative splicing using scRNA-seq
is low. This is likely to reflect uncertainty over what confounders are present when
trying to study alternative splicing using scRNA-seq, and how best to correct for
these confounders.
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1.12 Approaches for studying alternative splicing
with RNA-seq data
It is rare to study alternative splicing using scRNA-seq data, but far more common
to study splicing using bulk RNA-seq data. Indeed, a large number of software tools
have been developed to enable splicing analyses using bulk RNA-seq data (Li and
Dewey, 2011; Roberts and Pachter, 2013; Bray et al., 2016; Patro et al., 2017, 2014;
Trapnell et al., 2010). There are two common approaches to studying alternative
splicing using bulk RNA-seq data. The first is isoform quantification, in which the
goal is to determine the magnitude of expression of splice isoforms. RSEM, Salmon
and Kallisto are examples of popular isoform quantification software tools (Li and
Dewey, 2011; Bray et al., 2016; Patro et al., 2017). The second approach is some-
times described as an ‘exon centric’ approach. Instead of attempting to quantify the
expression of entire isoforms, a ratio or percentage is calculated for each exon, based
on the percentage of reads spanning the exon in which the exon is spliced in versus
the percentage of reads spanning the exon in which the exon is spliced out. MISO
is a popular example of the ‘exon centric’ approach (Katz et al., 2010). In my the-
sis, I have exclusively considered isoform quantification based approaches. My main
reason for doing this is that whilst it can be interesting to find the ratio at which
an exon is spliced in or out, it would usually be more interesting to know unambigu-
ously which isoforms were produced from the parent gene. From a basic biology and
disease perspective, we are often most interested in alternative splicing as a mecha-
nism for generating multiple protein structures from a single gene. If we know which
isoforms were produced, we have some chance of inferring which proteins might have
been translated. If we only have information at the level of exons, it can be far
harder to infer protein information. Therefore, I focus on isoform quantification in
my feasibility assessment.
It is recognised that isoform quantification is a hard problem (Garber et al., 2011;
Finotello and Di Camillo, 2015; Zhang et al., 2017). Despite a range of strategies hav-
ing been developed to quantify isoforms (Li and Dewey, 2011; Roberts and Pachter,
2013; Bray et al., 2016; Patro et al., 2017, 2014; Trapnell et al., 2010; Huang and
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Sanguinetti, 2017), in benchmarks no strategy is found to perform perfectly (Ger-
main et al., 2016; Teng et al., 2016). Previous scRNA-seq studies have detected one
or a small number of isoforms in individual cells for most genes, even if multiple iso-
forms were detected in matched bulk RNA-seq data (Shalek et al., 2013; Zhao et al.,
2016; Marinov et al., 2014; Song et al., 2017). If these observations are accurate,
they suggest that isoform quantification may be simpler using scRNA-seq compared
to bulk RNA-seq data due to fewer multi-mapping reads. However, at present most
scRNA-seq publications quantify reads at a gene rather than an isoform level, prob-
ably due to uncertainty over best practices when quantifying at an isoform level.
Although many isoform quantification tools are available for bulk RNA-seq, when
I began my thesis it was unclear whether these tools would perform well when run
on scRNA-seq. For tasks such as normalisation and network modelling, it has been
found that methods designed for bulk RNA-seq do not give accurate results when
run on scRNA-seq (Vallejos et al., 2017; Chen and Mar, 2018). Therefore, there
was a possibility that new software would need to be developed to enable accurate
isoform quantification using scRNA-seq.
Although there is currently no perfect strategy for quantifying isoforms (Germain
et al., 2016; Teng et al., 2016), existing methods are considered to be sufficiently
accurate to enable many studies to analyse alternative splicing using bulk RNA-seq.
An important observation from bulk RNA-seq studies is that most genes produce a
‘major’, more highly expressed isoform and one or more ‘minor’, less highly expressed
isoforms (Wang et al., 2008; Gonza`lez-Porta et al., 2013). How splicing is regulated
in individual cells to generate this pattern at the tissue level is not well understood.
One hypothesis is that cells exclusively express either the major or the minor isoform,
and that more cells express the major isoform than the minor isoform. A second
hypothesis is that all cells express both isoforms, and transcribe more copies of
the major than the minor isoform. Theoretically, scRNA-seq could enable us to
determine the extent to which each of these hypotheses are true by resolving which
isoforms are present in individual cells. However, such an approach would rely upon
it being possible to accurately resolve isoforms in individual cells using scRNA-seq.
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1.13 smFISH as an orthogonal approach for study-
ing alternative splicing at a cellular resolu-
tion
The main orthogonal approach to scRNA-seq for studying splicing in individual cells
is smFISH. In smFISH approaches, cells are fixed and permeabilised. The cells are
then hybridised with multiple short fluorescently labeled DNA probes (Femino et al.,
1998; Haimovich and Gerst, 2018). The probes have complementary sequences to
the targeted RNA species, and together the probes typically span the length of the
target transcript. In the permeabilised cell, the probes preferentially hybridise to the
target RNA molecule, generating spots of high intensity fluorescence corresponding
to target RNA molecules. An advantage of smFISH based approaches is that spatial
information (ie. the location of transcripts within the cell) can be obtained, whereas
this is not possible using scRNA-seq.
There are two main challenges for using smFISH to study alternative splicing.
The first is that it is technically challenging to design fluorescent probes that would
enable smFISH to resolve between highly similar isoforms. Previous smFISH studies
which have resolved isoforms from the same parent gene have typically used isoforms
with large unique regions to overcome this problem (Ciolli Mattioli et al., 2019; Waks
et al., 2011; Velten et al., 2015). A variant on smFISH has been developed which
enables smFISH to resolve between transcripts which only differ at a single nucleotide
variant (SNV) (Levesque et al., 2013). Whether this or a related approach could be
adapted to resolve between highly similar isoforms remains to be seen, to the best
of my knowledge it has never been attempted.
The second challenge for studying alternative splicing using smFISH is through-
put. Traditionally smFISH has been a low throughput technology. Consequently,
in previous smFISH experiments investigating how many isoforms are produced per
gene per cell, only a handful of genes were investigated (Ciolli Mattioli et al., 2019;
Waks et al., 2011; Velten et al., 2015). Whilst these experiments delivered splicing
insights for the particular genes investigated, they did not deliver much general in-
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sight into the cellular process of alternative splicing across the entire transcriptome.
In this respect, using scRNA-seq to study splicing delivers a major advantage over
smFISH based approaches. However, the throughput of smFISH based approaches
has improved in recent years (Eng et al., 2019; Moffitt et al., 2016). If the throughput
continues to improve, it may one day become possible to validate transcriptome wide
predictions from RNA-seq experiments using smFISH data.
1.14 Is it possible to study alternative splicing us-
ing scRNA-seq?
If we are not concerned about the accuracy of our measurements, it obviously is
possible to ‘study’ alternative splicing using scRNA-seq in the sense that there is
nothing to stop us running scRNA-seq data through an alternative splicing bioinfor-
matics pipeline. However, as researchers we are hopefully concerned about whether
the experiments we perform produce meaningful results. I consider a meaningful re-
sult to be a result for which we either have high confidence that the result is correct,
and/or for which we have a very good estimate of the error. If the error rate is very
high, it may still be challenging to draw biologically valid conclusions from our data,
even if we understand the errors in our data very well.
At the start of my PhD, I consider that the following questions were unanswered:
1. Do isoform quantification software tools designed for bulk RNA-seq give accu-
rate measurements when run on scRNA-seq?
2. What impact does the number of cells sequenced and the number of reads
sequenced per cell have on isoform quantification in scRNA-seq?
3. To what extent do isoform quantification errors confound alternative splicing
analyses in single-cell RNA-seq?
4. To what extent do dropouts confound alternative splicing analyses in scRNA-
seq?
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5. Could isoform choice within cells confound alternative splicing analyses in
scRNA-seq?
6. To what extent is it possible to distinguish between biological signal and tech-
nical noise when studying alternative splicing using scRNA-seq?
As a consequence of not knowing the answer to these questions, we had no clear
idea what errors we might encounter when studying alternative splicing using scRNA-
seq. Of course, this does not mean it is impossible to perform an alternative splicing
analysis with scRNA-seq data, as many have previously done. But it does mean that
after running such an analysis, it is hard to say how much confidence we can have
in the results of the analysis, because we do not understand what errors might be
present.
To address our lack of knowledge about the errors present in scRNA-seq, I first
performed a benchmark of isoform quantification softwares, which addressed ques-
tions 1 and 2. This work is presented in chapter 2. I next attempted to address a
series of biological alternative splicing questions using scRNA-seq, but found that
uncertainty over the degree of technical noise in scRNA-seq made interpreting my
results in a biological context impossible. These results are presented in chapter 3.
To address the challenges I faced in chapter 3, I used a novel simulation approach
to investigate the degree to which technical noise might be confounding my splicing
analyses in chapter 4. In chapter 4, I address questions 3-6, and thus answer the
over-arching question which motivated my thesis: Is it feasible to study alternative
splicing using scRNA-seq?
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2Simulation Based Benchmarking of
Isoform Quantification Using
scRNA-seq.
The truth is rarely pure and never simple.
– Oscar Wilde, The Importance of Being Earnest(Wilde, 1895)
Preface
The overall goal of the work presented in this chapter is to answer the following
questions:
1. Do isoform quantification software tools designed for bulk RNA-seq give accu-
rate measurements when run on scRNA-seq?
2. What impact does the number of cells sequenced and the number of reads
sequenced per cell have on isoform quantification in scRNA-seq?
I address these questions by carrying out a simulation based benchmark of isoform
quantification using scRNA-seq. I find that four of the five isoform quantification
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tools evaluated in my benchmark perform almost as well when run on scRNA-seq as
when run on bulk RNA-seq, thus answering question 1. I find that the number of cells
sequenced has no impact on the performance of a popular isoform quantification tool
called Salmon. Over a range of read depths per cells, the performance of Salmon
peaks at 1-2 million reads per cell, implying that there may be an optimum read
depth for performing isoform quantification using scRNA-seq.
The work presented in this chapter has been published, consequently some pas-
sages have been quoted verbatim from the following sources: (Westoby et al., 2018a,b).
Additionally, some figures have been reproduced from the aforementioned sources.
2.1 Introduction
Numerous isoform quantification tools have been developed for bulk RNA-seq (Li and
Dewey, 2011; Roberts and Pachter, 2013; Bray et al., 2016; Patro et al., 2017, 2014;
Trapnell et al., 2010), however at the start of my thesis, it was not clear whether
these tools would perform appropriately when run on scRNA-seq data. scRNA-seq
data differs from bulk RNA-seq data in several notable ways. For example, due to
the low amount of starting material, there is an increased frequency of dropouts
and increased PCR amplification bias in many scRNA-seq protocols relative to bulk
RNA-seq (Islam et al., 2014; Kharchenko et al., 2014). It was not obvious what
effect these technical factors, and others, might have on the performance of isoform
quantification tools.
In addition to general technical concerns, an interesting question was whether
the performance of isoform quantification tools might differ depending on the library
preparation protocol used to generate the scRNA-seq data. A wide range of library
preparation protocols have been developed for scRNA-seq (Hashimshony et al., 2012,
2016; Macosko et al., 2015; Klein et al., 2015; Jaitin et al., 2014; Gierahn et al., 2017;
Picelli et al., 2014; Ramsko¨ld et al., 2012; Islam et al., 2011), some of which are
likely to be more appropriate for isoform quantification than others. For example,
one way in which library preparation protocols could differ in their suitability for
isoform quantification is in their degree of gene length bias, which has been shown
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to be greater for full length transcript protocols compared with UMI based protocols
(Phipson et al., 2017). An understanding of which library preparation protocols gen-
erate data suitable for isoform quantification and which library preparation protocols
do not would allow researchers to better design experiments to suit their needs.
There is currently a trade-off in scRNA-seq between the number of cells sequenced
and the number of reads sequenced per cell (Bacher and Kendziorski, 2016). A
pertinent question is whether the number of cells sequenced or the number of reads
sequenced per cell impacts on the performance of isoform quantification tools when
run on scRNA-seq. For bulk RNA-seq, a wide range of read numbers have been
sequenced depending on the desired accuracy of quantification and whether it is
desirable to detect and quantify lowly expressed transcripts (Conesa et al., 2016).
However, it has been recognised that whilst sequencing at higher read depths can
increase the accuracy of quantification, in the context of differential expression, a
higher number of reads can also increase the number of false positives if not corrected
for (Tarazona et al., 2011). For scRNA-seq, a decision on how many reads to sequence
per cell is often driven by multiple factors, including how many cells should be
sequenced and whether the goal of the experiment is to find detailed information
on gene expression in each cell or to identify sub-populations of cells by clustering
or pseudotime analysis (Haque et al., 2017). A recent study suggests that if the
goal is clustering cells, it is more beneficial to sequence more cells than to sequence
fewer cells slightly more deeply (Svensson et al., 2019). Multiple studies have found
that the number of genes detected reaches saturation for current library preparation
protocols at around 1 million reads per cell (Wu et al., 2014; Ziegenhain et al.,
2017), suggesting that for gene detection there is little purpose in further increasing
sequencing depth. Whether increased sequence depth would improve the accuracy
of isoform quantification is not known.
To assess isoform quantification for scRNA-seq, I present a simulation based
benchmarking study using data generated from three different scRNA-seq projects.
Whilst benchmarking studies have been performed previously for bulk RNA-seq (Ger-
main et al., 2016; Teng et al., 2016), to the best of my knowledge this is the first
benchmark of isoform quantification performed for scRNA-seq. I evaluated the over-
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all accuracy of different isoform quantification methods when applied to scRNA-
seq, and I also specifically studied the impact of library preparation protocol and
dropouts. I tested five popular isoform quantification tools on simulated scRNA-seq
data based on three publicly available scRNA-seq datasets produced using different
library preparation protocols and cell types. Unless otherwise stated, in all of my
simulations in this chapter, all of the isoforms in the Ensembl 89 mouse transcrip-
tome were considered (approximately 120,000 transcripts). The entire transcriptome
was considered because researchers are commonly interested in a variety of different
isoforms, from highly expressed isoforms that are detected in most cells to lowly
expressed isoforms that are only rarely detected. With the exception of eXpress,
performance was generally good for simulated data based on SMARTer and SMART-
seq2 (Picelli et al., 2014) data. Compared to bulk RNA-seq, isoform quantification
was only slightly worse for SMARTer and SMART-seq2 data, suggesting that it is
appropriate to use these methods for full-transcript single-cell data.
2.2 Results
2.2.1 The performance of isoform quantification tools was
generally good and consistent across two different sim-
ulation methods.
The first dataset considered in this benchmark consisted of 96 mouse quiescent B
lymphocytes collected as part of the BLUEPRINT epigenome project (Adams et al.,
2012) (GEO accession code GSE94676). The SMARTer library preparation protocol
was used to collect this dataset, which has been shown to have a degree of 3’ coverage
bias (Wu et al., 2014). On average, just over 2.7 million reads had been sequenced
per B lymphocyte.
To perform the benchmark, simulated data was generated from the selected cells
using two simulation methods. The first simulation method used was RSEM (Li and
Dewey, 2011) (see Methods chapter for details). RSEM is an isoform quantification
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tool which uses a generative model and expectation maximization to estimate isoform
expression. In addition, RSEM is capable of simulating reads using its generative
model and input values for the latent variables in the model, which can be estimated
during isoform quantification. An important reason for selecting RSEM to perform
the simulations is that during the simulation process, RSEM records where each
simulated read originated in the transcriptome. Consequently, it is known how highly
expressed each isoform is in the simulated data. This will be referred to as the ‘ground
truth.’ Knowing the ground truth allows us to benchmark expression estimates from
isoform quantification tools using the simulated data.
The second simulation method relied on two tools, Splatter (Zappia et al., 2017b)
and Polyester (Frazee et al., 2015). The methodology used to generate simulated data
is illustrated in Figure 2.1. Splatter is a simulation tool which takes an expression
matrix of counts from an scRNA-seq experiment as input and gives a simulated
expression matrix of counts as output. Splatter was used to simulate counts data
based on an expression matrix of counts from the BLUEPRINT B lymphocytes
generated by isoform quantification tool Kallisto (Bray et al., 2016). The output of
Splatter is a gene count expression matrix, where the columns are cells and the rows
are non-specific gene names (e.g., ‘Gene1’, ‘Gene2’, ‘Gene3’). Polyester was then
used to simulate one read per count in the Splatter gene count expression matrix.
Since the exact origin in the transcriptome is not known from Splatter, Polyester
generated simulated reads using a transcriptome consisting of the isoforms called
as expressed by Kallisto in at least one cell. The rownames of the Splatter count
matrix were updated to reflect the isoforms simulated by Polyester. The Splatter
count matrix was then converted to a matrix of TPM values, which were used as the
‘ground truth’.
The RSEM- and Splatter- and Polyester-simulated reads data was then given as
input to RSEM, eXpress (Roberts and Pachter, 2013), Kallisto, Salmon (Patro et al.,
2017), and Sailfish (Patro et al., 2014). The isoform quantification tools provide
two useful pieces of information for each isoform—whether it is expressed and its
expression level. To quantify the ability of each method to detect the presence of
an isoform, the precision and recall were calculated. In this context, the precision is
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Figure 2.1: Flowchart showing methodology for generating Splatter- and Polyester-
simulated data
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the fraction of isoforms predicted to be expressed by each tool which are expressed
in the ground truth. The recall is the fraction of isoforms expressed in the ground
truth which are predicted to be expressed using the tool. For a single overall quality
score, I used the F1 score, which is defined as the harmonic mean of precision and
recall.
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Figure 2.2: Performance statistics for each isoform quantification tool for the
BLUEPRINT simulations. The yellow bars represent RSEM simulations, the blue
bars represent Splatter and Polyester simulations with 3’ coverage bias and the green
bars represent Splatter and Polyester simulations with no coverage bias. The bars
represent the average performance across all simulated cells, the error bar limits are
defined by the standard deviation. A F1 score, precision and recall of isoform detec-
tion. The F1 score is the harmonic mean of the precision and recall. The precision is
the proportion of the isoforms predicted to be expressed by an isoform quantification
tool which are expressed. The recall is the proportion of expressed isoforms which
are predicted to be expressed by the isoform quantification tool. B Spearman’s rho.
C Normalised root mean square error (NRMSE)
Salmon can be run in three modes—an alignment-based mode, in which aligned
reads are taken as input, or one of two alignment free modes (a quasi mode or an
SMEM mode). The performance of all three modes was evaluated in this benchmark.
For most isoform quantification tools, the mean F1 score was remarkably similar
and in the range of 0.777–0.888. The exception was eXpress, which had a slightly
higher recall but a much lower precision than other tools, and consequently had the
lowest mean F1 score (between 0.463 and 0.492 depending on the simulation method)
(Figure 2.2A). The mean F1 scores, precisions, and recalls calculated for each of these
tools were similar regardless of whether RSEM or Splatter and Polyester were used
to generate the simulated data. The statistics were not dramatically altered when
Polyester simulated reads using a 3’ coverage bias model compared to when Polyester
simulated reads uniformly across transcript length. However, as the Polyester 3’
coverage bias model is not based on single-cell RNA-seq data, care needs to be taken
when interpreting this result.
In addition to determining whether an isoform is expressed, it is often of in-
terest to estimate isoform abundance. To evaluate how well isoform quantification
tools perform this task, two measures were considered—Spearman’s rho and the nor-
malised root mean square error (NRMSE) (Figure 2.2B, C). Spearman’s rho gives a
measure of how monotonic the relationship between the ground truth expression and
each tool’s expression estimates is, while the NRMSE gives a measure of the extent
to which the relationship deviates from a one to one linear relationship (see Methods
chapter for details on how the NRMSE was calculated).
Consistent with the results for isoform detection, mean Spearman’s rho was
similar between isoform quantification tools and simulation methods and in the
range 0.782–0.891. The exception was eXpress, which had much lower mean Spear-
man’s rho than the other tools with values from 0.550 to 0.574. eXpress also per-
formed poorly relative to the other isoform quantification tools when considering
the NRMSE. Although the overall pattern of NRMSE results was similar for both
simulation methods, the NRMSE was consistently far higher for the Splatter and
Polyester simulations compared to the RSEM simulations. One possible explanation
is that the difference in the NRMSE is due to a small number of outliers. However,
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this did not appear to be the case (see Figure 2.3). Another explanation for the dif-
ference in the NRMSE could be that the differences are largely driven by differences
in the ground truth expression distributions of the RSEM simulations compared to
the Splatter and Polyester simulations. Since the NRMSE is proportional to the sum
of squared differences between the ground truth and the isoform quantification tool’s
expression estimates, it is plausible that it will be relatively rare for an unexpressed
isoform to have an estimated expression other than zero, but relatively common for
an expressed isoform to have an estimated expression that differs from the ground
truth expression. I found that the distribution of ground truth expression values
differs for each simulation method (see Figure 2.4). Therefore, differences in the
ground truth expression distributions seem to be the most likely explanation for the
systematic difference in the NRMSE between simulation methods.
The difference in the NRMSE between simulation methods was not the only
aspect in which the simulation methods differed. A comparison of the simulated data
with the real data was carried out using both a comparison tool included in Splatter
and using CountsimQC (Soneson and Robinson, 2018a), a package which facilitates
comparison of simulated datasets. The RSEM-simulated data more closely resembled
the real data than the Splatter and Polyester-simulated data by a number of metrics,
including the sample-sample correlations, the mean-variance relationship, and the
relationship between magnitude of expression and fraction of zeros (see Figure 2.5).
In contrast, when comparing the simulation tools using gene-level statistics such as
the distribution of mean expression, distribution of variance and percentage of zeros
per gene, the resemblance between the Splatter/Polyester-simulated data and real
data is much closer (see Figure 2.6). I suspect that these differences are because
Splatter loses gene names during its simulations. When the Splatter counts matrix
was used with Polyester to simulate reads data, I updated the row names to reflect
the transcripts simulated by Polyester. Consequently, I would expect there to be
little or no relationship between the expression of a given gene in real data and the
corresponding Polyester/Splatter-simulated data. Indeed, I find that the correlation
between ground truth isoform expression in the Splatter- and Polyester-simulated
data and isoform expression estimates generated by running Kallisto on the real
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BLUEPRINT B lymphocyte data is very low (see Figure 2.7). In contrast, the
correlation between ground truth expression in the RSEM simulations and Kallisto
expression estimates in the real data was much higher.
The difference in the correlation between the real data and the RSEM simulations
compared with the Splatter/Polyester simulations is probably due to a core difference
between the simulation methodologies. RSEM keeps isoform names throughout its
simulations, and bases the number of reads it simulates for each isoform in part on
how many reads it detected for that isoform in the real data. Therefore, we would
expect an isoform’s RSEM simulated expression level to correlate with its expression
level in the real data. In contrast, in the Splatter/Polyester simulations, isoform
names are not kept. Splatter simulates isoform expression levels based on the global
distribution of isoform expression, in addition to other factors. Splatter does not
name its isoforms based on the original isoform names, but renames them ’Gene1’,
’Gene2’, etc. The Splatter counts are then used by Polyester to simulate reads,
but the mapping between a given isoform’s expression in the real data and in the
simulated data is lost due to the loss of isoform names.
Therefore, different transcriptional profile in the Splatter- and Polyester-simulated
data compared with the real BLUEPRINT B lymphocyte data is a likely consequence
of updating the Splatter gene names to reflect the transcriptome used in the Polyester
simulations (Step 3 in Figure 2.1). An additional potential issue with this step in my
methodology is that factors which would normally impact on expression estimates,
such as gene length, GC content, and secondary structure, are not considered during
my simulation protocol. The relationships between these features and expression
estimates in my simulated data are unlikely to match the real data. Based on these
limitations and my findings above, I concluded that the RSEM simulations resembled
the real data more closely than the Splatter and Polyester simulations. I suspect that
this occurs due to the loss of gene labels during the Splatter simulations and subse-
quent reassignment during the Polyester simulations, leading to a radically different
transcriptional profile in the Splatter/Polyester-simulated data. Consequently, for
the rest of this chapter, all data was simulated using RSEM. Despite the differences
between the RSEM and Splatter and Polyester simulations, the results of the bench-
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mark were remarkably consistent. This suggests that the findings in this benchmark
are robust to some differences between datasets, including dramatic changes in the
transcriptional profile.
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Figure 2.4: Histograms of ground truth expressions values for different simulation
methods. A Histogram of ground truth expression values for RSEM simulations. B
Histogram of ground truth expression values for Splatter and Polyester simulations
with 3’ coverage bias. C Histogram of ground truth expression values for Splatter
and Polyester simulations with no coverage bias. D Percentage of isoforms which
are unexpressed (ie. have zero expression) in RSEM and Splatter and Polyester
simulations. Each point represents one simulated cell.
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Figure 2.5: A comparison of the RSEM and Splatter simulations with the real
BLUEPRINT data. CountsimQC(Soneson and Robinson, 2018a) was used to gen-
erate these figures, using expression estimates generated by running Kallisto(Bray
et al., 2016) on the real BLUEPRINT B lymphocytes (red), ground truth expression
values from the RSEM simulated data (green) and ground truth expression values
from the Splatter and Polyester simulated date (blue). A Boxplots of sample-sample
correlations. Each point represents the Spearman correlation coefficient between two
cells. B Frequency density plot of library sizes. C Scatter plots of the mean-variance
relationship for log2(CPM). D Scatter plots showing the relationship between the
fraction of zeros and the average log CPM.
Figure 2.6: Plots showing characteristics of the different simulation methods included
within Splatter, compared with the RSEM simulations and the real data. Based on
these plots, the Lun2 method was selected for use in the rest of this chapter.
Figure 2.7: The relationship between expression estimates generated by running
Kallisto on the real BLUEPRINT B lymphocytes and the ground truth expression
estimates from simulated data. Points are coloured by density.A Relationship be-
tween expression estimates generated by running Kallisto on the real BLUEPRINT B
lymphocytes and the ground truth expression values from the Splatter and Polyester
3’ bias simulated data. B Relationship between expression estimates generated by
running Kallisto on the real BLUEPRINT B lymphocytes and the ground truth ex-
pression values from the Splatter and Polyester simulated data with no coverage bias.
C Relationship between expression estimates generated by running Kallisto on the
real BLUEPRINT B lymphocytes and the ground truth expression values from the
RSEM simulated data
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2.2.2 Isoform quantification tools generally perform well on
SMART-seq2 data with high sequencing coverage.
To test whether the results of my benchmark were robust across different datasets,
I next considered a mouse embryonic stem cell (mESC) dataset published by
Kolodziejczyk et al. (Kolodziejczyk et al., 2015). On average, over 7 million reads
were sequenced per cell in this dataset, considerably more than in the BLUEPRINT
dataset. Intuitively, it seems likely that sequencing more reads per cell should lead to
improved isoform quantification. However, sequencing more reads per cell is expen-
sive and may come at the cost of being unable to sequence as many cells. Therefore,
determining whether sequencing a higher number of reads per cell improves isoform
quantification is likely to be of interest to many researchers.
From the Kolodziejczyk et al. dataset, 271 mESCs grown in standard 2i media +
LIF which passed quality control were used for the benchmark (see Methods chapter).
This dataset should therefore give a good indication of the performance of isoform
quantification tools when there are a high number of reads per cell but a relatively
low number of cells. In addition, this dataset has uniform coverage of transcripts, as
it was sequenced using the SMART-seq2 protocol (Picelli et al., 2014).
To perform the benchmark, simulated data was generated as described previously
from the selected cells from Kolodziejczyk et al. (see Methods chapter for details).
The simulated reads data were then given as input to RSEM, eXpress, Kallisto,
Salmon, and Sailfish. The highest F1 score was achieved by Salmon run in SMEM
mode (0.889), with RSEM, Salmon run in quasi mode, Sailfish, and Kallisto also
achieving mean F1 scores greater than 0.85 (Figure 2.8A). Again, eXpress performed
most poorly by a substantial margin, with a mean F1 score of 0.548, and again,
eXpress had a higher mean recall (0.997) but a much lower mean precision (0.378)
than other tools. It seems likely that eXpress’s low precision is due to it being too
liberal when calling isoforms as expressed. The average number of isoforms called as
expressed per cell was twice as high for eXpress, which called an average of 41,372
isoforms as expressed per cell, as for any other tool. The other isoform quantification
tools had high mean recalls between 0.956 and 0.960. In contrast, the highest mean
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Figure 2.8: Performance statistics for each isoform quantification tool for the
Kolodziejczyk et al. ES cell simulations. POints are coloured by density. A F1
score and precision and recall of isoform detection. The F1 score is the harmonic
mean of the precision and recall. The precision is the proportion of the isoforms pre-
dicted to be expressed by an isoform quantification tool which are expressed. The
recall is the proportion of expressed isoforms which are predicted to be expressed by
the isoform quantification tool. B Spearman’s rho. C Normalised root mean square
error (NRMSE)
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precision was just 0.831 by Salmon run in SMEM mode, which means that nearly one
in six isoforms predicted to be expressed by the best performing tool were not actually
expressed. The high recall values achieved by all the tools considered here indicate
that the vast majority of isoforms expressed in the simulated data are detected,
with the lower precision values being a greater cause for concern. Knowing that an
isoform is not expressed can be as important as knowing that an isoform is expressed,
especially if that isoform is being used as a marker, for example in clustering analysis.
A strategy for improving the detection ability as quantified by the F1 score of isoform
quantification tools for scRNA-seq could be to make future tools more conservative
when calling isoforms as expressed.
The highest mean value of Spearman’s rho was obtained by Salmon run in SMEM
mode (0.896), with Salmon run in quasi mode, Kallisto, RSEM, and Sailfish obtaining
similar values. The lowest mean value of the NRMSE was also obtained by Salmon
run in SMEM mode (19.5), with Salmon run in quasi mode, Kallisto, RSEM, and
Sailfish obtaining similar values. Again, of the tools considered, eXpress performed
most poorly by a substantial margin.
2.2.3 The performance of isoform quantification tools was
generally poor using the Drop-seq library preparation
method.
Droplet based library preparation methods for scRNA-seq enable tens or hundreds
of thousands of cells to be sequenced in a single experiment, but at a relatively
low coverage per cell (Macosko et al., 2015; Klein et al., 2015; Gierahn et al., 2017;
Zheng et al., 2017). To determine whether a high number of cells can compensate
for low sequencing depth, a Drop-seq dataset of retinal bipolar cells published by
Shekhar et al. (Shekhar et al., 2016) was considered. Approximately 45,000 cells
were sequenced at a median read depth of 8,200 mapped reads per cell in this dataset.
From the dataset, 1,000 cells were randomly selected and given as input to RSEM
to generate simulated data (see Methods chapter for details). The simulated reads
were then given as input to RSEM, eXpress, Kallisto, Salmon and Sailfish as before,
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and the performance of these tools for the Drop-seq simulated data was evaluated.
With the exception of RSEM, the mean F1 score is far lower for the Shekhar et
al. Drop-seq simulated data as compared with the Kolodziejczyk et al. or the
BLUEPRINT simulated data (Figure 2.9A). For most tools, this is a consequence
of a drop in both the precision and the recall. The mean precision is less than 0.5
for most isoform quantification tools, including those which performed well on the
Kolodziejczyk et al. and BLUEPRINT simulated data. Salmon run on SMEM mode,
which achieved the highest mean precision on the Kolodziejczyk et al. simulated data,
performed particularly poorly, achieving a mean precision of just 0.399. Only RSEM
and Kallisto achieved mean precisions greater than 0.5 (0.743 and 0.614 respectively).
This result has important implications for the notion that sequencing a high
number of cells could capture the overall transcriptional profile of a population of
cells despite a low number of reads per cell. If sequencing a high number of cells could
compensate for a low coverage per cell, a very high precision of isoform detection
would be required. Without a high precision, attempting to combine data from
multiple cells to recapture the population transcriptional profile will result in calling
a high number of unexpressed isoforms as expressed, whereas if low read numbers
only reduced recall it could be compensated for by combining data across cells.
In addition to a low precision and recall, the isoform quantification tools perform
relatively poorly on the Shekhar et al. Drop-seq simulated data when Spearman’s
rho and NRMSE are used as performance metrics (Figure 2.9B, C). Again, Kallisto
and RSEM perform relatively well by these metrics compared to the other tools.
The overall picture painted by these results is that a low number of reads per cell
reduces the performance of isoform quantification tools, and this cannot be compen-
sated for by sequencing more cells. RSEM appears to perform better than the other
isoform quantification tools when run on the Shekhar et al. Drop-seq simulated data,
however this result needs to be interpreted with caution. Since RSEM was used to
perform the Shekhar et al. Drop-seq simulations, and as it essentially uses the same
model to perform isoform quantification and simulations, it is plausible that RSEM’s
performance is close to optimal when run on its own simulated data. This was also
the case for the Kolodziejczyk et al. and some of the BLUEPRINT simulations, but
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Figure 2.9: Performance statistics for each isoform quantification tool for the Shekhar
et al. Drop-seq simulations. Points are coloured by density. A F1 score, precision
and recall of isoform detection. The F1 score is the harmonic mean of the precision
and recall. The precision is the proportion of the isoforms predicted to be expressed
by an isoform quantification tool which are expressed. The recall is the proportion of
expressed isoforms which are predicted to be expressed by the isoform quantification
tool. B Spearman’s rho. C Normalised Root Mean Square Error (NRMSE).
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for these simulations the performance of Sailfish, Salmon and Kallisto was not dissim-
ilar to the performance of RSEM. One hypothesis generated from these observations
is that on high quality single cell datasets, most isoform quantification tools perform
well, meaning that if RSEM is performing optimally, it provides a relatively small
advantage. However, on a dataset with a low number of reads per cell, short reads
and 3’ coverage bias, most tools perform poorly. If RSEM is performing optimally,
this may result in a much greater impact on relative performance.
2.2.4 The decrease in the performance of isoform quantifi-
cation using scRNA-seq compared with bulk RNA-seq
is generally small
I find that the performance of existing isoform quantification tools is generally good
when run on simulated data based on SMART-seq2 and SMARTer scRNA-seq data.
I next consider the performance of isoform quantification tools when scRNA-seq
data is used compared with bulk RNA-seq data. Although previous benchmarks
of isoform quantification have been performed using bulk RNA-seq data (Germain
et al., 2016; Teng et al., 2016), a direct comparison with my benchmark is challenging
due to differences in the experimental approaches taken. Consequently, it is not
possible to say whether any perceived change in the performance of a given tool in
my benchmark compared with a bulk RNA-seq benchmark is due to differences in
how the benchmark was performed, differences in which statistics were collected, or
due to a genuine difference in performance on bulk and single-cell data.
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To gain further insights regarding the performance of the tools, I made use of the
bulk RNA-seq data generated for the BLUEPRINT B lymphocytes and Kolodziejczyk
et al. standard 2i media + LIF mESCs. I used RSEM to simulate the bulk RNA-seq
data and collected the same performance statistics for my bulk RNA-seq bench-
mark as in my scRNA-seq benchmark. As the data used in my bulk and scRNA-seq
benchmark came from the same source, the same method was used to generate the
simulated bulk and scRNA-seq data, and the same performance statistics were col-
lected in both benchmarks, I was able to carry out a meaningful comparison of
isoform quantification tool performance on bulk and scRNA-seq data.
I find that all isoform quantification tools performed well on the simulated bulk
data, but since most methods also performed well on single-cell data, the improve-
ment was generally small (See Figure 2.10 and 2.11). In particular, there is very
little difference in the recall for bulk and scRNA-seq, for which performance seems
to be close to optimal. eXpress performs far better on bulk RNA-seq compared
with scRNA-seq. Since eXpress appears to be overly liberal in calling isoforms as
expressed, one explanation for the better performance of eXpress on bulk RNA-seq is
that more isoforms have non-zero expression in bulk (see Appendix 1, Figure 7.11).
Consequently, there are fewer unexpressed isoforms for eXpress to incorrectly call as
expressed.
2.2.5 Removing drop-outs can improve the performance of
isoform quantification tools.
While it is of interest to determine which isoform quantification tools perform best
overall when run on scRNA-seq data, it is important to recognize that such an
analysis may hide a lot of detail. For example, scRNA-seq data commonly contains
a high number of dropouts (Ziegenhain et al., 2017), and one question of interest
is whether the performance of isoform quantification tools differs between isoforms
with a high number of dropouts and isoforms with few or no dropouts.
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Figure 2.12: Effect of dropouts on isoform quantification. A Impact of removing
isoforms with more than a threshold number of dropouts on Spearman’s rho and
the NRMSE for the BLUEPRINT B lymphocytes (left) and the Kolodziejczyk et al.
ES cells (right). The x-axis gives the threshold percentage of zeros above which an
isoform is removed from the analysis. For example, a threshold percentage of 80%
would result in isoforms with zero expression in 80% or more of cells being removed
from the analysis. Each colored line is a linear fit for visual guidance and it represents
a different isoform quantification tool. B Relationship between how highly expressed
an isoform is and the percentage of cells in which it has zero expression. The rela-
tionship is considered in RSEM simulated BLUEPRINT B lymphocytes (top left),
the real BLUEPRINT B lymphocytes (bottom left), the simulated Kolodziejczyk et
al. ES cells (top right), and the real Kolodziejczyk et al. ES cells (bottom right).
Each point represents an isoform and the points are colored according to density.
To address the impact of dropouts on performance, Spearman’s rho and the
NRMSE were calculated when isoforms with zero expression in more than a specific
fraction of cells were removed from the analysis. Applying increasingly stringent
thresholds to remove isoforms with a high number of dropouts led to an increase in
the value of Spearman’s rho in both the Kolodziejczyk et al. and BLUEPRINT simu-
lations (Figure 2.12A). For isoforms which had dropouts in less than 20% of cells, the
value of Spearman’s rho became very high for Sailfish, Salmon, Kallisto, and RSEM
(in the range of 0.992–0.996 for the BLUEPRINT simulations, and 0.977–0.989 for
the Kolodziejczyk et al. simulations). This indicates that for isoforms with very few
dropouts, isoform quantification tools are extremely good at ordering their relative
expression correctly. Removing isoforms with a high number of dropouts had a more
variable effect on the NRMSE. Due to the inverse relationship between magnitude
of expression and number of dropouts (Kharchenko et al., 2014) in both the real and
simulated data (Figure 2.12B), one explanation for the increase in Spearman’s rho is
that lowly expressed isoforms are more likely to have a high number of dropouts and
are also more likely to be mis-ordered with respect to the ground truth. However,
because they are lowly expressed, removing them has a relatively small effect on the
NRMSE.
2.2.6 The performance of Salmon alters depending on read
depth.
So far in my benchmark, I have established that in general, isoform quantification
tools perform well when run on full length scRNA-seq data with a moderately high
read depth per cell and poorly when run on Drop-seq data with relatively low read
depth per cell. To further investigate the impact of number of cells sequenced and
number of reads sequenced per cell on the performance of isoform quantification
tools, I return to the BLUEPRINT B lymphocyte dataset with a modified version of
my simulation based approach. In my modified approach, I use RSEM to simulate
data in which I systematically vary the number of cells simulated and the number
of reads simulated per cell. The number of cells simulated was varied between 10
68
and 500 cells. As there are only 96 BLUEPRINT B lymphocytes, to generate my
simulated cells I randomly selected cells from the BLUEPRINT B lymphocytes, then
generated a simulated cell using RSEM run with a randomly selected seed. I varied
the number of reads simulated from 0.25 million to 8 million reads per cell. For each
datapoint, corresponding to a certain number of cells and a certain number of reads
per cell, I performed 10 rounds of simulations. I then ran Salmon SMEM on each
simulated cell and compared Salmon’s expression estimates to the ground truth to
generate performance statistics.
The reasons that Salmon and only Salmon was run on the simulated data are
as follows. The total number of simulations performed in this experiment was vast
(approximately 40,000), and consequently the computing resources required were also
large, both in terms of time and memory (this experiment took over a month to run
on the Sanger Institute’s HPC). I have already established that the performances
of Salmon, Sailfish, Kallisto and RSEM are very similar in multiple benchmarks,
consequently the main goal of the experiment described here was to establish whether
number of cells or number of reads per cell impact on isoform quantification tool
performance in general, rather than which tool performed best at a given number
of cells or read depth. This being so, in the interests of reducing computational
time, I decided to benchmark a single tool rather than the full five. Salmon is one of
the fastest and best performing tools investigated in this benchmark, consequently I
chose to investigate Salmon’s performance.
I first investigated how the number of cells simulated and the number of reads
simulated per cell impacted on the number of expressed isoforms in my simulations
and the number of isoforms detected by Salmon. The total number of expressed
and detected isoforms increases as read number and cell number increases (Figure
2.13). However, the total number of detected isoforms vastly exceeds the number of
expressed isoforms – over 6000 isoforms were detected when 500 cells were simulated
with 8 million reads per cell, but less than 4000 isoforms were expressed in the ground
truth. This means over one third of the total number of detected isoforms were false
positives, a finding with important implications for studies attempting to determine
the number of expressed genes and isoforms in a population of cells.
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Figure 2.13: The difference between the total number of isoforms detected as ex-
pressed by Salmon SMEM (left) and the number of isoforms expressed in the ground
truth (right) in RSEM simulated data. Each coloured line is a linear fit for visual
guidance and represents the number of reads sequenced per cell.
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Figure 2.14: The impact of the number of cells sequenced and the number of reads
sequenced per cell on the performance of Salmon run on SMEM mode. Each coloured
line is a linear fit for visual guidance and represents the number of cells sequenced.
71
I next considered the impact of the number of cells and the number of reads
per cell on performance. The number of cells simulated had little impact on perfor-
mance, however the number of reads simulated per cell had an impact on Spearman’s
Rho, the NRMSE and the precision and recall of isoform detection (Figure 2.14). As
read number increased, the recall of isoform detection increased and the NRMSE
decreased. It is perhaps unsurprising that the ability of Salmon to detect and accu-
rately quantify expressed isoforms increases as the number of reads increases. More
surprisingly, the precision of isoform detection and Spearman’s Rho peak at around
2 million reads then decrease as the number of reads further increase. To investigate
this result further, I decided to focus on the precision of isoform detection. The
precision is defined as:
Precision =
NumberOfTruePositives
NumberOfTruePositives+NumberOfFalsePositives
Where I define a true positive as an isoform which is called as expressed by the
isoform quantification tool which is expressed in the ground truth, and a false pos-
itive as an isoform which is called as expressed by the isoform quantification tool
which is not expressed in the ground truth. As the precision depends on the num-
ber of true positives and false positives, I investigated the relationship between the
number of true and false positives and the read number. I found that the number
of true positives plateaus over the range of read numbers considered in my experi-
ment whereas the number of false positives does not (Figure 2.15). Thus, the peak
in the precision is a consequence of the number of false positives increasing more
rapidly than the number of true positives at high read numbers. The slower rate of
increase in the number of true positives with increasing read numbers is most likely
a consequence of the plateau in the number of expressed isoforms at high read num-
bers in the simulated data (Figure 2.16). Note that RSEM generates ground truth
expression measures by counting where each of the reads it simulates originated in
the transcriptome, thus unlike in real scRNA-seq data, there are no expressed iso-
forms from which no reads are captured. Nonetheless, it is true that a sequenced
cell must express a fixed number of isoforms and that the number of true positives
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will be limited at high read numbers by the number of isoforms it expresses. My
findings suggest there is an optimum number of reads to sequence per cell if the aim
of the experiment is isoform detection, and that the optimum number may be partly
determined by the number of isoforms expressed by the cell.
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Figure 2.15: The impact of the number of reads sequenced per cell on the precision,
the number of true positives and the number of false positives. In this context, a
true positive is an isoform called as expressed by Salmon SMEM which is expressed
in the ground truth. A false positive is an isoform called as expressed by Salmon
SMEM which is unexpressed in the ground truth. Each coloured line is a linear fit
for visual guidance and represents the number of cells sequenced.
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Figure 2.16: The effect of read number on the number of expressed isoforms (left)
and the number of true positives (right). In this context, a true positive is an isoform
called as expressed by Salmon SMEM which is expressed in the ground truth. Each
coloured line is a linear fit for visual guidance and represents the number of cells
sequenced.
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2.3 Discussion
To date, scRNA-seq studies have mainly focussed on gene level quantification (Ste-
gle et al., 2015). This has partly been due to uncertainty over how best to perform
isoform quantification in scRNA-seq. In addition, there has been uncertainty over
whether the results obtained would be meaningful due to the low read coverage com-
pared with bulk RNA-seq. My analyses have demonstrated that Kallisto, Salmon,
Sailfish and RSEM can accurately detect and quantify isoforms in scRNA-seq to
nearly the same accuracy as bulk RNA-seq data, provided the datasets have a rea-
sonably high number of reads per cell. For simulated data based on Drop-seq, the
performance of isoform quantification tools was too poor to make the results of
performing isoform quantification worthwhile. Due to the low precision of isoform
detection, this problem cannot be overcome by incorporating information from a
large number of cells. It is possible that increasing the number of reads sequenced
per cell for Drop-seq protocols would improve the performance of isoform quantifi-
cation tools, although the short reads and 3’ coverage bias are likely to ensure that
accurate quantification remains challenging.
A potential limitation of my benchmark is that we might expect that the degree
of cellular heterogeneity might differ between quiescent B lymphocytes, mESCs and
retinal bipolar cells, potentially confounding the comparison of the three sequencing
technologies. As the benchmark is based on a comparison within each simulated cell
between its ground truth expression and quantification tool expression estimates,
I would expect structural differences in the real datasets to be a relatively minor
confounder. The confounder could be removed by repeating the benchmark with a
cell population that was sequenced using several different sequencing technologies.
A systematic investigation found that the number of cells sequenced has no per-
ceptible impact on the performance of isoform quantification. I find that the precision
of isoform detection peaked in my simulations at around 1-2 million reads per cell.
I hypothesise that this could occur because that the number of expressed isoforms
in my simulated data does not increase substantially beyond 2 million reads per
cell, and the majority of expressed isoforms are already called as expressed at 2 mil-
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lion reads. Consequently, beyond 2 million reads per cell, it is not possible for the
number of true positives to increase much further, whereas the number of false pos-
itives continues to increase. The position of the peak at 1-2 million reads per cell is
possibly an RSEM simulation artefact, as it likely occurs due to RSEM not substan-
tially increasing the number of isoforms expressed per gene per cell beyond 2 million
reads per cell. However, it is a fact cells express a finite number of isoforms, thus I
would predict that the precision of isoform detection will also peak at a particular
read depth in real scRNA-seq data. The position of the peak would depend on the
number of isoforms expressed by each cell, so consequently might vary between cell
types and species. This observation is highly relevant when analysing very deeply
sequenced scRNA-seq data, as it predicts that an increasing proportion of detected
isoforms and genes will be false positives at very high read depths.
In addition to benchmarking isoform quantification for scRNA-seq, I perform an
equivalent benchmark for bulk RNA-seq. I find that the performance of most isoform
quantification tools is slightly worse for scRNA-seq compared with bulk, but that the
difference is small. The cost in performance using scRNA-seq compared with bulk
RNA-seq for isoform quantification is therefore low. However, it should be noted that
this benchmark has evaluated the ability of isoform quantification tools to correctly
assign the reads present in an scRNA-seq experiment to the isoforms they originated
from. As a major technical issue with scRNA-seq is failure to capture reads from
a high proportion of expressed transcripts (Vallejos et al., 2017), it is likely that
in practice, many expressed isoforms will be missed by isoform quantification tools
when run on scRNA-seq data due to a lack of evidence in the captured reads that
the isoform was expressed. However, the extremely high recall of all the isoform
quantification tools considered in this benchmark means that the overwhelming ma-
jority of isoforms from which reads are captured will be called as expressed. More
problematic is the relatively low precision of isoform detection, as a consequence of
which around one in six isoforms called as expressed in deeply sequenced scRNA-seq
datasets will be false positives, even for the best performing tools.
Whilst my analysis has demonstrated that existing tools can accurately detect
and quantify isoforms for scRNA-seq, no tool performed perfectly. The tools bench-
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marked here were designed for use with bulk RNA-seq, and it is plausible that future
tools designed to perform isoform quantification specifically for scRNA-seq could per-
form better. I found that the tools benchmarked in this study tended to have a higher
recall than precision of isoform detection. Therefore, it is likely the performance
of isoform quantification tools designed for scRNA-seq data could be improved by
making the tools more conservative in calling isoforms as expressed relative to tools
designed for use on bulk data. In addition, I found that Spearman’s rho increased
when lowly expressed isoforms with a high number of dropouts were removed from
the analysis. Thus, it is likely that attempts to incorporate the effects of single cell
specific technical noise such as dropouts would improve the performance of isoform
quantification tools on scRNA-seq. An open question for isoform quantification in
scRNA-seq is whether incorporating information from Unique Molecular Identifiers
(UMIs) into isoform expression estimates could improve accuracy of quantification.
Whilst UMI information could reduce the effects of PCR amplification noise (Islam
et al., 2014), UMI based protocols tend to exhibit significant coverage bias, poten-
tially making isoform quantification challenging (Gru¨n and van Oudenaarden, 2015).
If UMI based protocols could be combined with long read sequencing technologies,
this problem could potentially be overcome.
2.4 Conclusions
For high-quality simulated scRNA-seq datasets with a high number of reads/cell,
RSEM, Kallisto, Salmon, and Sailfish can accurately detect and quantify isoform
expression. Isoforms with a high number of dropouts appear to be relatively chal-
lenging to quantify, possibly because such isoforms are often lowly expressed. In my
benchmark of bulk RNA-seq, I discover the performance of most isoform quantifica-
tion tools is slightly worse for scRNA-seq compared with bulk, but that the difference
is small.
Taken together, my findings show that isoform quantification is possible with
scRNA-seq for SMARTer and SMART-seq2 data. As single cells do not generally
express all of the isoforms seen at the population level, scRNA-seq may eventu-
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ally provide advantages over bulk RNA-seq for isoform quantification by essentially
deconvoluting the problem of isoform quantification. Future isoform quantification
tools designed explicitly for scRNA-seq could improve on the performance of existing
tools by being more conservative in calling isoforms as expressed, and by explicitly
modeling the technical noise inherent to scRNA-seq.
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3Attempts to Determine How Many
Isoforms Are Produced per Gene
per Cell Give Uninterpretable
Results.
Science, my boy, is made up of mistakes, but they are mistakes which it is
useful to make, because they lead little by little to the truth.
– Jules Verne, Journey to the Centre of the Earth(Verne, 1864)
3.1 Introduction
In the previous chapter, I demonstrated that Kallisto, Salmon, Sailfish and RSEM
perform almost as well when run on scRNA-seq as when run on bulk RNA-seq.
This is an exciting result, because it suggests that existing isoform quantification
software performs sufficiently well on scRNA-seq to theoretically enable alternative
splicing to be studied using scRNA-seq data. In this chapter, I therefore design a
series of experiments to answer a basic biological question related to splicing using
scRNA-seq.
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‘How many isoforms does a gene produce per cell’ is a fundamental question in
molecular biology, yet for most genes we do not have an answer to this question. In
addition to being of interest to basic biologists, establishing how isoform expression is
regulated at a cellular level could potentially be of therapeutic relevance to the many
patients suffering from diseases in which splicing has been implicated. If insight into
splicing regulation at a cellular level could be gained from scRNA-seq data, a far
higher number of genes could be studied at much lower cost than would be possible
using lower throughput approaches such as smFISH. In an attempt to shed some light
on how isoform expression is regulated in cells, I designed a series of experiments
investigating isoform number in individual cells using scRNA-seq. Unfortunately, my
main conclusion from these experiments was that without a better understanding of
the technical noise associated with scRNA-seq, it is often not possible to distinguish
between genuine splicing behaviour and technical noise in individual cells.
Some of the work presented in this chapter has been published, consequently
some passages have been quoted verbatim from the following sources: (Westoby
et al., 2018a,b, 2019). Additionally, some figures have been reproduced from the
aforementioned sources.
3.2 Results
3.2.1 For genes which express two isoforms in bulk RNA-
seq, usually only one isoform is detected per cell in
scRNA-seq.
To determine whether individual cells express all or only some of the isoforms seen
in a population of cells, I consider genes which have two isoforms, both of which are
expressed in the BLUEPRINT B lymphocyte or in the Kolodziejczyk et al. ES cell
bulk RNA-seq data. I then determine how many isoforms are expressed from these
genes in the corresponding scRNA-seq data. Kallisto was used to perform isoform
quantification for the bulk and single-cell data as it performed well in both my bulk
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RNA-seq and scRNA-seq benchmarks.
For genes which express two isoforms in bulk RNA-seq data, I first consider if
zero, one, or two isoforms are detected in single cells. For most genes which express
two isoforms in the bulk RNA-seq, neither isoform is detected in most cells in the
scRNA-seq (Figure 3.1A & 3.2A). A biological interpretation could be that the gene
expression detected in bulk RNA-seq reflects heterogeneous gene expression at a
cellular level. However, an arguably more realistic technical interpretation is that
technical dropouts are prevalent in scRNA-seq (Kharchenko et al., 2014; Marinov
et al., 2014; Svensson et al., 2017; Islam et al., 2014) and consequently I fail to detect
expressed genes in many cells. Of course, the two explanations are not necessarily
exclusive. It is possible that there is both heterogeneous gene expression, and that I
fail to detect gene expression in many cells due to dropouts.
In cells where gene expression is detected, it is more common to detect one rather
than two isoforms. To investigate this further, I consider the percentage of cells in
which both of the isoforms expressed in the bulk RNA-seq data are detected. I
find that for the majority of genes, both isoforms are detected in no or very few
cells; however, for a minority of genes in both the BLUEPRINT B lymphocytes and
Kolodziejczyk et al. ES cells, both isoforms are detected in a high percentage of cells
(Figure 3.1B & 3.2B). There are more genes for which both isoforms are detected
in the Kolodziejczyk et al. ES cells compared to the BLUEPRINT B lymphocytes.
This may partly reflect the higher number of cells and the higher number of reads
per cell in the Kolodziejczyk et al. ES cells, possibly enabling better detection
of lowly and/or infrequently expressed isoforms. In addition, the globally elevated
transcription rates in ES cells relative to other cell types might lead us to expect
that expression of multiple isoforms from a single gene would be more common in
ES cells (Efroni et al., 2008), especially compared to quiescent and transcriptionally
inactive B lymphocytes.
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Figure 3.1: Investigation into how many isoforms are expressed per cell in the scRNA-
seq data for genes which express exactly two isoforms in bulk data. The BLUEPRINT
B lymphocyte (left) and the Kolodziejczyk et al. ES cell (right) bulk RNA-seq
data are shown. The B lymphocyte graphs shown here are from the first biological
replicate of the BLUEPRINT male B lymphocyte bulk RNA-seq; equivalent graphs
for the second and third BLUEPRINT male B lymphocyte biological replicates can
be found in Figure 3.2. A Number of genes which express two isoforms in the
bulk RNA-seq data expressing zero, one or two isoforms in each cell in the scRNA-
seq data. B Histogram of the percentage of cells which express both the isoforms
detected in the bulk RNA-seq data. C Relationship between the percentage of cells
which express both the isoforms detected in the bulk RNA-seq. The y axis represents
the log transformed parent gene expression, found by summing the expression of the
two isoforms. Spearman’s rho is 0.623 for the BLUEPRINT B lymphocytes and
0.795 for the Kolodziejczyk et al. ES cells. Points are coloured by density. Note that
the B lymphocyte replicates appear extremely similar because the replicates refer
to bulk RNA-seq replicate samples. The same scRNA-seq B lymphocyte dataset is
used each time.
Figure 3.2: Investigation into how many isoforms are expressed per cell in the scRNA-
seq data for genes which express exactly two isoforms using the second (left) and
third (right) biological replicates for the BLUEPRINT B lymphocyte bulk RNA-
seq data. A: Number of genes which express two isoforms in the bulk RNA-seq
data which express zero, one or two isoforms in each cell in the scRNA-seq data.
B: Histogram of the percentage of cells which express both the isoforms detected
in the bulk RNA-seq data. C: Relationship between the percentage of cells which
express both the isoforms detected in the bulk RNA-seq. The y axis represents the
log transformed parent gene expression, found by summing the expression of the two
isoforms. Spearman’s rho is 0.625 for replicate 2 and 0.626 for replicate 3. Points
coloured by density. Note that the B lymphocyte replicates appear extremely similar
because the replicates refer to bulk RNA-seq replicate samples. The same scRNA-seq
B lymphocyte dataset is used each time.
Finally, I ask whether more highly expressed genes are more likely to express
multiple isoforms. I find a positive correlation between gene expression and the
percentage of cells in which both isoforms are detected (Figure 3.1C & 3.2C). The
observation that in scRNA-seq, it is more common to detect multiple isoforms in
individual cells for highly expressed genes relative to lowly expressed genes is not
new (Zhao et al., 2016; Marinov et al., 2014). Marinov et al. proposed that this
reflects a biological phenomenon and that more highly expressed genes on average
undergo more alternative splicing and produce more isoforms in individuals cells
compared to lowly expressed genes (Marinov et al., 2014). However, there is also a
potential technical explanation. The probability of a transcript becoming a dropout
is inversely proportional to how highly expressed that transcript is (Kharchenko
et al., 2014). Consequently, if isoform expression was identical in all cells, we would
expect to be able to detect highly expressed isoforms in a higher proportion of cells
and lowly expressed isoforms in a lower proportion of cells. It is likely that many
isoforms from highly expressed genes are themselves highly expressed. Therefore, one
explanation for the correlation between magnitude of gene expression and percentage
of cells in which both isoforms are detected is that the probability of detecting both
isoforms increases as gene expression increases. In other words, it is possible that
lowly expressed genes produce both isoforms in individual cells, but the probability
of dropout is so high that we fail to detect them.
3.2.2 A novel simulation approach suggests that Tbx3, Klf4
and Pou5f1 are differentially spliced in mESCs cul-
tured in different conditions.
The results shown in Figure 3.1 & 3.2 indicate that for genes where two isoforms are
detected in bulk RNA-seq, it is rare to detect both isoforms in scRNA-seq, but more
common for highly expressed genes. Without knowing how to appropriately correct
for dropouts, it is challenging if not impossible to distinguish whether this reflects
biological reality or technical noise.
I rationalised that a different approach, in which dropouts were explicitly ac-
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counted for, was required to analyse alternative splicing using scRNA-seq. I there-
fore designed a novel simulation based approach. In my approach, a gene of interest
is selected and the total number of detected isoforms over an entire real scRNA-seq
dataset, N , is established. I then simulate N scenarios. In the first scenario, I simu-
late a situation in which 1 isoform is expressed from the gene of interest in all cells.
In the second scenario, I simulate a situation in which 2 isoforms are expressed in
all cells, and so on up to the Nth scenario, where N isoforms are expressed in all
cells. Importantly, in each scenario, I simulate dropout events using a Michaelis-
Menten model developed by Andrews and Hemberg (Andrews and Hemberg, 2018a),
and simulate quantification errors using error rates estimated from my benchmark in
chapter 2. I record the number of detected isoforms in each cell after dropouts and
quantification errors are simulated, then find the mean number of isoforms detected
across all cells. I then repeat this process thousands of times to generate distribu-
tions of the mean number of isoforms detected per cell when n in range 1:N isoforms
are expressed per cell. This process is illustrated in Figures 3.3 and 3.4.
The distributions of the mean number of isoforms detected per cell generated
by my simulations can be considered to be null distributions - they are the distri-
butions of the mean number of isoforms detected per cell if exactly n isoforms are
expressed in every cell, assuming that I am modelling dropouts, isoform choice and
quantification errors appropriately. Onto these distributions, I draw a vertical black
line representing the mean number of isoforms detected per cell in the real data. If
the black line falls to the right of the distribution for n isoforms, or into the 2.5%
largest values of the distribution, my simulation model predicts that cells produce
significantly more than n isoforms per cell in reality. If the black line is to the left
of the n isoform distribution, or in the 2.5% lowest values of the distribution, my
model predicts that cells produce significantly less than n isoforms per cell. If the
black line falls into the middle 95% of values of the n isoform distribution, my model
predicts that cells produce n isoforms per cell.
To test the predictive ability of my model, I returned to the Kolodziejczyk et
al. ES cell dataset. The mESCs in this dataset were cultured under three different
cuture conditions (Kolodziejczyk et al., 2015). One culture condition consisted of
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Figure 3.3: Schematic of my simulation approach. The final output is a graph show-
ing N distributions, each corresponding to the mean number of isoforms detected
when n isoforms are expressed per gene per cell. The black line shown on the graph
is the mean number of isoforms detected per gene per cell in the real data - in this
case, the mean number of isoforms detected in the real data is consistent with two
isoforms being expressed in every cell.
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Figure 3.4: An example of the output at each stage of my simulation approach.
For example, simulated Cell 1 expresses the short isoform from our gene of interest.
However, the short isoform is not detected due to a dropout event. A quantification
error then occurs, leading to the long isoform being detected, despite the long isoform
never having been expressed in Cell 1.
serum + LIF, which I will refer to as the ‘serum’ culture condition, one culture con-
dition was 2i + LIF, which I will refer to as ‘standard 2i’, and one culture condition
was a2i + LIF, which I will refer to as ‘a2i’. It is known that the morphology and
transcriptional properties of mESCs can substantially differ depending on the condi-
tions that they are cultured in (Morgani et al., 2017; Marks et al., 2012). In addition,
it has been observed that the expression of some pluripotency factors is more het-
erogeneous in mESCs cultured in serum/LIF than in mESCs cultured in 2i (Toyooka
et al., 2008; Chambers et al., 2007). It would be interesting to establish whether
key players in the pluripotency network are differentially spliced when mESCs are
cultured in different conditions. If differential splicing is occurring, it could partly
explain the morphological and transcriptional differences that have been observed
between culture conditions.
To investigate whether key players in the pluripotency network are differentially
spliced between mESC culture conditions, I applied my model to 15 genes implicated
in playing a role in maintaining pluripotency (see Methods chapter for a complete
list). These 15 genes were chosen as a starting point to this study due to their well
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established role in the pluripotency network. Of these 15 genes, my model suggested
that 7 genes (Klf4, Pou5f1, Tbx3, Jarid2, Myc, Stat3 and Tcf3) produced differing
numbers of isoforms depending on culture condition (Figures 3.5-3.11). Of these
7 genes, 4 genes (Jarid2, Myc, Stat3, Tcf3) had a very large number of detected
isoforms (Figures 3.8-3.11). I would expect isoform quantification to be more error
prone when genes produce a very large number of similar isoforms, and therefore have
less confidence in my model’s predictions for these genes. Consequently, I decided to
focus on the 3 remaining genes (Tbx3, Klf4 and Pou5f1) for which six or less isoforms
were detected as candidates for differential splicing between culture conditions.
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A: a2i
B: Serum
C: Standard 2i
Figure 3.5: Simulation results for Klf4 gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line
on each plot represents the mean number of isoforms detected per cell in the real
data.
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A: a2i
B: Serum
C: Standard 2i
Figure 3.6: Simulation results for Pou5f1 gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line on
each plot represents the mean number of isoforms detected per cell in the real data.
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A: a2i
B: Serum
C: Standard 2i
Figure 3.7: Simulation results for Tbx3 gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line on
each plot represents the mean number of isoforms detected per cell in the real data.
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Figure 3.8: Simulation results for Jarid2 gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line on
each plot represents the mean number of isoforms detected per cell in the real data.
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A: a2i
B: Serum
C: Standard 2i
Figure 3.9: Simulation results for Myc gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line
on each plot represents the mean number of isoforms detected per cell in the real
data.
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Figure 3.10: Simulation results for Stat3 gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line on
each plot represents the mean number of isoforms detected per cell in the real data.
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Figure 3.11: Simulation results for Tcf3 gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line on
each plot represents the mean number of isoforms detected per cell in the real data.
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3.2.3 My novel simulation approach makes unlikely predic-
tions.
An ideal means of validating my model’s predictions would be to carry out smFISH
to resolve the number of isoforms produced in individual cells. However, resolv-
ing between isoforms using smFISH is not trivial, and the experiments would take
some time to carry out. Before arranging such experiments, I decided to carry out
additional bioinformatics experiments to search for further evidence of differential
splicing between culture conditions.
If differential splicing is occurring between culture conditions, I would expect the
proportion of counts allocated to each isoform to differ between conditions. To test
whether this is the case for our three candidate genes, I have plotted the number
of counts allocated to each isoform from Tbx3 (Figure 3.12 & 3.13), Klf4 (Figure
3.14 & 3.15) and Pou5f1 (Figure 3.16 & 3.17). Although the number of counts
allocated to each isoform does appear to systematically differ between culture con-
dition, reflecting differential gene expression and/or library size differences, I can
see no evidence that the number of isoforms produced differs between culture con-
ditions. For example, in Figure 3.12, more counts are systematically mapped to
Tbx3 in the a2i and standard 2i culture conditions compared to serum. However,
there is good evidence of expression of three isoforms (ENSMUST00000202034.1,
ENSMUST00000121021.7 and ENSMUST0000018748.8) in all three culture condi-
tions and little detection of ENSMUST00000079719.10, ENSMUST00000145647.1
and ENSMUST00000154680.1. This appears to contradict my model’s prediction
that 3-4 Tbx3 isoforms are expressed in a2i, 1-2 isoforms are expressed in serum and
4-5 isoforms are present in standard 2i. It is of course possible that more isoforms
are produced across a group of cells than in individual cells, but my model’s pre-
dictions that more isoforms are produced in individual cells than can be detected
across a group of cells are less plausible. In Figure 3.13, I investigated how many
Tbx3 isoforms could be detected in the matched bulk RNA-seq data, and find good
evidence that three isoforms are produced in all three culture conditions, further call-
ing into question my model’s prediction that more than three isoforms are produced
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in some cells. Similarly, in Figures 3.14 - 3.17 there is good evidence of expression
of one isoform in all three culture conditions for Klf4 and Pou5f1 in both the bulk
and scRNA-seq data, despite my model predicting substantially more isoforms being
produced in individual cells. Based on these results, I am forced to conclude that as
my model currently stands, it cannot make reliable predictions about the number of
isoforms produced in individual cells.
Figure 3.12: Boxplots of scRNA-seq counts mapping to each Tbx3 isoform in the
three culture conditions. Points and boxplots are coloured by culture condition.
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Figure 3.13: Plots of matched bulk RNA-seq counts mapping to each Tbx3 isoform
in the three culture conditions. Points are coloured by culture condition.
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Figure 3.14: Boxplots of scRNA-seq counts mapping to each Klf4 isoform in the
three culture conditions. Points and boxplots are coloured by culture condition.
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Figure 3.15: Plots of matched bulk RNA-seq counts mapping to each Klf4 isoform
in the three culture conditions. Points are coloured by culture condition.
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Figure 3.16: Boxplots of scRNA-seq counts mapping to each Pou5f1 isoform in the
three culture conditions. Points and boxplots are coloured by culture condition.
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Figure 3.17: Plots of matched bulk RNA-seq counts mapping to each Pou5f1 isoform
in the three culture conditions. Points are coloured by culture condition.
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3.3 Discussion
I began this chapter by investigating how many isoforms are detected in scRNA-seq
for genes where two isoforms are detected in matched bulk RNA-seq in a dataset of
mESCs and quiescent B lymphocytes. I found that it is rare to detect both isoforms
and common to fail to detect gene expression at all in many cells. However, both
isoforms were detected for some genes, and it was more common to detect both
isoforms in individual cells if the parent gene was highly expressed. Without a clear
idea of how best to correct for dropouts, it is impossible to state to what extent these
observations reflect biological facts, and to what extent they are consistent with every
cell producing both isoforms but few isoforms being detected due to dropouts.
I attempted to correct for this by developing a simulation based model for pre-
dicting how many isoforms are produced from a gene of interest in individual cells.
I explicitly simulated dropouts using a popular model for dropout probability (An-
drews and Hemberg, 2018a). However, my model made some questionable predic-
tions, most notably that more isoforms were produced per cell than could be detected
across all cells. This is not entirely impossible if the rate of dropouts is so high that
we almost entirely fail to detect some expressed isoforms across a population of cells.
However, that we detect fewer isoforms than my model predicts are produced in the
matched bulk RNA-seq data makes the dropout hypothesis unlikely. I believe the
most likely explanation is that my model is not making accurate predictions, sug-
gesting that the model needs to be refined. Identifying how best to refine my model
is not trivial. Possible issues with my model include the following:
1. My model might be sensitive to library size.
2. I might not be modelling dropouts sufficiently accurately.
3. In reality, different cells might produce different numbers of isoforms. This
behaviour is not captured in my simulations.
4. I might not be modelling quantification errors sufficiently accurately.
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5. I might not be modelling the process of isoform choice within individual cells
accurately.
Some of these issues are more straightforward to address than others. Incremen-
tally tweaking my model, and probably making it increasingly complex, is likely to
eventually generate a model that generates plausible seeming predictions. However,
whether the model that is eventually generated has any actual predictive power or
biological relevance is uncertain. More generally, I am concerned that tweaking my
model until it produces results that I like is not a very scientific way to develop a
predictive model for the number of isoforms produced per gene per cell. A small
number of studies have used smFISH to investigate the number of isoforms produced
per gene per cell (Velten et al., 2015; Ciolli Mattioli et al., 2019; Waks et al., 2011),
but this is not a large or comprehensive enough ground truth dataset to facilitate a
machine learning approach to solve this problem. If more smFISH data resolving the
number of isoforms produced per gene per cell were generated, a machine learning
approach might become more feasible.
Unfortunately, I lack the skills and time necessary to create a large smFISH
dataset, so a different approach is required. The major issue underlying my list of
possible modelling issues is that as a field, we do not have a sophisticated under-
standing of the technical noise that is present in scRNA-seq data. We are aware that
technical noise, in the form of dropouts, quantification errors, batch effects, PCR
amplification bias and other sources, exists. However, the extent to which these
different sources of technical noise confound alternative splicing analyses and how
best to correct for these confounders is not known. In the next chapter, I attempt
to start solving this problem. I take another simulation based approach in which
I vary the amount of technical noise in scRNA-seq data and investigate what the
biggest confounders are when studying alternative splicing. After identifying the
major confounders, I propose solutions that could allow the field to overcome these
confounders and enable accurate alternative splicing analyses using scRNA-seq.
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3.4 Conclusions
Intriguing patterns of isoform expression exist in scRNA-seq data, but establishing
to what extent these patterns are biologically real requires a more sophisticated
understanding of the technical noise that exists in scRNA-seq. I will investigate the
extent to which technical noise confounds splicing analyses in scRNA-seq in the next
chapter.
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4Obstacles to Detecting Isoforms
Using Full-Length scRNA-seq
Data.
Negative results are just what I want. They’re just as valuable to me as
positive results. I can never find the thing that does the job best until I find
the ones that don’t.
– Attributed to Thomas Edison
Introduction
Thus far in my thesis, I have established that although software to accurately quan-
tify isoforms using scRNA-seq data exists, it remains challenging to analyse splicing
using scRNA-seq data due to uncertainty over how to correct for the large amounts of
technical noise present. To begin to understand how to correct for confounding fac-
tors in scRNA-seq to enable splicing analyses, we first need to establish what factors
are actually confounding our analyses. For example, I hypothesised in the previ-
ous chapter that technical dropouts could be confounding my splicing experiments.
Whilst it seems reasonable to suppose that scRNA-seq’s low capture efficiency might
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prevent us from accurately detecting the number of isoforms expressed in individual
cells, to the best of my knowledge this hypothesis has never been systematically
tested. Consequently, the extent to which dropouts confound splicing analyses using
scRNA-seq data is not known. The same is true for other sources of technical noise
associated with scRNA-seq.
In this chapter, I take a novel approach to investigate what confounders are
present when studying splicing using scRNA-seq. I take real scRNA-seq datasets and
select genes for which four isofoms are detected. I then use these genes to simulate
the following four scenarios: 1) all cells express one isoform per gene per cell, 2) all
cells express two isoforms per gene per cell, 3) all cells express three isoforms per gene
per cell, and 4) all cells express four isoforms per gene per cell. Importantly, in each
scenario I explicitly simulate dropout events and quantification errors. I then use
the simulated output of each scenario to ask two questions. Firstly, to what extent
is it possible to distinguish between these global differences in alternative splicing
using scRNA-seq? And secondly, what should be done to enable more accurate
splicing analysis with scRNA-seq? I find that dropouts are a major confounder when
attempting to study alternative splicing using scRNA-seq, whereas quantification
errors are a much lesser confounder. I find that different models of isoform choice
meaningfully impact on my simulation results, indicating that isoform choice may
need to be considered in future splicing analyses.
The work presented in this chapter has been released on bioRxiv, consequently
some passages have been quoted verbatim from the following source: (Westoby et al.,
2019). Additionally, some figures have been reproduced from the aforementioned
source. At the time of writing, this work is in revision for Genome Biology.
4.1 Results
A detailed description of my simulation approach can be found in the Methods
chapter, a brief description is given here for convenience. My approach for the first
scenario, in which I simulate one isoform being expressed per gene per cell, is to first
identify genes for which the expression of exactly four isoforms is detected in a real
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scRNA-seq dataset. The reasoning for selecting genes which express four isoforms is
that four isoforms is a sufficiently large number of isoforms to be sufficient to study
a range of splicing behaviours. At the same time, four isoforms is sufficiently few iso-
forms that there are not substantial concerns about an increase in the quantification
error rate due to the presence of many isoforms sharing a high degree of sequence
identity.
In the second step, I randomly select one isoform based on a plausible model
of isoform choice for the first of the genes in the first cell in the simulated dataset.
For my default model of isoform choice, I choose the isoform based on a model of
alternative splicing described by Hu et al. (Hu et al., 2017). Third, I simulate
dropouts based on a Michaelis-Menten model described by Andrews and Hemberg
(Andrews and Hemberg, 2018a). Fourth, I simulate quantification errors based on
isoform detection error estimates based on work by Westoby et al. (Westoby et al.,
2018b). I repeat these four steps for every four isoform gene and cell in our simulated
dataset, then calculate the mean number of isoforms detected for that gene per cell.
The entire process described above is one complete simulation. I run 100 simulations
for each of our four scenarios, where each scenario corresponds to one, two, three or
four isoforms being expressed per gene per cell. I then plot the distributions of the
mean number of isoforms detected per gene per cell for each scenario. A schematic
of my simulation approach is displayed in Figure 4.1. Negative control models, in
which my simulations are repeated but with no dropouts and/or quantification errors
are simulated, can be found in Figures 4.2 - 4.4.
In Figures 4.5 & 4.6, I apply my simulation approach to a dataset of H1 and H9
human embryonic stem cells (hESCs) (Bacher et al., 2017). In this dataset, each
cell’s cDNA was split into two groups and sequenced at two different sequencing
depths, enabling me to directly compare our simulation results at different sequencing
depths without biological confounders. One group was sequenced at approximately
1 million reads per cell and the other group at approximately 4 million reads per cell
on average. My simulation results for the two H1 groups are compared side by side in
Figure 4.5A. My simulation results for the two H9 groups are shown in Figure 4.6A.
scRNA-seq experiments have been found to saturate in terms of the number of genes
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detected per cell at approximately 1 million reads per cell (Svensson et al., 2017;
Ziegenhain et al., 2017). However, I observe differences in the number of isoforms
detected per gene per cell at 1 and 4 million reads per cell, indicating that the
saturation depth may differ for gene and isoform level analyses. Next, I calculate
the fraction of overlap between the isoforms expressed in the ground truth and the
isoforms detected as expressed in our simulations. In Figures 4.5B & 4.6B, I show
the distributions of the mean fraction of overlap for each gene. I will refer to the each
gene’s mean fraction of overlap between isoforms expressed in the ground truth and
isoforms detected as expressed as the ‘overlap fraction’ hereafter in the text. The
mean overlap fraction is consistently higher at 4 million reads per cell compared to
at 1 million reads per cell, indicating that our ability to accurately detect isoforms
is improved at higher sequencing depths.
Figures 4.5 & 4.6 illustrate some of the difficulties associated with splicing analysis
in scRNA-seq. At both sequencing depths, the distributions of the observed mean
number of isoforms per gene per cell are shifted to the left of their true value. In
addition, the highest mean overlap fraction observed is less than 0.8, indicating that
even in a best case scenario, we fail to detect over 20% of the isoforms expressed in the
ground truth. These effects are less extreme, but still present, for the group sequenced
at approximately 4 million reads per cell compared to the group sequenced at 1
million reads per cell. This is consistent with the hypothesis that sequencing at higher
depth reduces the extent to which isoform number is underestimated. However, even
at approximately 4 million reads per cell our simulations suggest that scRNA-seq
substantially underestimates the mean number of isoforms per gene per cell for almost
all genes. A naive analysis of these two datasets would most likely underestimate the
number of isoforms expressed per gene per cell. This casts doubt on the biological
relevance of previous observations suggesting only one isoform was typically produced
per gene per cell, although admittedly the sequencing depth per cell was generally
much greater than 4 million reads per cell in those studies (for example, Shalek et
al. sequenced approximately 27 million reads per cell (Shalek et al., 2013)).
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Figure 4.1: Schematic of our simulation approach.
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Figure 4.2: Negative control model for H1 hESCs. In the simulation results displayed,
no dropouts or quantification errors were simulated. The simulation procedure was
otherwise unchanged.
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Figure 4.3: Negative control model for H1 hESCs. In the simulation results displayed,
no dropouts were simulated. The simulation procedure was otherwise unchanged.
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Figure 4.4: Negative control model for H1 hESCs. In the simulation results displayed,
no quantification errors were simulated. The simulation procedure was otherwise
unchanged.
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Figure 4.5: The effect of sequencing depth on isoform detection. A Distributions of
the mean number of isoforms detected per gene per cell for H1 hESCs whose cDNA
was split and sequenced at approximately 1 million reads per cell or 4 million reads
per cell on average. B Distributions of the overlap fraction. Black vertical lines
represent the mean value of the distributions.
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Figure 4.6: The effect of sequencing depth on isoform detection. A Distributions of
the mean number of isoforms detected per gene per cell for H9 hESCs whose cDNA
was split and sequenced at approximately 1 million reads per cell or 4 million reads
per cell on average. B Distributions of the overlap fraction. Black vertical lines
represent the mean value of the distributions.
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One hypothesis for why our ability to detect isoforms increases with increased
sequencing depth is that the rate of dropouts is reduced. In Figures 4.7A & 4.8A, I
investigate this hypothesis by plotting the distribution of the probabilities of dropout
for each isoform (p(dropout)), as estimated using the Michaelis-Menten equation
(Andrews and Hemberg, 2018a) (see Methods chapter). I find that the distribution
is skewed towards high probabilities of dropout for the group sequenced at around
1 million reads per cell. In contrast, the distribution for the group sequenced at
around 4 million reads per cell is more skewed towards low probabilities of dropouts.
This demonstrates that my estimated dropout probabilities are different at the two
sequencing depths, as expected.
Overall, the data in Figures 4.5 & 4.7A and in Figures 4.5 & 4.8A support the
hypothesis that when the rate of technical dropouts decreases, the accuracy of isoform
number estimation increases. However, as the dataset was only sequenced at two
depths, I only have two data points available to investigate my hypothesis. To extend
my investigation, I assume that the distributions of dropout probabilities observed in
Figures 4.7A & 4.8A can be modelled as Beta distributions. The Beta distribution is
parameterised by two values, α and β, and I find that it approximates the probability
distributions well (see bottom panels of Figures 4.7A & 4.8A). Therefore, I select five
values of α and β that generate differently shaped dropout distributions, as shown
in Figures 4.7B & 4.8B. I then perform five further simulation experiments. In
each simulation experiment, I sample our dropout probabilities from one of our Beta
distributions. The results of these experiments are shown in Figures 4.7C & D and
in Figures 4.8C & D.
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Figure 4.7: The impact of dropouts on isoform detection. A shows the distribution
of the probabilities of dropouts (p(Dropout)) in each group of H1 hESCs and an
approximation of these distributions using a Beta distribution. At 1 million reads
per cell, α = 1.31 and β = 0.74 in the approximated Beta distribution. At 4 million
reads per cell, α = 0.72 and β = 1.03 in the approximated Beta distribution. B
shows five Beta Distributions from which dropout probabilities were sampled from
in the simulations used to generate C and D. In C, the distribution of the mean
number of isoforms detected per gene per cell is shown for simulations in which one
isoform was produced per gene per cell. Each plot corresponds to a simulation in
which dropout probabilities were sampled from one of the distributions shown in B.
D shows the overlap fraction for each simulation. Plots shown in C & D are for H1
hESCs sequenced at 4 million reads per cell. Black vertical lines represent the mean
value of the distributions.
Figure 4.8: The impact of dropouts on isoform detection. A shows the distribution
of the probabilities of dropouts (p(Dropout)) in each group of H9 hESCs and an
approximation of these distributions using a Beta distribution. At 1 million reads
per cell, α = 1.31 and β = 0.74 in the approximated Beta distribution. At 4 million
reads per cell, α = 0.72 and β = 1.03 in the approximated Beta distribution. B
shows five Beta Distributions from which dropout probabilities were sampled from
in the simulations used to generate C and D. In C, the distribution of the mean
number of isoforms detected per gene per cell is shown for simulations in which one
isoform was produced per gene per cell. Each plot corresponds to a simulation in
which dropout probabilities were sampled from one of the distributions shown in B.
D shows the overlap fraction with the ground truth for each simulation. Plots shown
in C & D are for H9 hESCs sequenced at 4 million reads per cell.
In Figures 4.7C & 4.8C, I show the mean detected number of isoforms per gene
per cell for the scenario where each gene produces one isoform per gene per cell. As
I move from the top to the bottom of Figures 4.7C & 4.8C, the value of α decreases,
corresponding to scenarios where the probability of dropout is more frequently close
to zero. As α decreases, the distributions of mean detected isoforms per gene per
cell shift further to the right and closer to the true number of isoforms produced per
cell. In Figures 4.7D & 4.8D, I find that the mean overlap fraction increases as α
decreases, corresponding to the mean probability of dropout decreasing. I conclude
from Figures 4.7 C & D and from Figures 4.8 C & D that reducing the dropout rate
would likely improve the accuracy of splicing analyses performed using scRNA-seq.
4.1.1 Quantification errors are a relatively minor obstacle to
studying alternative splicing
A benchmark of isoform quantification softwares in full length coverage mouse scRNA-
seq datasets found that the error rate of many software tools was low and comparable
to bulk RNA-seq (Westoby et al., 2018b). This is encouraging, however it should be
noted that the error rate is likely to be substantially higher for non-model organisms
with less well annotated genomes than the mouse genome. As isoform quantification
is a key step of many scRNA-seq alternative splicing analysis pipelines, it would
be beneficial to understand how quantification errors impact our ability to study
alternative splicing, both when the error rate is high and when the error rate is low.
As my interest in this study is the detected number of isoforms per gene per cell,
I am only interested in quantification errors which lead to changes in the number of
isoforms detected. We simulate two types of quantification errors, false positives and
false negatives. In this context, a false positive occurs when an isoform is called as
expressed by the quantification software when there are no reads from that isoform.
Note that this means that if an isoform is expressed in a cell but no reads are captured
from it (i.e. a dropout), but the quantification software calls it as expressed, we
would define this as a false postive event. A false negative occurs when an isoform is
not called as expressed by the isoform quantification software when reads from that
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isoform are present. Based on my previous benchmark (Westoby et al., 2018b), I
estimate that the probability of false positive events (pFP ) is around 1% and that
the probability of false negative (pFN) events is around 4% (see Methods chapter).
In my simulations in Figure 4.9, I vary both of these probabilities in the range of
0% to 50% . Figure 4.9A shows how the mean number of isoforms detected per gene
per cell distributions changes as the probability of false positives and false negatives
alters when every gene expresses one isoform per cell. Importantly, even when the
probability of false positives and false negatives is zero, there are many genes for
which the mean number of detected isoforms per gene per cell is not equal to one,
the true number of expressed isoforms. This indicates that even if a perfect, 100%
accurate isoform quantification tool existed, there would still be substantial barriers
to studying alternative splicing using scRNA-seq. We suspect that the reason a 100%
accurate isoform quantification tool would underestimate the number of isoforms per
gene per cell is that isoform quantification tools usually only quantify the reads that
are present. Due to the high number of dropouts in scRNA-seq, many expressed
isoforms do not generate reads and thus would be called as unexpressed by a 100%
accurate isoform quantification tool, leading to an underestimate of the number of
isoforms present.
Unsurprisingly, increasing the probability of false positives causes an increase in
the mean number of detected isoforms, whilst increasing the probability of false neg-
atives causes the mean number of detected isoforms to decrease, as shown in Figure
4.9B. Somewhat counterintuitively, increasing the probability of false positives from
0.0 to 0.1 could be considered to ‘improve’ the accuracy of isoform detection by
shifting the distribution of the mean number of isoforms detected to slightly higher
values and away from zero. This is probably because slightly increasing the proba-
bility of false positives allows some dropout events to be detected. In Figure 4.10, I
investigate how the overlap fraction is affected by changes in the probability of false
positives and negatives. I find that the overlap fraction increases as the probabil-
ity of false positives increases, supporting the hypothesis that some dropout events
are ‘rescued’ by false positive events. However, I note that in addition to ‘rescuing’
some dropouts, many unexpressed isoforms are also called as expressed, as indicated
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by mean numbers of detected isoforms per gene per cell that are greater than one.
When the probability of false positives and false negatives are equally increased (the
diagonal of Figure 4.9A), the mean number of detected isoforms increases, suggesting
that the increased rate of false positives dominates over the increased rate of false
negatives. This is likely to be because more isoforms are unexpressed than are ex-
pressed, and thus there are more opportunities for false positive events than for false
negative events. Overall, I find that high probabilities of false positives and false
negatives decrease my ability to accurately detect expressed isoforms in scRNA-seq.
In Figure 4.9A, I showed that even when isoform quantification is 100% accurate,
we underestimate the number of expressed isoforms for many genes. One hypothesis
for why we are less able to detect isoforms in scRNA-seq data compared to in bulk
RNA-seq data is that the sequencing depth is typically lower. A lower sequencing
depth could mean that for many expressed isoforms, there are too few or no reads
that would allow the expressed isoform to be uniquely identified.
To investigate whether sequencing depth could explain the difference in our abil-
ity to detect isoforms in bulk and scRNA-seq, I first identified a matched bulk
and scRNA-seq dataset. The dataset I selected was a mouse Embryonic Stem Cell
(mESC) dataset in which mESCs were cultured in 2i + LIF media (Kolodziejczyk
et al., 2015). In the mESC dataset, each cell was sequenced to approximately 7 mil-
lion reads on average, whilst the matched bulk data was sequenced to approximately
44 million reads.
To determine whether sequencing depth was responsible for the difference in
our ability to detect isoforms in bulk and scRNA-seq, I randomly downsampled the
bulk mESC RNA-seq dataset to 7 million reads 50 times. Using the orginal, un-
downsampled bulk RNA-seq dataset as the ground truth, in Figure 4.11 I plotted
the mean overlap fractions for each gene in the downsampled bulk RNA-seq dataset
and the matched scRNA-seq dataset. I found that the mean overlap fraction was sig-
nificantly higher (p < 2.2x10−16, Welch two sample t-test) for the downsampled bulk
RNA-seq than for the matched scRNA-seq. This indicates that a lower sequencing
depth does reduce our ability to detect isoforms, but that this does not fully ex-
plain the reduction in ability to detect isoforms between bulk and scRNA-seq. One
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explanation for the reduction in ability to detect isoforms in scRNA-seq, over and
above the reduction expected due to reduced sequencing depth, is that there could
be heterogeneous isoform expression between individual cells. If this were the case,
using the isoforms detected in bulk RNA-seq as the ground truth would not be ap-
propriate. There are also potential technical explanations for the reduced ability to
detect isoforms using scRNA-seq. For example, the enzymatic reactions associated
with library preparation may have reduced efficiency when there is a lower amount
of starting material, as is the case for scRNA-seq. Determining to what extent het-
erogeneous isoform expression and technical factors are responsible for our reduced
ability to detect isoforms in scRNA-seq will require further study of cellular isoform
heterogeneity and the technical noise associated with scRNA-seq.
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Figure 4.9: The impact of quantification errors on isoform detection. A Distribu-
tions of the mean number of isoforms detected per gene per cell when one isoform
is expressed per gene per cell. The probability of false positives (pFP ) increases
from left to right and the probability of false negatives (pFN) increases from top to
bottom. The dataset shown is H1 hESCs whose cDNA was split and sequenced at
approximately 4 million reads per cell on average. B Summary plots of the average
of the mean number of isoforms detected per gene per cell when pFP , pFN , or pFP
and pFN are increased.
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Figure 4.10: The impact of quantification errors on isoform detection. Distributions
of the overlap fraction with the ground truth when one isoform is expressed per gene
per cell. The probability of false positives (pFP ) increases from left to right and
the probability of false negatives (pFN) increases from top to bottom. The dataset
shown is H1 hESCs whose cDNA was split and sequenced at approximately 4 million
reads per cell on average.
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Figure 4.11: Boxplots of the mean overlap for each gene in the downsampled bulk
and matched scRNA-seq datasets. The mean overlaps for each gene are overlaid on
the boxplots as black points. Plots shown for Kolodziejczyk et al. mESCs cultured
in standard 2i media + LIF (Kolodziejczyk et al., 2015).
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4.1.2 Different models of isoform choice meaningfully change
our simulation results
It is possible that different mechanisms of isoform choice at the cellular level could al-
ter our ability to correctly detect which isoforms are present in scRNA-seq. Because
there is uncertainty over the mechanism of isoform choice within single cells, I imple-
ment four different models of isoform choice in our simulations. I then ask whether
different models of isoform choice alter the mean number of detected isoforms per
gene per cell in our simulations.
I give a detailed description of how each of these models was implemented in
the Methods chapter, here I provide a brief description of each model and the ratio-
nale behind it. I first model the alternative splicing process as a type III Weibull
distribution, using a model described by Hu et al. (Hu et al., 2017). Based on ob-
servations about the molecular process of alternative splicing, Hu et al. suggested
that the process could be well modelled by an extreme value distribution, and they
found that a Weibull distribution best fits the expression levels of isoforms in bulk
RNA-seq. In my second implemented model, I attempt to infer the probability of
each isoform being ‘chosen’ to be expressed in a cell. I calculate the probability
of an isoform being chosen based on the observed probability of the isoform being
detected. My third model is identical to the second except that I allow the proba-
bility of an isoform being ‘chosen’ to vary between cells. I achieve this by sampling
the probability of an isoform being chosen from a Beta distribution, using a similar
approach as Velten et al. (Velten et al., 2015). In my final model, I choose a random
number between 0 and 1 for each isoform. The random number is assigned to be
that isoform’s probability of being chosen, weighted against the probabilities of the
gene’s other isoforms being chosen. For brevity, I will refer to these four models as
the Weibull model, the inferred probabilities model, the cell variability model and
the random model below.
Figures 4.12 & 4.13 show the distributions of the mean number of detected iso-
forms when one, two, three or four isoforms are expressed per gene per cell for each
model. Importantly, the distributions visibly differ between models. To quanti-
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tatively confirm this, I perform a K-sample Anderson-Darling test on each row of
graphs in Figures 4.12 & 4.13. I find that the distributions for 1, 2 and 3 isoforms
significantly differ between the isoform choice models (p<0.001, see Appendix 3 Ta-
bles for details). In contrast, the distributions for 4 isoforms have a p-Value of 1.0
(1 million reads) and 0.999999 (4 million reads), consistent with these distributions
originating from the same population. This is as expected, as in the 4 isoform simu-
lations all of the isoforms are picked, and thus we would not expect isoform choice to
matter. My qualitative and quantitative analyses indicate that different mechanisms
of isoform choice alter my ability to detect splice isoforms in scRNA-seq. Therefore,
a better understanding of the mechanism of isoform choice across the transcriptome
could be key to enabling splicing analysis using scRNA-seq data. Without knowing
how best to model isoform choice, my results suggest the presence of a substantial
confounder.
My simulation results when using the inferred probability model compared with
the cell variability model are almost identical. Given that the only difference between
these models is whether or not isoform preference is allowed to vary between cells,
this indicates that cellular heterogeneity in isoform preference does not change our
ability to detect isoforms under the inferred probability model. I perform a K-
sample Anderson-Darling test between the inferred probabilities and cell variability
models for each row of Figures 4.12 & 4.13, and I find that these distributions do
not significantly differ (see Appendix 3 Tables). I also observe that the results of
the random model of isoform choice look more like the inferred probability and
cell variability models than the Weibull model. This could be because the Weibull
model determines the probability of an isoform being chosen based on the rank of
that isoform, whereas all of the other models do not use a rank based approach.
These observations and the difficulty I have interpreting them illustrate the need for
a better understanding of how best to model isoform choice.
I hypothesise that the reason that different models of isoform choice differ in
ability to detect isoforms could be because some models of isoform choice prefentially
pick isoforms with a low probability of dropout, whereas other models do not exhibit
this preference. To investigate whether different models of isoform choice differ in
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their preference for picking isoforms with a low probability of dropout, in Figures
4.14-4.17, I plot the distributions of the probabilities of dropout for the isoforms
chosen when one, two, three or four isoforms are picked using each of our four models.
I would expect models with a preference for picking isoforms with a low probability
of dropout to have distributions of dropout probabilities more skewed towards zero
when small numbers of isoforms are chosen. When larger numbers of isoforms are
chosen, I would expect to observe less skewed distributions, because the model is
effectively forced to choose isoforms with higher probabilities of dropout due to a lack
of alternatives. In contrast, if a model had no preference for picking isoforms with
a low probability of dropouts, I would expect the distributions of the probabilities
of dropout to be identical regardless of whether one, two, three or four isoforms are
chosen.
In Figures 4.14-4.17, I find that only the Random model does not exhibit any
preference for choosing isoforms with a low probability of dropout. Of the Weibull,
inferred probability and cell variability models, the Weibull model has the dropout
probability distribution most skewed towards zero when one isoform is picked, in-
dicating that the Weibull model has the strongest preference for picking isoforms
with a low probability of dropout. The Weibull model also detects the highest mean
number of isoforms per gene per cell when one isoform is expressed in the ground
truth, consistent with the hypothesis that the difference in the performance of the
isoform choice models may be related to their preference for picking isoforms with a
low probability of dropout.
If isoform detection ability of the isoform choice models is mainly determined by
their preference for picking isoforms with a low probability of dropout, I would expect
that if the probability of dropout was globally changed, it would alter the isoform
choice models’ abilities to detect isoforms. I investigate this in Supplementary Figure
4.18 by sampling dropout probabilities from the Beta distributions shown in Figure
4.7B. I find that more isoforms are detected by all isoform choice models when
dropouts are sampled from distributions that are more skewed towards zero. This
supports the hypothesis that choosing isoforms with a low probability of dropout
improves the ability of isoform choice models to accurately detect isoforms.
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Figure 4.12: Different models of isoform choice alter our ability to detect isoforms.
A Distributions of the mean number of isoforms detected per gene per cell for H1
hESCs sequenced at approximately 1 million reads per cell using the Weibull model
of isoform choice (Bacher et al., 2017; Hu et al., 2017). B shows the same distribu-
tions when the random model is used. C shows the distributions when the inferred
probabilities model is used. D shows the distributions when the cell variability model
is used. See the main text for a detailed description of each model. Equivalent plots
for the H9 datasets can be found in Appendix 3, Figures 9.3 & 9.5
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Figure 4.13: Different models of isoform choice alter our ability to detect isoforms.
A Distributions of the mean number of isoforms detected per gene per cell for H1
hESCs sequenced at approximately 4 million reads per cell using the Weibull model
of isoform choice. B shows the same distributions when the random model is used.
C shows the distributions when the inferred probabilities model is used. D shows the
distributions when the cell variability model is used. See the main text for a detailed
description of each model. Equivalent plots for the H9 datasets can be found in
Appendix 3, Figures 9.3 & 9.5
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Figure 4.14: Distributions of the probabilities of dropouts for the isoforms selected
by the Weibull model when one, two, three and four isoforms were picked by the
model.
132
Figure 4.15: Distributions of the probabilities of dropouts for the isoforms selected
by the Random model when one, two, three and four isoforms were picked by the
model.
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Figure 4.16: Distributions of the probabilities of dropouts for the isoforms selected by
the inferred probabilities model when one, two, three and four isoforms were picked
by the model.
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Figure 4.17: Distributions of the probabilities of dropouts for the isoforms selected
by the cell variable model when one, two, three and four isoforms were picked by the
model.
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Figure 4.18: Distributions of the mean number of isoforms detected per gene per cell
under different isoform choice models when dropout probabilities are sampled from
the Beta distributions in Figure 4.7B.
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4.1.3 Some models of isoform choice are more plausible than
others
In the previous section, I observed that our simulation results for the inferred proba-
bility and cell variability models were extremely similar. To investigate how general
my observation that allowing isoform preference to vary between cells does not alter
our simulation results is, I developed three additional models of isoform choice. In
the first model, the probability of selecting each isoform was sampled from a trun-
cated Normal distribution with a mean of 0.25 and a standard deviation of 0.06 in
each cell. In the second model, I sample the probability of selecting each isoform
from a Bernoulli distribution, in which the value 1 is chosen 25% of the time and the
value 0 is chosen 75% of the time in each cell. In the final model, the probability
of selecting each isoform is always 0.25 (the ‘p=0.25’ model). The three models are
illustrated in Figure 4.19A and additional details are given in the Methods chapter.
Under the Normal and the Bernoulli models, the probability of picking each isoform
varies between cells, whereas the probability of picking each isoform is constant be-
tween cells under the p=0.25 model. Importantly, although the distributions I am
sampling isoforms from have very different shapes, the mean probability of picking
each isoform is 0.25 for all three distributions.
In the second to fifth rows in Figure 4.19, I show the distribution of the mean
number of isoforms detected per gene per cell when we simulate one isoform being
expressed per gene per cell. There is no visible difference between my simulation
results in each row regardless of which model of isoform choice is used. This is sup-
ported by a non-significant result in a K-sample Anderson-Darling test (p = 0.998).
These findings are consistent with the hypothesis that my simulation results are un-
changed whether or not the model of isoform choice used allows cell variability in
isoform choice. I suggest that this is because we are reporting the mean number
of isoforms detected per gene per cell in our simulations. Across many cells and
rounds of simulation, the mean probability of selecting isoforms seems to determine
the shape of our simulation result distributions, whereas the higher moments of the
isoform choice probability distribution are apparently unimportant. Thus, includ-
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ing cell variability in our isoform choice model appears not to matter. For future
scRNA-seq studies in which the mean number of isoforms detected per gene per cell
is an important metric, I conjecture that there is no need to model cellular variabil-
ity in isoform choice, regardless of whether or not such variability exists in reality.
Of course, if future studies are interested in precisely what isoforms are present in
individual cells rather than a population mean, understanding whether or not cell
variability in isoform choice exists is likely to be important.
I have established that our ability to detect isoforms using scRNA-seq is severely
affected by the high rate of dropouts in scRNA-seq. Therefore, attempts to infer a
biologically meaningful model of isoform choice from scRNA-seq data are likely to
fail. However, I can make some general observations to help rule out certain models
of isoform choice. In Figure 4.20A, I have ranked isoforms by their mean expression
relative to other isoforms from the same gene (so for example, an isoform with rank
1 has the highest mean expression, an isoform with rank 2 has the second highest
mean expression, and so on). Unsurprisingly, we find that the most highly ranked
isoforms are substantially more highly expressed than lowly ranked isoforms. This is
consistent with the finding that many genes appear to have a ‘major’, more highly
expressed isoform, and one or more ‘minor’, less highly expressed isoform (Wang
et al., 2008; Gonza`lez-Porta et al., 2013). I suggest that this behaviour needs to
be represented in some way in future models of isoform choice, and models that do
not represent it (for example, our Random, Normal, Bernoulli and p=0.25 models)
are probably overly simplistic. In Figure 4.20B I rank isoforms by their probability
of dropout, where the isoform with the lowest probability of dropout compared to
other isoforms from the same gene has rank 1. I observe a very similar pattern
in which highly ranked isoforms have a substantially lower probability of dropout
relative to lowly ranked isoforms, further supporting the finding that ‘major’ and
‘minor’ isoforms exist for many genes. I find a similar pattern of results for the H9
hESCs and the H1 hESCs sequenced at 4 million reads, shown in Figures 4.21 - 4.23.
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Figure 4.19: Some models of isoform choice are more plausible than others. We model
the probability of picking any given isoform as a Normal distribution, a Bernoulli
distribution and a constant probability, all with the same mean (0.25) (top row of
graphs). In the following rows, I show the distributions of the mean number of
isoforms per gene per cell detected when each model of isoform choice is used. The
second row is H1 hESCs sequenced at 1 million reads, the third row is H1 hESCs
sequenced at 4 million reads, the fourth row is H9 hESCs sequenced at 1 million
reads and the fifth row is H9 hESCs sequenced at 4 million reads.
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Figure 4.20: A Histograms of mean isoform expression, ordered by isoform rank. B
Histograms of dropout probability, ordered by isoform rank. All plots shown are for
H1 hESCs sequenced at 1 million reads per cell.
Figure 4.21: A Histograms of mean isoform expression, ordered by isoform rank. B
Histograms of dropout probability, ordered by isoform rank. All plots shown are for
H1 hESCs sequenced at 4 million reads per cell.
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Figure 4.22: A Histograms of mean isoform expression, ordered by isoform rank. B
Histograms of dropout probability, ordered by isoform rank. All plots shown are for
H9 hESCs sequenced at 1 million reads per cell.
Figure 4.23: A Histograms of mean isoform expression, ordered by isoform rank. B
Histograms of dropout probability, ordered by isoform rank. All plots shown are for
H9 hESCs sequenced at 4 million reads per cell.
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4.1.4 A mixture modelling approach suggests genes for which
four isoforms are detected typically express around
three isoforms per cell
I ask whether my simulation based approach could shed any light on the biological
question of how many isoforms are expressed per gene per cell. To do this, I simulate
one, two, three and four isoforms being expressed per gene per cell and compare
the mean isoforms detected distributions to the distribution of isoforms detected per
gene per cell for genes for which four isoforms were detected in the real dataset (see
Figure 4.24A & B). I then approximate each distribution as a log normal distribution
and take a mixture modelling approach to estimate the mixing fraction for each of
our simulated distributions in the real distribution.
Figure 4.24C shows the mixing fractions found over 100 iterations of expectation
maximisation for H1 hESCs sequenced at approximately 1 million reads per cell. In
Figure 4.24C, the mixing fraction for the distribution corresponding to four isoforms
being expressed per gene per cell is over 90%. This suggests that genes detected to
express four isoforms in this dataset typically express four isoforms per gene per cell.
However, in Figure 4.24D, after 100 iterations of expectation maximisation for H1
hESCs sequenced at 4 million reads per cell, the distribution with the largest mixing
fraction is that corresponding to three isoforms per gene per cell. This suggests
that genes detected to express four isoforms in this dataset most often express three
isoforms per gene per cell. As the cDNA sequenced at 1 and 4 million reads per cell
came from the same population of cells, it is unlikely that both of these statements
are true. I propose several possible explanations for why we might observe this result.
First, I might be over-estimating the dropout rate at 1 million reads per cell. As
there is less information with which to infer the dropout rate at 1 million reads per
cell compared to at 4 million reads per cell, it is plausible that our estimates of the
dropout rate are less accurate at 1 million reads per cell. Whether or not there is a
systematic bias towards over-estimating the dropout rate at low sequencing depths
is unknown, and goes beyond the scope of this thesis.
Second, I have established that the model of isoform choice influences the outcome
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of our simulations but we do not know which model of isoform choice is correct.
Therefore I am (almost certainly) attempting to fit distributions that do not represent
reality. Figure 4.24 shows my mixture modelling approach using the Weibull model
of isoform choice. I note however that fitting our alternative models of isoform choice
achieves a similar result, in that the largest mixing fraction goes to four isoforms at
1 million reads per cell and to three isoforms or fewer at 4 million reads per cell (see
Appendix 3 Figures 9.8-9.14).
Third, the genes detected to express four isoforms differ between the sequencing
depths of 1 and 4 million reads. More genes are detected to express four isoforms at
4 million reads (1443 versus 1543 for the H1 cells, 1453 versus 1524 for the H9 cells).
Whilst this is not a dramatic difference, it does mean that the mixing fractions
between these two depths could genuinely differ, although this is unlikely to fully
explain the observed difference.
Fourth, I assume all genes for which four isoforms are detected in the real data
actually express four isoforms. Due to dropouts and quantification errors, this may
not be accurate, and some genes for which four isoforms are detected may express a
different number of isoforms in reality.
Fifth, my parameter estimation for quantification errors and isoform choice mod-
elling is not one hundred percent accurate. I cannot rule out that this could be
confounding the results of our mixture modelling approach.
My mixture modelling experiments broadly support the hypothesis that it might
be common for a cell to produce more than one isoform per gene. However, there
are clearly a lot of potential confounders in our approach, many of which relate to
uncertainty about dropouts, quantification errors and isoform choice. I note that
without having either a ground truth knowledge of how many isoforms are produced
from given genes in given cells, or good estimates of dropout probabilities, quantifi-
cation errors and isoform choice mechanism, it is hard to imagine how an accurate
and reliable estimate of the number of isoforms produced per gene per cell could be
obtained.
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Figure 4.24: Mixture models. A and B Distributions of detected isoforms per gene
per cell (blue) and log normal fitted distributions (orange) for H1 cells sequenced at
1 million reads per cell (A) or 4 million reads per cell (B) under the Weibull model.
C and D Mixing fractions vs iterations of expectation maximisation for 1 million
reads per cell (C) and 4 million reads per cell (D). Each coloured line represents the
distributions for one, two, three or four isoforms being simulated as expressed per
gene per cell. Equivalent plots for other isoform choice models and H9 cells can be
found in Appendix 3, Figures 9.8-9.14.
4.2 Discussion
In this study, I use a novel simulation based approach to ask whether it is possible
to study alternative splicing at the level of individual cells using scRNA-seq. In my
simulations, I simulate four scenarios in which every gene produces one, two, three or
four isoforms per gene per cell. That it is difficult to clearly distinguish between these
four situations emphasises the challenges associated with distinguishing the much
subtler and more complex patterns of alternative splicing that likely exist in reality.
Whilst scRNA-seq is capable of detecting some splicing events, the confounding
effect of dropouts means we are likely to underestimate the number of splicing events
occurring in individual cells.
I next ask what limitations must be overcome to make alternative splicing anal-
ysis possible using scRNA-seq. I find that reducing the probability of dropouts
improves our ability to accurately detect isoform number. Therefore, reducing the
frequency of dropouts could be one method to improve the accuracy of splicing anal-
yses in scRNA-seq. To some extent, this could be achieved by sequencing cells more
deeply, although I note that at 4 million reads per cell we still substantially underes-
timate isoform number in the H1 hESCs. Unfortunately, extremely deeply sequenced
datasets (eg. >10 million reads per cell) are likely to suffer more with PCR arte-
facts and potentially a higher false positive rate of isoform detection (Islam et al.,
2014; Kanagawa, 2003). Fundamentally, the low capture efficiency of scRNA-seq is
likely to be a consequence of a small amount of starting material. This can probably
be rescued to some extent by more PCR cycles and sequencing at higher depths,
however I would not expect this to fully solve the problem.
A more radical way to overcome confounders due to dropouts would be if scRNA-
seq technologies changed in some fundamental way that increased capture efficiency.
Whether this is feasible is unclear. Alternatively, I note that if we could estimate
the probability of dropout for each isoform more accurately, in theory it should
be possible to correct for confounding effects due to dropouts in splicing analyses.
Therefore, to enable splicing analysis using scRNA-seq, either the capture efficiency
of the technology needs to improve, or more work characterising the probability of
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dropouts at an isoform level is required.
In this chapter, I exclusively considered the impact of technical dropouts on
isoform detection. However, it is known that many genes are heterogeneously ex-
pressed, whether due to ‘bursty’ transcription or cell type specific expression (Urban
and Johnston, 2018). Ideally, the impact of biological dropouts on isoform detection
would be evaluated alongside the impact of technical dropouts. Unfortunately, to
the best of my knowledge, there is currently no reliable methodology to distinguish
between biological and technical dropouts. The goal of imputation approaches is
to identify and correct for technical dropouts, but a recent benchmark found that
imputation approaches often introduce a high rate of false positive results (Andrews
and Hemberg, 2018b). This indicates that the problem of distinguishing between
biological and technical dropouts is not yet solved. As it is not currently possible
to resolve between biological and technical dropouts, it is also challenging to accu-
rately model biological dropouts, as little is known about their prevalence and how
the frequency of biological dropouts might vary with genomic features. I hope that
future work in this space will enable more accurate identification of biological and
technical dropouts, thus enabling studies such as mine to be extended to account for
biological as well as technical dropouts.
Long read technologies could in theory enable 100% accurate isoform quantifica-
tion, if issues due to a high base calling error rate could be overcome (Fu et al., 2019).
However I find that even when no isoform detection errors occur, our ability to ac-
curately detect isoforms is very limited. Therefore, long read technologies or isoform
quantification software improvements alone are not sufficient to enable accurate splic-
ing analysis in scRNA-seq. In addition, I note that at present, the read throughput
of long read platforms is too low to enable meaningful isoform detection and quan-
tification across a large number of cells (Arzalluz-Luque and Conesa, 2018). A more
immediate way in which long read technologies could improve isoform quantification
accuracy is by using long read technologies to improve transcriptome annotations.
In many non-model organisms, a high proportion of isoforms are missing from ref-
erence transcriptomes, making the problem of isoform detection and quantification
substantially harder. Long read approaches combined with tissue specific transcrip-
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tome curation could dramatically improve isoform quantification accuracy in poorly
annotated organisms. More accurate isoform detection and quantification would in
turn improve our ability to gain biological insight from sequencing data collected
from these organisms.
A limitation of the methodology in this chapter is that my approach for simulating
quantification errors is very simplistic. In particular, I assume that the probability
of a false positive or a false negative event is constant, and does not depend on
the GC content, length, magnitude of expression or any other relevant features of
the isoform being simulated. In reality, the probability of isoform detection errors
probably does depend on factors such as GC content and how highly expressed the
isoform is. However, relatively little research has been done into the relationship
between features of isoforms, such as GC content and magnitude of expression, and
the probability of isoform detection errors. Further research into how genomic and
other features of isoforms affect the likelihood of isoform detection and quantification
errors would enable more accurate error models to be built in future. This would
be valuable both in studies such as this one and more generally, as it would enable
more sophisticated error correction models to be developed.
Little is known about the biological process of isoform choice in individual cells
for most genes. Thus, accurately modelling this process is challenging. I find that
different models of isoform choice alter our simulation results. This indicates that
without better understanding of the process of isoform choice, alternative splicing
analyses are potentially confounded by this unknown factor. Research into the pro-
cess of isoform choice within individual cells across the transcriptome would enable
more accurate models of isoform choice to be built, reducing or removing this con-
founder from future alternative splicing analyses. An important finding from my
study is that the ability of isoform choice models to accurately detect isoforms is
correlated with the preference of isoform choice models for choosing isoforms with a
low probability of dropout. It would therefore be highly relevant to establish whether
cells have a preference for expressing isoforms with a low probability of dropout. Iso-
forms with a low probability of dropout are in practice usually isoforms which are
highly expressed. Therefore, if cells have a preference for expressing highly expressed
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isoforms with a low probability of dropout, I would expect it to be relatively easy to
accurately detect how many isoforms are expressed in individual cells. In contrast, if
it is common for cells to express lowly expressed isoforms with a high probability of
dropout, I would expect it to be much harder to accurately detect the number of ex-
pressed isoforms using scRNA-seq. Establishing which scenario is more biologically
relevant would therefore be highly valuable to the single cell community.
It is important to note that the probabilistic models of isoform choice used in our
study are unlikely to be realistic models of isoform choice for two reasons. Firstly, we
know little about the underlying biological process of isoform choice for most genes.
Therefore at best the models we have devised in this study are educated guesses as
to what the true underlying process might be. Secondly, it is likely that the isoforms
chosen by our isoform choice models will have an impact on the probability of a quan-
tification error occurring. Different isoforms have different read generation biases,
and will generate reads with different mapping properties. In our simulations, we
have not modelled the impact of, for example, different splice junction abundances
on our ability to detect isoforms, although factors such as this are likely to have an
impact on our ability to detect isoforms. I would welcome future studies addressing
the more nuanced issues associated with the interplay between isoform choice and
quantification errors, although I believe that a better understanding of how to ac-
curately model isoform choice and quantification errors would be a prerequisite to
such studies. If isoform expression is found to be heterogeneous between cells, inter-
play between isoform choice and isoform quantification errors could partly explain
why we were less able to detect isoforms present in mESC scRNA-seq data than in
downsampled bulk RNA-seq.
I am able to detect evidence in support of ‘major’ and ‘minor’ isoforms, and pro-
pose that future models of isoform choice should attempt to capture this behaviour.
However, I note that whilst my observations help discard models of isoform choice, I
believe that scRNA-seq is currently too confounded by dropouts to accurately infer
a model of isoform choice at the single cell level. I suggest that smFISH would be a
more appropriate technology to investigate how isoform choice is regulated in indi-
vidual cells. Indeed, smFISH has previously been used to study alternative splicing
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and isoform choice in individuals cells for a small number of genes (Velten et al.,
2015; Ciolli Mattioli et al., 2019; Waks et al., 2011)
The results of our mixture modelling experiments are consistent with multiple
isoforms being produced per gene per cell, however I note that our mixture modelling
experiments are heavily confounded by a lack of understanding about dropouts,
isoform choice and perhaps quantification errors to a lesser extent. Therefore, I
argue that at this time, scRNA-seq will not be able to provide the answer to basic
biological questions about how many isoforms are produced per gene per cell.
In addition to detecting isoforms, isoform quantification tools attempt to deter-
mine how highly expressed isoforms are. Isoform quantification is a substantially
harder problem than isoform detection. Due to uncertainties over how highly ex-
pressed isoforms are in individual cells, how best to model PCR amplification bias
and differences in library sizes between individual cells and how best to incorporate
relative expression into a model of isoform quantification errors, I suspect isoform
quantification is also likely to be substantially harder to model than isoform de-
tection. For these reasons, I have focused on isoform detection in this study, but
suggest that future work investigating our ability to detect the relative expression
of isoforms would be highly valuable to the field. I note that although we have not
directly evaluated our ability to resolve the relative expression magnitude of isoforms
in this study, that we often struggle to accurately detect isoforms implies that we
would often struggle to determine how highly expressed they are.
Based on my findings, at this time I do not recommend attempting alternative
splicing analysis using scRNA-seq. As my analysis suggests that one of the greatest
confounders in studying splicing is dropouts, it may be relatively safe to study al-
ternative splicing using only highly expressed isoforms with very few dropouts. For
many genes in many datasets, this severely limits the scope in which splicing can
be studied. However, I make actionable suggestions for how splicing analysis could
be enabled in the future. An improved understanding of the prevalence of techni-
cal dropouts at the isoform level could enable us to reduce confounding effects due
to dropouts. Improvements to the capture efficiency of scRNA-seq would similarly
reduce confounding effects due to dropouts. Increased study of isoform choice at
149
the single cell level using technologies such as smFISH would enable better models
of isoform choice to be generated, eliminating confounders. Although I find quan-
tification errors to be a relatively small confounder, further reducing quantification
errors using long read technologies and more accurate quantification tools would be
welcome. Although I have concluded that accurate alternative splicing analysis with
scRNA-seq is not possible today, I am optimistic that it could become possible in
the near future.
Conclusions
At present, alternative splicing analyses using scRNA-seq are substantially con-
founded. Better characterisation of dropouts or improvements in capture efficiency
would reduce confounding effects due to dropouts. Further research into the process
of isoform choice at a single cell level would reduce confounding effects caused by a
lack of knowledge about isoform choice. Quantification errors are a relatively minor
confounder, although improvements in this area are still welcome. At present, to the
best of my knowledge, a large scale unconfounded analysis of the number of isoforms
produced per gene per cell has not been performed. Therefore, we still do not know
how many isoforms are typically produced per gene per cell.
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5Methods
The proper method for inquiring after the properties of things is to deduce
them from experiments.
– Isaac Newton, quoted by (Strong, 1951)
5.1 Simulation based benchmarking of isoform quan-
tification using scRNA-seq
The methods in section 5.1 are for the experiments carried out in chapter 2, and the
experiments presented in Figures 3.1 & Figures 3.2.
5.1.1 Software tools
A variety of software tools were used in chapter 2. An overview of each tool and its
assumptions are provided below. Table 5.1 is a summary table of the isoform quan-
tification tools evaluated in this benchmark provided at the end of this subsection.
STAR
STAR was the aligner used in the RSEM simulations, and by RSEM and eXpress
in the benchmark of isoform quantification (Dobin et al., 2013; Li and Dewey, 2011;
151
Roberts and Pachter, 2013). STAR was chosen as the aligner of choice in part
because the algorithm underlying STAR is designed to facilitate the alignment of
reads originating from alternatively spliced isoforms (Dobin et al., 2013). STAR’s
alignment algorithm works by first finding the longest genomic region that maps to
the start of the read. If the read contains a single exon, the entire read is aligned
in this step. However, many reads contain multiple exons which are separated by
intronic sequences in the genome. If the read being aligned contains multiple exons,
after finding the longest genomic region that maps to the start of the read, the
algorithm proceeds to try and find the longest genomic region that maps to the
unmapped portion of the read. This process is repeated until the entire read is
aligned, potentially with some mismatches. STAR then stitches together the aligned
regions of the read, initially searching for a complete alignment within a user-defined
genomic window but also allowing for chimeric alignments. A user-defined score
for matches, mismatches, indels and splice junction gaps, is used to identify the
alignment with the lowest score. This alignment is the one reported by STAR. For
multimapping reads, STAR reports all alignments within a certain score threshold of
the optimal alignment. The main assumptions made by STAR are that the genomic
window and penalty scores defined by the user are appropriate. In this benchmark, I
used the default windows and scores provided by STAR, as I believe this is the most
common user behaviour.
RSEM
RSEM is an isoform quantification tool and a read simulator, which was used both
to simulate reads and to perform isoform quantification in my benchmark (Li and
Dewey, 2011). To perform isoform quantification, RSEM first generates a set of
reference transcript sequences. Importantly, RSEM aligns reads to these reference
transcript sequences rather than the entire genome. Next, RSEM uses an aligner
to align reads to these reference sequences. In my benchmark, STAR was used as
the aligner (Dobin et al., 2013). Following alignment, RSEM uses an Expectation-
Maximisation (EM) algorithm to estimate isoform abundance. RSEM’s directed
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graphical model is shown in Figure 5.1.
Figure 5.1: RSEM’s directed graphical model. Observed variables, which can be
directly observed from the reads data, are shown in grey. Latent variables, which
must be inferred by the EM algorithm, are shown in white. This figure is adapted
from Figure 4 in (Li and Dewey, 2011).
The goal of Expectation-Maximisation algorithms is to find the maximum like-
lihood parameters for equations which can not be directly solved. In the directed
graphical model above, we know the value of the observed values in white boxes,
but not of the unobserved or latent values in grey boxes. We infer the values of
these latent variables using RSEM’s EM algorithm. For the first twenty iterations
of RSEM’s EM algorithm, and for every hundredth iteration after, the values of the
orientation, read start position distribution, fragment length and parent transcript
are updated. In all other iterations, RSEM only updates the prior probabilities of
a fragment being derived from each transcript. The algorithm continues until the
prior probabilities of a fragment being derived from each transcript converge (ie. the
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prior probabilities no longer change meaningfully between one EM iteration and the
next).
Once RSEM has completed quantification, in addition to outputting expression
estimates, it saves the values it inferred for the latent variables in its graphical model.
This enables RSEM to act as a reads simulator, using the latent variable parameters
it inferred from real data. When RSEM uses its graphical model to probabilistically
simulate reads, it counts where each read originated in the transcriptome. Thus
RSEM can be used to generate reads data with ground truth expression data.
The core assumption of RSEM is that its directed graphical model combined with
the EM algorithm is capable of generating accurate estimates of isoform expression,
meaning that underlying asumptions about the fragment length distribution and re-
lationships between the variables illustrated in Figure 5.1 must be at least somewhat
realistic. When RSEM simulates reads, a key assumption in the ground truth ex-
pression is that every expressed transcript generates one and only one read. This
is unlikely to be true, especially for scRNA-seq. Therefore, benchmarks of isoform
quantification tools using RSEM as a read simulator assess the ability of quantifica-
tion tools to correctly determine where reads originated from in the transcriptome,
as oppose to their ability to determine what transcripts were originally present in
the cell(s).
eXpress
eXpress is an isoform quantification tool whose performance was evaluated in my
benchmark (Roberts and Pachter, 2013). eXpress takes a bam file of aligned reads
as input. In my benchmark, STAR produced the input bam file (Dobin et al., 2013).
eXpress uses an online algorithm, meaning that eXpress’s algorithm does not
require the entire input all at once at the start, but can process the input piece by
piece in the order it arrives. The authors suggest this could enable eXpress to be
coupled directly to a sequencer that produced reads one at a time. Whether this was
ever realised is unclear.
Like RSEM, eXpress uses a directed graphical model combined with an EM al-
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gorithm to generate its expression estimates (Li and Dewey, 2011). eXpress’s EM
algorithm is illustrated in Figure 5.2.
Figure 5.2: eXpress’s directed graphical model. Observed variables, which can be
directly observed from the reads data, are shown in grey. Latent variables, which
must be inferred by the EM algorithm, are shown in white. This figure is adapted
from Supplementary Figure 11 in (Roberts and Pachter, 2013).
Like RSEM, eXpress’s core assumption is that its directed graphical model com-
bined with its EM algorithm can generate accurate expression estimates. This means
that assumptions about variables in the model (eg. the shape of the fragment length
distribution) as well as assumptions about the relationships between variables in the
model must be accurate to some degree.
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Sailfish
Sailfish is an isoform quantification tool whose performance was evaluated in my
benchmark (Patro et al., 2014). Sailfish differs from the other isoform quantification
tools discussed thus far in that Sailfish is an ’alignment free’ tool. Instead of mapping
reads, Sailfish breaks both the transcriptome and the input sequencing reads into
shorter strings of a user-defined length. These shorter strings are referred to as
k-mers, and as a default are of length 31.
The first step of performing isoform quantification with Sailfish is to build an
index from a set of reference transcripts. Sailfish builds its index by splitting the
reference transcripts into k-mers and creating a minimal perfect hash function. In
simple terms, the minimal perfect hash function can be used to very quickly match
a k-mer generated from reads to a location in the reference transcripts.
In the second step of quantification, Sailfish splits the input reads into k-mers
and uses the minimal perfect hash function to count how many times each k-mer
in its index occurs in the input reads. Sailfish then uses a conceptually similar EM
algorithm to RSEM (Li and Dewey, 2011) to estimate transcript abundances based
on k-mer counts.
Sailfish assumes that its k-mer hashing procedure provides a good approximation
of where reads originated from in the transcriptome. The extent to which this is
likely to be true depends on the k-mer length and the sequencing error rate. In
addition, Sailfish assumes that its EM algorithm can generate accurate expression
estimates. Sailfish also assumes that the reference transcripts passed to it represent
all of the transcripts present in the transcriptome. This is potentially a problematic
assumption when working with non-model organisms with poorly annotated tran-
scriptomes.
Salmon
Salmon is an isoform quantification tool whose performance was evaluated in my
benchmark (Patro et al., 2017). Salmon has three modes - an alignment mode, a
quasi mode and an SMEM mode. In the alignment mode, Salmon takes a bam
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file containing aligned reads as input. The quasi and SMEM modes use a similar
indexing and k-mer hashing procedure to Sailfish in place of alignment. The quasi
mode is a newer mode which constructs the index and performs hashing faster than
the older SMEM mode.
In addition to providing a range of alignment and alignment free modes, Salmon
differs from Sailfish in that it has a more complex and sophisticated abundance esti-
mation procedure. Salmon’s abundance models account for and attempt to correct
for factors such as GC-bias and positional biases in a sample-specific manner. Salmon
estimates abundance in a multi-step process, beginning with a lightweight mapping
step and ending with an EM algorithm to infer abundance.
Salmon assumes that its three read mapping methods provide a good approxima-
tion of where reads originated in the transcriptome. In addition, it assumes that its
abundance estimation procedure can generate accurate expression estimates, mean-
ing that it assumes that its GC bias and positional bias models accurately model
these biases. When run in quasi or SMEM model, Salmon assumes that the reference
transcripts passed to it represent all of the transcripts present in the transcriptome.
Kallisto
Kallisto is an isoform quantification tool whose performance was evaluated in my
benchmark (Bray et al., 2016). Kallisto uses a process described as pseudoalignment
to map reads. In practice, pseudoalignment is similar to the k-mer hashing process
used by Salmon and Sailfish. Like Salmon and Sailfish, Kallisto requires an index to
be constructed from reference transcripts. Unlike Salmon and Sailfish, Kallisto begins
indexing by constructing a data structure known as a coloured de Bruijn graph. Each
node in the graph corresponds to a k-mer, and each colour corresponds to a different
transcript. Nodes (k-mers) are assigned colours based on which transcripts the k-mer
maps to. Contigs are linear stretches of the de Bruijn graph with the same colours
and therefore the same transcripts. Once the de Bruijn graph is constructed, Kallisto
generates a hash table which maps each k-mer to a contig.
During pseudoalignment, Kallisto looks up k-mers from reads in its hash table
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and uses the intersect of the contigs stored in the hash table to determine which
transcripts could have generated a read. Based on these pseudoalignments, Kallisto
then uses an EM algorithm to infer transcript abundances.
Kallisto assumes that its pseudoalignment procedure provides a good approxima-
tion of where reads originated in the transcriptome. Kallisto also assumes that its
EM algorithm can generate accurate abundance estimates. Like Salmon and Sail-
fish, Kallisto assumes that the reference transcripts passed to it represent all of the
transcripts present in the transcriptome.
Splatter
Splatter is a scRNA-seq counts simulator that was used with Polyester to simulate
reads data (Zappia et al., 2017b; Frazee et al., 2015). Splatter originally implemented
six counts simulation models, although Splatter is actively maintained and more
simulation models have subsequently been added. Each simulation model has two
steps. In the first step, simulation parameters are estimated from real counts data.
In the second step, Splatter uses these parameters to generate a simulated counts
dataset. Simulation models included in the Splatter package vary in complexity,
from a very simple negative binomial model named Simple, to the more complex
Splat model that accounts for mean gene expression, cell library size, the mean-
variance relationship of gene expression observed in scRNA-seq and dropouts. The
assumptions made by Splatter vary depending on which simulation model is used,
the core assumption always being that the simulation model can generate biologically
realistic counts data.
Polyester
Polyester is a reads simulator that was used with Splatter to simulate reads data
(Frazee et al., 2015; Zappia et al., 2017b). Polyester can be run using a number of
different models to simulate reads. In addition, the user can specify exactly how
many reads Polyester should simulate for each transcript. In my benchmark, the
output of Splatter was used to dictate exactly how many reads Polyester should
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simulate for each transcript. In addition, I specified that fragment length should
be drawn from a normal distribution, sequencing errors should be added based on
an error model that Polyester derived from a real dataset (McElroy et al., 2012)
and that either no coverage bias should be simulated, or that coverage bias should
be simulated based upon a cDNA fragmentation protocol. The assumptions made
running Splatter with these parameters were than fragment length can be modelled
as a normal distribution, the error model used was a realistic representation of error
frequencies in scRNA-seq data, and that coverage bias in a SMARTer library prepa-
ration protocol could be captured with coverage bias model based upon a generic
cDNA fragmentation protocol.
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Table 5.1: A summary table of the isoform quantification tools used in my bench-
mark.
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5.1.2 Availability of data and materials
The Kolodziejczyk et al. ES cell data was accessed from the ArrayExpress database
(http://www.ebi.ac.uk/arrayexpress) using the accession number E-MTAB-2600,
as described in the Kolodziejczyk et al. paper (Kolodziejczyk et al., 2015). The
BLUEPRINT data was accessed under GEO accession number GSE94676 (Adams
et al., 2012). The Shekhar et al. Drop-seq data was accessed under GEO accession
number GSE81905, as described in the Shekhar et al. paper (Shekhar et al., 2016).
The pipeline used to perform the BLUEPRINT benchmark, including code to
reproduce figures, can be found at https://github.com/AFS-lab/BLUEPRINT. The
pipeline used to perform the Kolodziejczyk et al. benchmark, including code to repro-
duce figures, can be found at https://github.com/AFS-lab/ES_cell_pipeline.
The pipeline to perform the Drop-seq simulation based benchmark can be found
at https://github.com/jenni-westoby/Drop-seq_pipeline. The pipeline used
to perform the systematic investigation into cell number and read depth can be found
at https://github.com/jenni-westoby/coverage_cell_number_study. The op-
tions and parameters passed to tools used to perform simulations and isoform quan-
tification can be found at the above links. A bug was encountered whilst using RSEM
to simulate Drop-seq data. The bug was fixed and a pull request was made on the
RSEM github page (https://github.com/deweylab/RSEM/pull/79).
5.1.3 Genomes
The Ensembl release 89 genome and transcriptome with 92 spike-in sequences de-
veloped by the External RNA Control Consortium (ERCC) appended were used
wherever genome files in FASTQ format and/or transcriptomes in GTF format were
required as input for tools in this study (Aken et al., 2017; Jiang et al., 2011).
The exception to this was when isoform quantification was carried out using the
BLUEPRINT and Kolodziejczyk et al. bulk RNA-seq datasets. No ERCC spike-ins
were added to these datasets, so the Ensembl release 89 genome and transcriptome
without spike-ins appended were used to perform this analysis. To perform sim-
ulation and isoform quantification, RSEM produces a reference which includes a
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reference transcriptome in FASTQ format. This reference transcriptome produced
by RSEM was used for isoform quantification tools which required a reference tran-
scriptome in FASTQ format as input (See Github repository for code).
5.1.4 Data Processing Prior to Analysis
Sequencing adaptors were trimmed from the Kolodziejczyk et al. and BLUEPRINT
data using Cutadapt (Martin, 2011). Reads from each cell in these datasets were
aligned to the Ensembl genome release 89 using STAR (Aken et al., 2017; Dobin
et al., 2013). RSeQC was used to collect alignment quality statistics for each cell
(Wang et al., 2012). These statistics and the number of reads sequenced in each cell
were used to remove low quality cells from each dataset (see Appendix 1, figures 7.1,
7.5 & 7.8). In addition, scater was used to plot the percentage of reads mapping
to mitochondrial RNA and remove cells with greater than 10% of reads mapping to
mitochondrial RNA (McCarthy et al., 2017) (See Appendix 1, figures 7.1, 7.2, 7.3, 7.4,
7.5, 7.6, 7.8, 7.9). Traditionally, Drop-seq data is not demultiplexed during gene level
quantification (Macosko et al., 2015). However, with the exception of Kallisto, the
tools used in this study cannot take multiplexed UMI data as input. When Kallisto
does take multiplexed UMI data as input, it gives expression estimates for equivalence
classes rather than for specific isoforms as output. Given that an anticipated issue
with using Drop-seq for isoform quantification was that a UMI based method with
3’ coverage bias may not contain enough information to resolve between different
isoforms from the same gene, it was decided that the performance of Kallisto when
run in this mode would not be evaluated. Instead, the Shekhar et al. dataset
was demultiplexed and RSEM was used to simulate a subset of the demultiplexed
cells. The performance of eXpress, Kallisto, Sailfish, Salmon and RSEM was then
evaluated in the simulated cells. The cell barcodes used to demultiplex the Drop-seq
data were selected by following the instructions on the Drop-seq website to generate
a gene expression matrix. The barcodes were extracted from the gene expression
matrix and used to demultiplex the data. Further details can be found at https:
//github.com/jenni-westoby/Drop-seq_pipeline.
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5.1.5 Simulations
Two simulation methods were used in this study. The first method used to simulate
single-cell RNA-seq data was RSEM. RSEM is an isoform quantification tool which
makes use of a generative model and an expectation maximization algorithm to
perform isoform quantification (Li and Dewey, 2011). When performing isoform
quantification, RSEM infers values for the latent variables in its generative model in
addition to estimating isoform expression. To perform simulations, RSEM takes the
inferred values of the latent variable and the expression estimates and uses them in
its generative model to probabilistically simulate reads. As RSEM simulates reads,
it counts where in the transcriptome each of the reads came from. RSEM thus
simulates reads data for which it is known how highly expressed each isoform in the
transcriptome is.
For each cell in the Kolodziejczyk et al. and the BLUEPRINT datasets that
passed quality control and for each of the selected cells in the Drop-seq dataset,
one RSEM simulation was performed. Isoform quantification was performed on each
cell and the isoform expression estimates and inferred estimates for RSEM’s latent
variables were used to perform the simulation. Consequently, each RSEM simulated
cell used in this study was simulated using variables inferred from a real cell.
The second simulation method was based on two tools, Splatter and Polyester.
Splatter is a simulation tool which takes an expression matrix of counts from a single-
cell RNA-seq experiment as input and gives a simulated expression matrix of counts
as output (Zappia et al., 2017a). The Splatter package in fact contains six simulation
methods. To select which performed best, data was simulated using the Lun, Lun2
and Simple simulation methods. The Splat simulation method was discounted as it
was unable to simulate large enough expression matrices to account for the larger
number of isoforms compared with genes, and the scDD method was discounted as
it simulates differential expression, and no differential expression was expected. The
BASiCS method had not been implemented at the time when the simulations were
performed. Based on Splatter-generated graphs, the lun2sim method, inspired by
a simulation method developed by Lun & Marioni (Lun and Marioni, 2017) was
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selected as it bore the closest resemblance to the real data (see Figure 2.6).
The lun2sim method was used to simulate a matrix of counts based on an expres-
sion matrix of counts from the BLUEPRINT B lymphocytes generated by Kallisto
(Bray et al., 2016). The simulated expression matrix of counts was then given as
input to Polyester, which simulated reads based on the lun2sim counts matrix. Sim-
ulations were performed both using Polyester’s uniform coverage model and using
Polyester’s 3’ coverage bias model. The Splatter counts matrix was converted to a
matrix of TPM values, which were used as the ‘ground truth’ for how highly ex-
pressed each isoform was in the Polyester simulated reads data.
5.1.6 Post Simulation Data Processing
Reads from each cell in the datasets simulated by RSEM based on the Kolodziejczyk
et al. and BLUEPRINT datasets were aligned to the Ensembl genome release 89
using STAR. RSeQC was used to collect alignment quality statistics for each cell.
The alignment quality statistics and the number of reads for each simulated cell
were used to remove low quality cells from each dataset (see Appendix 1, Figures
7.2, 7.3, 7.4, 7.6 & 7.9). Scater was used to plot the percentage of reads mapping
to mitochondrial RNA and remove cells with greater than 10% of reads mapping to
mitochondrial RNA.
5.1.7 Bulk RNA-seq analysis
Prior to isoform quantification, RSeQC was used to remove rRNA mapping reads
from the BLUEPRINT B lymphocyte bulk RNA-seq data. The code used to generate
the isoform expression matrices used in the bulk RNA-seq benchmark can be found
at https://github.com/jenni-westoby/Benchmark_Bulk_Analysis.
5.1.8 Statistics
Precision and recall were used to evaluate the performance of isoform detection,
whilst Spearman’s Rho and the normalised root mean square error (NRMSE) were
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used to evaluate the ability of tools to assign the correct magnitude of expression to
each isoform. The choice of which statistics to use to evaluate performance will always
be to some extent arbitrary. The precision was selected to evaluate isoform detection
because the proportion of isoforms called as expressed that are truly expressed is an
informative metric when determining how much confidence we can have that isoforms
called as expressed are truly expressed. The recall was selected to evaluate isoform
detection because the proportion of expressed isoforms called as expressed tells us
how many expressed isoforms are missed by the quantification tool. Spearman’s Rho
was used to evaluate the ability of tools to correctly order isoform expression from
the most lowly expressed to the most highly expressed, something we would hope
quantification tools would be able to do well. The NRMSE was used as a measure
of the error in expression estimates, which we would hope would be generally low.
The formula used to calculate the NRMSE is:
NRMSE = 100
√
1
N
∑N
i=1(Si −Oi)2
sd(O)
Where N is the number of isoforms that could have been simulated, S is the
isoform expression estimates for the isoform quantification tool of interest, O is the
ground truth expression estimates and sd(O) is the sample standard deviation of the
ground truth expression estimates.
Prior to calculating the NRMSE, the ground truth and the isoform expression
estimates were transformed using the formula:
Stransformed = log2(Soriginal + 1)
Where Soriginal was the original value of the ground truth or the expression esti-
mate. This transformation reduces the impact of a small number of highly expressed
isoforms on the value of the NRMSE.
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5.2 Novel simulation approaches
In chapters 3 and 4, I developed two novel simulation based approaches. I present
my methodology for these approaches here.
5.2.1 Availability of data and materials
The Kolodziejczyk et al. mESCs were accessed as described in the previous section
(Kolodziejczyk et al., 2015). The hESC datasets were accessed under GEO accession
number GSE85917 (Bacher et al., 2017).
My quantification pipelines, which download scRNA-seq data, perform transcript
level quantification and generate an isoform-cell matrix, can be found at: https://
github.com/jenni-westoby/Isoform_Cell_Matrix_Generation. My simulation
pipeline can be found at: https://github.com/jenni-westoby/Obstacles.
5.2.2 Data processing prior to analysis
My two simulation approaches require an isoform-cell counts matrix as input. To
generate isoform-cell counts matrices, I used Kallisto to quantify reads from each
cell(Bray et al., 2016). For the hESC dataset, I used the Gencode human v20 tran-
scriptome as a reference transcriptome (Frankish et al., 2019). For the mESC dataset,
I used the Gencode mouse vM20 transcriptome as a reference transcriptome (Frank-
ish et al., 2019).
5.2.3 Simulation Approach
My two simulation approaches are summarised as algorithms below.
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Step 1a: Establish how many isoforms are detected for gene of interest in
total across all cells in our scRNA-seq data.
for simulation in 1:100 do
for i in 1:NumCells do
for j in 1:NumExpressedIsoforms do
end
Step 2: Choose j isoforms to be expressed in the ith cell based on
isoform choice model
Step 3: Introduce dropouts based on Andrews and Hemberg’s
Michaelis-Menten model
Step 4: Introduce isoform quantification errors
end
Step 5: Find mean number of isoforms per gene per cell.
end
Step 6: Plot distributions of mean number of isoforms per gene per cell (eg.
as in Figure 3.3)
Algorithm 1: Simulation approach presented in chapter 3
Step 1b: Select genes for which four isoforms are detected in scRNA-seq data
for simulation in 1:100 do
for gene in DetectedGenes do
for j in 1:4 do
for i in 1:NumCells do
Step 2: Choose j isoforms to be expressed in the ith cell based
on isoform choice model
Step 3: Introduce dropouts based on Andrews and Hemberg’s
Michaelis-Menten model
Step 4: Introduce isoform quantification errors
end
Step 5: Find mean number of isoforms per gene per cell.
end
end
end
Step 6: Plot distributions of mean number of isoforms per gene per cell (eg.
as in Figure 4.7)
Algorithm 2: Simulation approach presented in chapter 4
167
Many steps are shared between the two algorithms as the two approaches are
highly similar. I expand upon each step below.
Step 1a: Establish how many isoforms are detected in total across all cells
in our scRNA-seq data.
For my simulation approach in chapter 3, I define an isoform as detected if it has
more than five counts in at least two cells.
Step 1b: Select genes for which four isoforms are detected in scRNA-seq
data
My simulation approach in chapter 4 takes an isoform-cell counts table as input. I
define an isoform as detected if it has more than five counts in at least two cells. I
select genes for which exactly four isoforms pass this threshold.
Step 2: Choose i isoforms to be expressed in the jth cell based on isoform
choice model
In this step, I probabilistically choose i isoforms to be expressed in each cell, where i
is one, two, three or four. The default model used in chapters 3 & 4 was the Weibull
model, which was used to produce all figures unless otherwise stated. In chapter 4,
additional isoform choice models were also used in some figures, which are described
below.
The Weibull model
In (Hu et al., 2017), Hu et al. found that the median frequency, mf(k,M), of the
kth dominant isoform of a gene with M detected isoforms can be described as:
mf(k,M) =
1
k ×HM exp
[
−
(
1 +
k
M
)2]
where HM is the Mth generalised harmonic number:
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HM =
M∑
m=1
1
m
exp
[
−
(
1 +
m
M
)2]
In my implementation of this model of isoform choice, I first rank the isoforms in
order of magnitude expression for each gene, with the most highly expressed isoform
having rank 1, the second most highly expressed isoform having rank 2 and so on.
I calculate magnitude of expression by summing the total number of counts across
all cells for that isoform. I then use the median frequency formula above to find the
predicted median frequency for each isoform. I define the probability of picking an
isoform with rank k for a gene with M detected isoforms as:
p(isoformk) =
mf(k,M)∑M
m=1mf(m,M)
With M = 4, the probabilities become [0.55, 0.28, 0.12, 0.05].
The inferred probabilities model
In this model, I attempt to infer the probability of an isoform being chosen from its
probability of being detected. The formula below relates the probability of choosing
an isoform, P (Choice), to its probability of being detected, P (Detected):
P (Detection) = P (Choice)× P (Detection|Choice) +
P (¬Choice)× P (Detection|¬Choice) (5.1)
Where P (¬Choice) is the probability of not choosing an isoform. In practice:
P (Detection) = P (Choice)× P (¬Dropout)× (1− pFN) +
P (¬Choice)× pFP (5.2)
Where P (¬Dropout) is the probability that there is not a dropout, pFN is the
probability that there is a false negative event due to a quantification error and pFP
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is the probability that there is a false positive event due to a quantification error.
This rearranges to:
P (Choice) =
|P (Detection)− pFP |
|P (¬Dropout)(1− pFN)− pFP |
In practice, I sometimes find P (Choice) is greater than 1, probably because our
estimation of P (6 Dropout), pFN and/or pFP is inaccurate for that isoform. When
this occurs, I set P (Choice) equal to one. I take absolute values of the numerator
and denominator to avoid negative or complex numbers, which probably also occur
due to inaccurate estimation of P (6 Dropout), pFN and/or pFP .
In my simulations, I calculate P (Choice) for each isoform from a given gene. The
probability of picking a particular isoform to be expressed in our simulation is that
isoform’s P (Choice) divided by the sum of P (Choice)s for that gene’s isoforms.
The cell variability model
The cell variability model is identical to the inferred probabilities model except that
the probability of picking a given isoform, i is allowed to vary between cells. This is
acheived by sampling the probability of picking isoform i in a given cell c, pic, from
a Beta distribution, taking a similar approach to that described in (Velten et al.,
2015) :
pic ∼ Beta(α, β)
where
α = (
1− µ
σ2
− 1
µ
)× µ2
β = α× ( 1
µ
− 1),
where µ is the mean probability of choosing i across all cells, i.e. µ = P (Choice).
Based on attempts to characterise the mean-variance relationship for the probability
of choosing a particular gene by Velten et al. (Velten et al., 2015), I estimate that
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the sample standard deviation, σ, is approximately 0.002. I find pic for each isoform
for a given gene. In my simulations, the probability of picking isoform i in cell c is
that isoform’s pic divided by the sum of pics for that gene’s isoforms.
The random model
For this model, each isoform is associated a weight randomly sampled between zero
and one. The probability of picking a particular isoform to be expressed in our
simulation is that isoform’s weight divided by the sum of all the weights for that
gene’s isoforms.
The Normal model
The weights for each isoform were sampled from a truncated Normal distribution
with a mean of 0.25 and a standard deviation of 0.06. This sampling was performed
for each isoform in each cell. Within each cell, the probability of picking a particular
isoform to be expressed in our simulation is that isoform’s weight divided by the sum
of all the weights for that gene’s isoforms.
The Bernoulli model
The weights for each isoform were sampled from a Bernoulli distribution with a mean
of 0.25. This sampling was performed for each isoform in each cell. Within each cell,
the probability of picking a particular isoform to be expressed in my simulation is
that isoform’s weight divided by the sum of all the weights for that gene’s isoforms.
If all four isoforms for a given gene had a zero weight, we set the probability of
picking each isoform to 0.25.
The p=0.25 model
The probability of choosing each isoform was always 0.25.
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Step 3: Introduce dropouts based on Andrews et al.’s Michaelis-Menten
model.
I calculate the probability of dropouts for each isoform using a Michaelis-Menten
model proposed by Andrews and Hemberg (Andrews and Hemberg, 2018a). I calcu-
late the probability of dropouts for each isoform as:
P (Dropout) = 1− S
KM + S
Where S is the mean expression of that isoform across cells and KM is the Michaelis-
Menten constant. To find S and KM I normalise the isoform expression values
by converting Counts to Counts Per Million (CPM), as suggested in the M3Drop
vignette (Andrews and Hemberg, 2018a). I estimate the value of KM for each dataset
by applying maximum-likelihood estimation using the equation above and the rate
of dropouts and the mean expression of isoforms across the entire transcriptome.
Step 4: Introduce quantification errors.
Based on my benchmarking study in chapter 2 (Westoby et al., 2018b), I estimate
that the probability of a false positive given an isoform has no reads mapping to it,
pFP , is about 0.01 and the probability of a false negative given an isoform has reads
mapping to it, pFN , is about 0.04 for Kallisto when run on full length coverage
scRNA-seq data. Unless otherwise stated in the text, these were the error rates
applied in my simulations. In other words, on average 1% of isoforms with no reads
mapping were assigned an expressed status, and 4% of isoforms with reads mapping
were assigned an unexpressed status.
Step 5: Find mean number of isoforms per gene per cell.
After iterating over every cell in our simulation, I sum the the number of isoforms
detected in each cell and divide by the number of cells to find the mean number of
detected isoforms per gene per cell.
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Klf4
Pou5f1
Tbx3
Jarid2
Myc
Stat3
Tcf3
Esrrb
Nanog
Nr0b1
Sall4
Sox2
Zfp42
Zfp281
Zfx
Table 5.2: Pluripotency factor genes.
Step 6: Plot distributions of mean number of isoforms per gene per cell
To make my simulation results figures shown in chapter 3, I plot the distributions of
the mean number of detected isoforms for each number of expressed isoforms, from
1 to the total number of isoforms detected. A vertical black line representing the
mean number of isoforms detected per cell is drawn on the same plot (for example,
see Figure 3.3).
The distributions plotted in chapter 4 differ. In chapter 3, the distributions
generated are for a single gene of interest. In chapter 4, the distributions produced
are for every gene in which 4 isoforms were detected in the real scRNA-seq data (eg.
see Figure 4.7).
5.2.4 Genes investigated in chapter 3
I ran my model on 15 pluripotency factor genes. The 15 genes are shown in Table
5.2.
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5.2.5 Mixture Modelling
In my mixture modelling experiments in chapter 4, I begin by fitting log normal
distributions to each of our simulation distributions and to the distribution of mean
isoforms detected for genes with four detected isoforms in the real data. I then use
expectation maximisation to estimate the mixing fraction of each of the simulated
distributions in the real distribution. In my expectation step, I calculate the prob-
ability that each data point belongs to a given distribution, which I refer to as the
responsibility. The responsibility for the ith mean number of isoforms per gene per
cell and the cth simulation distribution is:
ric =
kc × LN(xi|µc, σc)∑j=4
j=1 kj × LN(xi|µj, σj)
where k is the mixing fraction, xi is the ith mean number of isoforms per gene
per cell and LN(xi|µc, σc) is the probability density function for the log normal with
mean µc and variance σ
2
c . The maximisation function for the mixing fraction is:
kc =
∑
i ric
n
Where n is the number of datapoints in ric. Note that I only perform expectation
maximisation for the mixing fractions of the distributions and not for the means or
standard deviations.
Overlap Fraction
The overlap fraction is the proportion of isoforms detected in our simulations that
were expressed in the ground truth. The formula for the overlap fraction is:
OverlapFraction =
|GroundTruth ∩Detected|
|GroundTruth|
Where GroundTruth is the set of isoforms that are expressed in the ground truth,
and Detected is the set of isoforms that are detected in our simulations. The overlap
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fractions reported in all Figures & Supplementary Figures are the mean overlap
fractions for each gene, averaged across all of the simulated cells in that simulation
round.
Downsampling
Random downsampling of reads in chapter 4 was performed using seqtk (Li, 2013).
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6Discussion
I once wrote a lecture for Manchester University called ‘Moments of Discov-
ery’ in which I said that there are two moments that are important. There’s
the moment when you know you can find out the answer and that’s the pe-
riod you are sleepless before you know what it is. When you’ve got it and
know what it is, then you can rest easy.
– Dorothy Hodgkin (Hodgkins)
The main goal of my thesis was to assess the extent to which it is feasible to
study alternative splicing using scRNA-seq. I have established that from a software
perspective, existing isoform quantification tools perform well when run on scRNA-
seq data. However, I have also established that this alone is not sufficient to enable
splicing to be accurately studied at a cellular resolution. Without a better under-
standing of dropouts and isoform choice, our ability to accurately detect isoforms
in individual cells is poor. In the final chapter of my thesis, I will discuss the main
findings from my PhD and consider how the field could move forward.
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6.1 My benchmarking study demonstrated that
isoform quantification tools designed for bulk
RNA-seq perform well when run on scRNA-
seq
Most scRNA-seq studies quantify reads at the level of genes rather than isoforms (Ste-
gle et al., 2015), partly due to uncertainty over whether appropriate tools to quantify
reads at the isoform level exist for scRNA-seq. My benchmark demonstrated that
Kallisto, Salmon, Sailfish and RSEM perform almost as well when run on scRNA-seq
as when run on bulk RNA-seq. Thus, it seems unlikely that a lack of appropriate
isoform quantification software could prevent us from studying alternative splicing
using scRNA-seq.
Important insight came when data was simulated based on Drop-seq rather than
SMARTer or SMART-seq2 data. The performance of almost all isoform quantifica-
tion tools was so poor when run on simulated Drop-seq data that accurate quantifi-
cation or detection of isoforms was impossible. This indicates that choice of library
preparation protocol matters if the goal of an scRNA-seq experiment is to study
alternative splicing. I considered three library preparation protocols in my bench-
mark. Further work evaluating the suitability of other popular library preparation
protocols for studying splicing is likely to be valuable to the single cell community.
An unexpected finding from my benchmark was that the precision of isoform
detection peaks at around 1-2 million reads per cell. I hypothesise that this occurs
because RSEM does not substantially increase the number of isoforms it expresses
per cell beyond 1-2 million reads per cell. As the number of reads simulated in-
creases beyond 2 million reads per cell, the opportunity to increase the number of
true positives (expressed isoforms which are called as expressed) is therefore limited.
However, if there is a fixed probability that a randomly selected read will be mis-
assigned to the wrong isoform, as the number of reads increases we would expect the
number of false positives to continue to rise. As the formula for the precision is:
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Precision =
No.TruePositives
No.TruePositives+No.FalsePositives
we would therefore expect the precision to decrease at read depths greater than
1-2 million reads per cell.
As previously stated, I believe that the position of the peak in precision at 1-2
million reads per cell is likely a simulation artefact of RSEM. However, it is a fact
that cells express a finite number of isoforms. Therefore if my hypothesis is correct,
I would predict that there is also a peak in the precision of isoform detection in
real scRNA-seq data. Indeed, if I am correct, I predict that this phenomenon is not
limited to scRNA-seq or to isoform level quantification, but that this phenomenon
would also occur for other sequencing technologies (eg. bulk RNA-seq) and for gene
level quantification. I predict that the location of the precision peak would be deter-
mined by the number of isoforms (or genes, in the case of gene level quantification)
expressed per cell. It has been established that for gene level quantification, the num-
ber of genes detected plateaus at 1 million reads per cell (Wu et al., 2014; Ziegenhain
et al., 2017). Therefore my prediction is that the peak in the precision of gene de-
tection occurs at around 1 million reads per cell. Establishing the read depth at
which isoform detection plateaus could give insight into the read depth at which the
precision of isoform detection is likely to peak.
I make a lot of predictions in the previous paragraph, so an obvious question is
how these predictions could be tested. One way to test my predictions would be
by performing a scRNA-seq experiment in which spike-in mixtures, composed of a
mixture of a known number transcript species spiked at known concentrations, are
sequenced in place of cells. By sequencing the spike-in mixture at varying depths, it
could be established whether the number of transcript species predicts the position
of the peak in isoform detection precision. Datasets such as these could be used to
build a model to predict the precision of isoform detection at various read depths.
This could give insight into what statistical frameworks could be used to best correct
for an increasing proportion of false positives as read depth increases.
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My observation that the precision of isoform detection peaks raises a lot of un-
resolved issues. The experiments that gave this insight were only performed using
Salmon. It is possible that other isoform quantification tools may correct for the
increased proportion of false positives at higher read depths more effectively. Estab-
lishing whether the precision peaking phenomenon is common to all isoform quantifi-
cation tools, or if it is a quirk of Salmon, would be of relevance to the bioinformatics
community. If it is a common phenomenon, new statistical frameworks should be
generated to correct for it, potentially based on results from spike-in sequencing data
as described above. Correcting for the peak in precision is especially relevant when
analysing data which has been sequenced to very high depths. An important im-
plication of the precision peaking phenomenon is that many of the ‘rare’ or ‘lowly
expressed’ genes only detected when sequencing at very high depths and/or with
vast numbers of cells are likely to be false positives.
Although I believe that my benchmarking study has generated many useful in-
sights, no simulation based approach is without limitations. I have carefully eval-
uated the similarities and differences between the simulated and real data, but the
possibility remains that the simulated data in some way fails to capture some mean-
ingful aspect of the real data. However, given that the results of my benchmark
remain consistent across two unrelated simulation methods, I am optimistic that the
results of my benchmark are sufficiently reliable to be applied to real data.
An important aspect of my simulation based approach is that the ‘ground truth’
is based on where reads originated from in the transcriptome. In other words, my
benchmark evaluated the ability of isoform quantification tools to correctly determine
where reads originated from in the transcriptome. This is an important ability for an
isoform quantification tool to have, however it should be recognised that scRNA-seq
has a high frequency of technical dropouts and PCR amplification bias. Because my
benchmark only considers the ability of quantification software to quantify the reads
that are present, I entirely ignore the issues arising from all the reads from expressed
isoforms that are absent due to dropouts and the issues arising from amplification
bias. The only way to benchmark the ability of isoform quantification tools to cor-
rectly infer the original expression of isoforms in cells would be if an scRNA-seq
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experiment were carried out where the exact expression of isoforms was known at
the moment that the RNA was extracted from the cells. At present, no technology
exists that could generate this type of data. Consequently, I made identifying iso-
form quantification tools that can accurately quantify the reads that are present the
goal of my benchmarking study, and consider how best to correct for technical noise
such as dropouts to be a separate issue.
6.2 Initial attempts to determine how many iso-
forms are produced per gene per cell gave un-
interpretable results
How many isoforms does a gene produce in a cell? This deceptively simple question
holds a fundamental place in molecular biology. I began my attempts to investigate
how many isoforms a gene produces in a cell by considering genes for which two
isoforms are detected in bulk RNA-seq, and asking how many isoforms are detected
per cell using scRNA-seq. I found that I frequently failed to detected gene expression
at all, and when I did detect gene expression, it was more common to only detect
the expression of only one isoform. This is consistent with two hypotheses. The first
hypothesis is that gene expression genuinely is heterogeneous between cells, and that
it is rare for cells to simultaneously express two isoforms from the same parent gene.
The second hypothesis is that we commonly fail to detect gene and isoform expression
due to technical dropouts. Without a better understanding of how best to model
dropouts, it is challenging to determine to what extent each of these hypotheses are
true. Similarly, my later observation that two isoforms are more frequently detected
for more highly expressed genes is consistent with the hypothesis that more highly
expressed genes undergo more splicing, and is also consistent with the hypothesis
that dropouts are more prevalent for less expressed transcripts. Again, it is not
currently possible to determine which of these hypotheses is most accurate without a
more sophisticated understanding of dropouts. Therefore, I conclude that at present,
the results of the experiment are uninterpretable.
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As dropouts made the results of my previous experiment uninterpretable, the
approach taken in my next experiment explicitly accounted for dropouts using a
Michaelis-Menten model developed by Andrews and Hemberg (Andrews and Hem-
berg, 2018a). However, the model I developed to predict how many isoforms are
produced per gene per cell failed at the first hurdle by predicting that more isoforms
were produced per cell than could be detected across all cells. This prediction is
possible if the rate of dropouts is extremely high, but given that my model’s pre-
dictions are not supported by matched bulk RNA-seq data either, this explanation
seems unlikely. One solution would be to test the predictions using smFISH. Whilst
this would establish whether the model makes accurate predictions or not, it would
be expensive, technically challenging and time consuming to carry out smFISH ex-
periments for a large enough number of genes to confidently evaluate the model’s
accuracy. Ultimately I think smFISH experiments resolving the number of isoforms
produced from a gene in individual cells would be hugely valuable from both a molec-
ular biology and single cell perspective, however they go beyond the scope of this
thesis. A more realistic solution could be to modify my model so that it makes more
‘realistic’ predictions. Modifying my model is clearly feasible, however whether it
would be useful is another question. Altering a model with the goal of making its
predictions more ‘realistic’ without knowing how many isoforms are produced per
gene per cell in reality is likely to create a model that reflects my own biases more
than anything else.
The main outcome from these two experiments was the realisation that a lack
of understanding about technical noise in scRNA-seq can make a biological inter-
pretation of scRNA-seq data challenging, if not impossible. If more was understood
about dropouts, and how to correct for dropouts in individual cells, the two ex-
periments discussed above would become far easier to interpret. To address this
lack of understanding about the extent to which technical noise confounds scRNA-
seq experiments, I embarked on a final simulation based study. In my final study,
I investigated the extent to which certain variables confound our ability to detect
isoforms in individual cells.
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6.3 Dropouts are a major obstacle to studying al-
ternative splicing using scRNA-seq
In the final Results chapter of my thesis, I developed a novel simulation based ap-
proach and considered to what extent certain variables confound our ability to study
alternative splicing in individual cells. I considered one biological and two techni-
cal variables. The technical variables considered were dropouts, which I found to
be a major confounder, and isoform quantification errors. Isoform quantification
errors could theoretically be entirely or almost entirely removed as a source of tech-
nical noise in scRNA-seq experiments, especially if long read technologies improve.
Therefore, establishing whether quantification errors are a major confounder is of
interest to the field because there are clear actions that could be taken to reduce or
remove confounding. In practice however, I found that isoform quantification errors
were a relatively minor confounder. Indeed, even when all quantification errors were
removed from my simulations, substantial confounding remained. This illustrates
that improvements in the accuracy of isoform quantification would not be sufficient
to enable accurate splicing analyses using scRNA-seq.
In addition to dropouts and quantification errors, I asked whether different models
of isoform choice, in which each cell ‘chooses’ which isoforms should be expressed,
have an impact on my simulation results. I found that different models of isoforms
choice significantly altered my simulation results, indicating that there could be value
in including it in future models for studying alternative splicing using scRNA-seq.
Insight into the cellular process of isoform choice could be gained from smFISH
experiments, which would enable more accurate models of isoform choice to be built.
My results suggest that we are less able to detect isoforms in individual cells when
cells use models of isoform choice in which isoforms with a high probability of dropout
are frequently chosen. Determining whether lowly expressed isoforms with high
dropout probabilities are frequently expressed by cells will therefore be important
and give an indication of the extent to which we are currently able to detect isoforms
in individual cells using scRNA-seq.
I considered three potentially confounding variables in my simulations, however
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I recognise that other sources of biological and technical noise exist in scRNA-seq
that could potentially confound splicing experiments. Because I focus on detecting
rather than quantifying isoforms, I do not consider PCR amplification bias, which
in theory should not directly impact on isoform detection. With good experimental
design batch effects can often be avoided in scRNA-seq experiments, so I do not
consider batch effects in my simulations either. Biological dropouts, for example
due to transcriptional bursting or cell type specific expression of isoforms, are a
potential confounder when studying splicing using scRNA-seq. Distinguishing be-
tween biological and technical dropouts is challenging and little work has been done
to resolve between biological and technical dropouts in individual cells in scRNA-
seq data. Andrews and Hemberg’s Michaelis-Menten model was originally designed
to identify genes with more dropouts than expected based on the gene’s mean ex-
pression, the rationale being that the excess dropouts must be biological dropouts
(Andrews and Hemberg, 2018a). However, to build an evidence based model of bi-
ological dropouts for use in my simulations or related approaches, this work would
need to be substantially extended. Additionally, models have previously been built
which attempt to capture transcriptional bursting behaviour from scRNA-seq data
(Kim and Marioni, 2013; Kim et al., 2015; Larsson et al., 2019; Ochiai et al., 2019).
However these models do not account for cell type specific expression of isoforms,
thus are not comprehensive models of all biological dropouts. Additionally, many
of these models were not validated using any orthogonal method (eg. smFISH) to
test their predictions, meaning their biological relevance is unclear. Therefore, in my
simulations I do not consider biological dropouts due to a lack of appropriate models
of biological dropouts. I am hopeful that further work might be done in this space,
as I think it would be of great value to the community.
In the final Results chapter of my thesis, I established that alternative splicing
analyses using scRNA-seq are currently confounded by dropouts and a lack of under-
standing about the cellular process of isoform choice. As a field, we do not currently
know how best to correct for these confounders. Consequently, I conclude that at
present I cannot recommend attempting alternative splicing using scRNA-seq data.
So how should we move forwards?
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6.4 Future Directions
A recurring theme throughout my thesis has been that dropouts can be a substantial
confounder when attempting to detect isoforms in individual cells, but it is unknown
how best to correct for this confounder. There are three very different approaches
to attempt to solve this problem. The first is to build models of technical and
biological dropouts that would enable dropouts to be resolved in individual cells in a
high confidence manner. This is essentially isoform-level imputation. Multiple tools
have been developed that attempt to impute scRNA-seq data quantified at the gene
level (Wagner et al., 2017; Li and Li, 2018; Huang et al., 2018; Gong et al., 2018; van
Dijk et al., 2018; Eraslan et al., 2019), however their poor performance in a recent
benchmark illustrates that this is a highly challenging problem that we are some way
from solving (Andrews and Hemberg, 2018b). In general, bioinformatics dropout
based methods such as imputation and Andrews and Hemberg’s Michaelis-Menten
model have focused on correcting for dropouts for applications such as clustering
and feature selection. Different approaches might be required when attempting to
resolve dropouts in individual cells - for example, factors such as the cell’s library
size and physical size might need to be accounted for. Attempting to develop such
approaches could enable more accurate splicing analyses to be performed in future.
However, this is an extremely challenging problem to solve, as illustrated by the poor
performance of existing imputation tools (Andrews and Hemberg, 2018a).
The second approach that could be taken to attempt to solve confounding effects
caused by dropouts would be to increase the capture efficiency of scRNA-seq. It is hy-
pothesised that dropouts occur due inefficiencies in the enzymatic process of reverse
transcription (Kharchenko et al., 2014). If this hypothesis is correct, improvements
to the efficiencies of the enzymatic reactions that occur during library preparation
could reduce the frequency of dropouts in scRNA-seq. Whilst this thesis was be-
ing written, a new library preparation protocol called SMART-seq3 was released
(Hagemann-Jensen et al., 2019). One of the stated improvements in SMART-seq3
relative to SMART-seq2 was that the efficiency of several enzymatic reactions in
library preparation had been improved, which could theoretically improve the cap-
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ture efficiency of SMART-seq3. Indeed, in their preprint, Hagemann-Jensen et al.
showed that SMART-seq3 detected more genes per cell on average than SMART-
seq2, which would be consistent with an increased capture efficiency. Hagemann-
Jensen et al. also claimed that SMART-seq3 on average detected an estimated
69% of the molecules detected from four moderately expressed genes using smFISH.
However, only four genes were reported and it is unclear how these estimates were
generated, so these claims should perhaps be taken with a pinch of salt. An in-
dependent benchmark of library preparation protocols, including SMART-seq3, is
required to determine whether the capture efficiency of SMART-seq3 is genuinely el-
evated relative to other library preparation methods. If SMART-seq3 truly does have
a higher capture efficiency, it could play an important role in enabling the detection
of isoforms in individual cells.
The final approach to solving confounding factors caused by dropouts in scRNA-
seq data is to use a different technology to detect isoforms in individual cells. sm-
FISH is the most obvious candidate. Whilst smFISH has traditionally been a low
throughput technology which struggles to resolve between isoforms, recent and future
improvements in throughput (Eng et al., 2019; Moffitt et al., 2016) and techniques to
resolve between similar molecules (Levesque et al., 2013) could make a high through-
put study of how many isoforms are expressed per gene per cell increasingly feasible.
An smFISH dataset resolving the number of isoforms detected per gene per cell for
a hundred or so genes would be hugely valuable to the scRNA-seq community. This
dataset could be used as a ground truth dataset to benchmark scRNA-seq methods
for inferring isoform number. Additionally, such an smFISH dataset could be used
to train and test machine learning approaches, which are currently impossible due
to a lack of training data.
An important point to recognise is that my simulation based approach only fo-
cussed on isoform detection. Establishing the relative magnitude of expression of
isoforms is likely to be of interest to many researchers, however simply detecting
isoforms accurately is currently problematic. Therefore, accurately inferring the rel-
ative magnitude of expression of isoforms in individual cells is not yet feasible in my
view. Furthermore, the two library preparation protocols which performed well in my
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benchmarking study (SMARTer and SMART-seq2) do not add UMIs to transcripts
and so suffer from PCR amplification bias. This is likely to substantially confound
attempts to infer magnitude of expression. SMART-seq3 does add UMIs to some
reads, however Hagemann-Jensen et al. demonstrate that the UMI containing reads
have substantial bias towards the 5’ end of the transcript (Hagemann-Jensen et al.,
2019). This 5’ bias is likely to make the detection and quantification of isoforms that
differ at their 3’ end challenging.
scRNA-seq is a very dynamic field, and many researchers are actively working on
new technological developments. In the next section, I consider whether up and com-
ing developments in scRNA-seq technologies could improve the feasibility of studying
splicing in the future.
6.5 scRNA-seq technologies on the horizon
As the timeline in Figure 1.5 illustrates, many scRNA-seq technologies have been
developed in the past decade. However, further developments are on the horizon.
In this section, I will discuss several exciting technological developments that are on
the verge of becoming practical and consider whether in the future, they could play
a role in enabling splicing to be studied using scRNA-seq.
6.5.1 SMART-seq3
A preprint for a new scRNA-seq library preparation protocol called SMART-seq3
was recently released (Hagemann-Jensen et al., 2019). SMART-seq3 has been widely
described as the first technology to combine full length reads and reads containing
UMIs. However, it is important to recognise that full length reads containing UMIs
are not generated by this protocol. Rather, this protocol generates a set of UMI
containing reads which are heavily biased towards the 5’ end of the transcript, and
a set of full length reads that do not contain UMIs and have relatively a uniform
coverage.
SMART-seq3 is certainly a very novel approach, however it is not immediately
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obvious what its applications will be. In their preprint, Hagemann-Jensen et al.
propose that the UMI containing reads could be used to infer isoform structure and
allelic information. However, as the UMI containing reads are 5’ biased, it is unclear
how effective this approach would be, especially compared to potential developments
in long read technologies. Given the mix of UMI and non-UMI containing reads gen-
erated by this protocol, research into the best bioinformatics methods for analysing
this data may be required to determine how best to use data generated by the new
protocol. In addition, independent benchmarks comparing SMART-seq3 to other li-
brary preparation protocols would be valuable. In their preprint, Hagemann-Jensen
et al. attempt to improve the efficiency of enzymatic reactions in their library prepa-
ration protocol. If the enzyme reaction efficiency has been improved, the capture
efficiency of SMART-seq3 could be higher than that of other library preparation
protocols. The capture efficiency of SMART-seq3 should be independently investi-
gated and compared to other scRNA-seq technologies to establish whether it truly is
elevated. If SMART-seq3 does have a higher capture efficiency than other scRNA-seq
technologies, this could have important implications for the feasibility of studying
splicing using scRNA-seq. I have established in this thesis that dropouts are a major
confounder when trying to study splicing with scRNA-seq. A reduction in the rate of
technical dropouts could meaningfully increase the feasibility of accurately detecting
the number of isoforms in individual cells.
6.5.2 Long read scRNA-seq
At the time of writing, most sequencing experiments use Illumina sequencing. How-
ever, other sequencing platforms are available. A distinct advantage of some se-
quencing platforms is that they enable longer reads to be sequenced than is cur-
rently possible using Illumina. If we are interested in studying alternative splicing
this is exciting news. Longer reads would cover more of the length of each transcript,
theoretically enabling more accurate transcript identification. If the entire length of
the transcript could be covered by a single read, in theory that transcript could be
identified with perfect accuracy.
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In practice, existing long read sequencing platforms such as PacBio and Oxford
Nanopore have a much higher base calling error rate than Illumina (Koren et al.,
2012; Rang et al., 2018; Fu et al., 2019). Thus, it is unclear whether the accu-
racy of transcript identification would overall be higher or lower using this platform
compared with using Illumina. Independent comparative benchmarks are needed
to address this. In addition, improvements in base calling accuracy are likely to
improve the accuracy of transcript identification. However, I note that in my simu-
lations in chapter 4, when the isoform quantification error rate was reduced to zero,
our ability to detect isoforms in individual cells remained poor. This is most likely
due to confounding caused by dropouts. Long read technologies would represent an
important advance in scRNA-seq and could dramatically improve transcript identi-
fication. But unless long read technologies are accompanied with improvements in
the capture efficiency of scRNA-seq or better methodologies to correct for dropouts,
long read technologies will not solve all of the issues currently faced when trying to
study splicing with scRNA-seq.
To date, a small number of long read scRNA-seq publications exist (Singh et al.,
2019; Gupta et al., 2018; Karlsson and Linnarsson, 2017; Lebrigand et al., 2019).
However, long read technologies are still young. Consequently, challenges relating
to cost, technical difficulties, a lack of well established protocols and uncertainty
over data quality mean that few labs have attempted long read scRNA-seq to date.
In addition, at present the read throughput of long read platforms is too low to
enable meaningful isoform detection and quantification across a large number of
cells (Arzalluz-Luque and Conesa, 2018). Notwithstanding, long read scRNA-seq is
of interest to the single cell community and can be expected to develop and grow in
years to come.
6.5.3 Spatial transcriptomics
Spatial transcriptomics is a field in which information about where cells are located
in tissues is linked with information about what genes or isoforms they transcribe.
Given that one of the most common applications of scRNA-seq is cell identification,
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there is interest in the single cell community in incorporating spatial information
with scRNA-seq analyses, as spatial information could be used to validate predicted
cell identities and to provide new insight into how tissues are organised at the cellular
level. From a splicing perspective, spatial transcriptomics could enable researchers
to correlate differential splicing with a cell’s physical location. This would represent
a genuine advance on what is currently possible using scRNA-seq.
Broadly speaking, spatial transcriptomics falls into two main categories - FISH
based spatial transcriptomics and scRNA-seq based spatial transcriptomics. From
a validation perspective, it is valuable that both FISH and scRNA-seq based ap-
proaches exist. FISH based approaches could provide an orthogonal means of validat-
ing splicing and other biological predictions from scRNA-seq based approaches. Tra-
ditionally FISH based spatial transcriptomics approaches were relatively low through-
put in terms of the number of genes that could be assayed. However throughput has
been improving. A recently developed FISH based spatial transcriptomic technology,
seqFISH+, was used to profile 10,000 genes in nearly 3,000 cells (Eng et al., 2019).
In recent years, a series of scRNA-seq based spatial transcriptomic methods have
been developed. The details of the protocols vary, however the general principle is
that a thin tissue section is prepared, then is laid over a slide coated with beads
or probes which capture RNA (Rodriques et al., 2019; Vickovic et al., 2019; St˚ahl
et al., 2016). These procedures are not truly single cell as the beads or probes often
capture RNA from more than one cell. Nonetheless, they represent a genuine break-
through in our ability to link spatial and transcriptomic information. Improvements
to this technology, such as only capturing transcriptomic information from one cell,
reduced cost and simpler protocols, could lead to spatial transcriptomics becoming
increasingly widespread in the future.
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6.6 Alternative splicing and scRNA-seq: conclu-
sions from my feasibility assessment
I began my feasibility assessment by asking whether existing isoform quantification
tools give accurate results when run on scRNA-seq data. I found that in general,
existing isoform quantification tools perform well when run on scRNA-seq data,
provided that the data has full length reads and the sequencing depth is moderately
high for each cell. However, when I attempted to address biological questions using
tools that performed well in my benchmark, I found that a lack of knowledge about
what confounders were present in the scRNA-seq data made my results impossible
to interpret.
I therefore continued my feasibility assessment by investigating the extent to
which various technical and biological factors confounded splicing analyses using
scRNA-seq. I found that dropouts are a major technical confounder when attempting
to detect isoforms in individual cells. Isoform quantification errors were a much lesser
confounder. Importantly, even when isoform quantification is error free, substantial
confounding remains. This indicates that perfect isoform quantification alone is
insufficient to enable accurate splicing analyses. My results indicate that isoform
choice can impact on our ability to detect isoforms in individual cells, so should be
accounted for in future splicing analyses.
At present, it is unclear whether the capture efficiency of scRNA-seq could be
increased and accurate methodologies to correct for technical dropouts do not exist.
In addition, little is known about the cellular mechanisms of isoform choice for most
genes. As I have shown that dropouts and a lack of knowledge about isoform choice
confound our ability to analyse splicing using scRNA-seq, I conclude that at present,
it is often not feasible to accurately analyse alternative splicing using scRNA-seq.
However, I am optimistic that with a combination of bioinformatics methods devel-
opment, wet lab experiments and improvements to scRNA-seq technologies, it may
become feasible to study alternative splicing using scRNA-seq in the future.
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6.7 A methods-driven approach to biology
As a bioinformatician, I have often been encouraged not to lose sight of the biology.
However, as I have become more experienced over the course of my PhD, I have
come to question how much biology it is currently possible to see through the lens
of genomics. Bioinformatics is not, and should not be regarded as, a magic wand
that removes all of the flaws and noise in genomics data. Bioinformatics software
can be blindly applied to genomics data and it will often produce an answer. We
have many roles as scientists, and one of those roles should be to question whether
it was appropriate to apply that bioinformatics methodology to that dataset. If it
was not, the answer that was generated should be questioned.
The methods-driven approach I took in chapter 4 of my thesis was in some re-
spects entirely detached from the underlying biological process of isoform choice in
individual cells. The four situations that I simulated, in which each cell expressed
exactly one, two, three or four isoforms, most likely bear no resemblance to the cellu-
lar regulation of isoform expression in reality. Nonetheless, I regard chapter 4 as the
most important chapter of my thesis. Chapter 4 delivered insight into what biologi-
cal questions currently can and can not be answered using scRNA-seq. It is my view
that genomics data should only be used to answer biological questions if there is a
reasonable expectation that the answer will be accurate. As I have demonstrated in
this thesis, determining whether an accurate answer is obtainable can require con-
siderable research. I am hopeful that similar approaches to the approach taken in
chapter 4 will be used more frequently in future.
Academia can be slow to change and I am a very minor player. However, if I could
persuade a few scientists to question and systematically evaluate the bioinformatics
methodologies and approaches used in their research, I would feel that the last three
years were exceptionally well spent.
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7Appendix 1
This appendix contains quality control and other descriptive plots from chapter 2.
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Figure 7.1: Plots of quality control statistics for the BLUEPRINT B lymphocytes.
In all of these plots, one point represents one cell. Based on these plots, cells with
more than 10% of reads mapping to mitochondrial RNA, more than 4 million reads,
more than 8.2 million alignments, more than 8 million uniquely mapping reads or
more than 350,000 non-uniquely mapping reads were removed. Dashed red lines
indicate the thresholds selected to remove cells. A Percentage of reads mapping
to mitochondrial RNA. Graph produced using the scater package(McCarthy et al.,
2017). B Number of reads per cell. C Number of alignments per cell. D Number
of uniquely mapping reads per cell. E Number of non-uniquely mapping reads per
cell. F Number of unmapped reads.
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Figure 7.2: Plots of quality control statistics for the RSEM(Li and Dewey, 2011)
simulated data based on the BLUEPRINT B lymphocytes. In all of these plots, one
point represents one cell. Based on these plots, cells with more than 10% of reads
mapping to mitochondrial RNA were removed. A Percentage of reads mapping to
mitochondrial RNA. Graph produced using the scater package. B Number of reads
per cell. C Number of alignments per cell. D Number of uniquely mapping reads
per cell. E Number of non-uniquely mapping reads per cell. F Number of unmapped
reads.
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Figure 7.3: Plots of quality control statistics for the Splatter(Zappia et al., 2017b)
and Polyester(Frazee et al., 2015) 3’ bias simulated data based on the BLUEPRINT B
lymphocytes. In all of these plots, one point represents one cell. Based on these plots,
cells with more than 250,000 non-uniquely mapping reads were removed. Dashed red
lines indicate the thresholds selected to remove cells. A Percentage of reads mapping
to mitochondrial RNA. Graph produced using the scater package. B Number of reads
per cell. C Number of alignments per cell. D Number of uniquely mapping reads
per cell. E Number of non-uniquely mapping reads per cell. F Number of unmapped
reads.
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Figure 7.4: Plots of quality control statistics for the Splatter and Polyester simulated
data based on the BLUEPRINT B lymphocytes, simulated with no coverage bias.
In all of these plots, one point represents one cell. Based on these plots, no poor
quality cells were removed. Based on these plots, cells with more than 250,000 non
uniquely mapping reads were removed. Dashed red lines indicate the thresholds
selected to remove cells. A Percentage of reads mapping to mitochondrial RNA.
Graph produced using the scater package. B Number of reads per cell. C Number
of alignments per cell. D Number of uniquely mapping reads per cell. E Number of
non-uniquely mapping reads per cell. F Number of unmapped reads.
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Figure 7.5: Plots of quality control statistics for mESCs grown in standard 2i media
+ LIF, published by Kolodziejczyk et al.(Kolodziejczyk et al., 2015) In all of these
plots, one point represents one cell. Based on these plots, cells with more than
10% of reads mapping to mitochondrial RNA, more than 12 million or less than 3.5
million reads, more than 32 million or less than 4 million alignments, or more than
2.5 million non-uniquely mapping reads were removed. Dashed red lines indicate the
thresholds selected to remove cells. A Percentage of reads mapping to mitochondrial
RNA. Graph produced using the scater package. B Number of reads per cell. C
Number of alignments per cell. D Number of uniquely mapping reads per cell. E
Number of non-uniquely mapping reads per cell. F: Number of unmapped reads.
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Figure 7.6: Plots of quality control statistics for simulated mESCs. In all of these
plots, one point represents one cell. Based on these plots, cells with more than 10%
of reads mapping to mitochondrial RNA or less than 5 million uniquely mapping
reads were removed. Dashed red lines indicate the thresholds selected to remove
cells. A Percentage of reads mapping to mitochondrial RNA. Graph produced using
the scater package. B Number of reads per cell. C Number of alignments per cell.
D Number of uniquely mapping reads per cell. E Number of non-uniquely mapping
reads per cell. F Number of unmapped reads.
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Figure 7.7: Histogram of ground truth expression values for simulated mESCs.
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Figure 7.8: Plots of quality control statistics for 1000 randomly selected Drop-seq
cells. In all of these plots, one point represents one cell. Based on these plots, cells
with more than 10% of reads mapping to mitochondrial RNA, more than 20,000
reads, more than 25,000 alignments, more than 15,000 uniquely mapping reads or
more than 3,000 non-uniquely mapping reads were removed. Dashed red lines in-
dicate the thresholds selected to remove cells. A Percentage of reads mapping to
mitochondrial RNA. Graph produced using the scater package. B Number of reads
per cell. C Number of alignments per cell. D Number of uniquely mapping reads
per cell. E Number of non-uniquely mapping reads per cell. F Number of unmapped
reads.
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Figure 7.9: Plots of quality control statistics for the simulated Drop-seq cells. In all
of these plots, one point represents one cell. Based on these plots, cells with more
than 10% of reads mapping to mitochondrial RNA, less than 1,000 alignments, less
than 1,000 uniquely mapping reads or more than 500 non-uniquely mapping reads
were removed. Dashed red lines indicate the thresholds selected to remove cells. The
number of alignments differs substantially in the simulated data compared to the real
data. One explanation for this could be inaccurate quantification of the number of
alignments. A Percentage of reads mapping to mitochondrial RNA. Graph produced
using the scater package. B Number of reads per cell. C Number of alignments per
cell. D Number of uniquely mapping reads per cell. E Number of non-uniquely
mapping reads per cell. F Number of unmapped reads.
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Figure 7.10: Histogram of ground truth expression values for simulated Drop-seq
cells.
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Figure 7.11: Comparison of the percentage of isoforms which are unexpressed (ie.
have zero expression) in Kolodziejczyk et al. ES cell bulk and scRNA-seq data. For
the single cell data, each point represents a simulated single cell. For the bulk data,
each point represents a single simulated bulk RNA-seq sample.
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8Appendix 2
This appendix contains simulation results from chapter 3 for pluripotency factors not
predicted to express differing numbers of isoforms under different culture conditions.
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A: a2i
B: Serum
C: Standard 2i
Figure 8.1: Simulation results for Esrrb gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line on
each plot represents the mean number of isoforms detected per cell in the real data.
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A: a2i
B: Serum
C: Standard 2i
Figure 8.2: Simulation results for Nanog gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line on
each plot represents the mean number of isoforms detected per cell in the real data.
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A: a2i
B: Serum
C: Standard 2i
Figure 8.3: Simulation results for Nr0b1 gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line on
each plot represents the mean number of isoforms detected per cell in the real data.
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A: a2i
B: Serum
C: Standard 2i
Figure 8.4: Simulation results for Sall4 gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line
on each plot represents the mean number of isoforms detected per cell in the real
data.
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A: a2i
B: Serum
C: Standard 2i
Figure 8.5: Simulation results for Sox2 gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line
on each plot represents the mean number of isoforms detected per cell in the real
data.
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A: a2i
B: Serum
C: Standard 2i
Figure 8.6: Simulation results for Zfp42 gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line on
each plot represents the mean number of isoforms detected per cell in the real data.
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A: a2i
B: Serum
C: Standard 2i
Figure 8.7: Simulation results for Zfp281 gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line on
each plot represents the mean number of isoforms detected per cell in the real data.
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A: a2i
B: Serum
C: Standard 2i
Figure 8.8: Simulation results for Zfx gene in mESCs cultured in A a2i culture
conditions, B serum and C standard 2i culture conditions. The vertical black line
on each plot represents the mean number of isoforms detected per cell in the real
data.
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9Appendix 3
Tables of statistical results and additional results figures from chapter 4 are presented
in this chapter.
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Figure 9.1: Distributions of the overlap fraction with the ground truth when the A
Weibull model (Bacher et al., 2017; Hu et al., 2017), B random model, C inferred
probabilities model and D cell variability model of isoform choice is used. All distri-
butions are for H1 cells sequenced at approximately 4 million reads per cell. See the
main text for a detailed description of each model.
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Figure 9.2: Different models of isoform choice alter our ability to detect isoforms.
A Distributions of overlap fraction with the ground truth for H1 hESCs sequenced
at approximately 1 million reads per cell using the Weibull model of isoform choice
(Bacher et al., 2017; Hu et al., 2017). B shows the same distributions when the
random model is used. C shows the distributions when the inferred probabilities
model is used. D shows the distributions when the cell variability model is used. See
the main text for a detailed description of each model.
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Figure 9.3: Different models of isoform choice alter our ability to detect isoforms.
A Distributions of the mean number of isoforms detected per gene per cell for H9
hESCs sequenced at approximately 4 million reads per cell using the Weibull model
of isoform choice (Bacher et al., 2017; Hu et al., 2017). B shows the same distribu-
tions when the random model is used. C shows the distributions when the inferred
probabilities model is used. D shows the distributions when the cell variability model
is used. See the main text for a detailed description of each model.
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Figure 9.4: Different models of isoform choice alter our ability to detect isoforms.
a Distributions of overlap fraction with the ground truth for H9 hESCs sequenced
at approximately 4 million reads per cell using the Weibull model of isoform choice
(Bacher et al., 2017; Hu et al., 2017). b shows the same distributions when the
random model is used. c shows the distributions when the inferred probabilities
model is used. d shows the distributions when the cell variability model is used. See
the main text for a detailed description of each model.
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Figure 9.5: Different models of isoform choice alter our ability to detect isoforms.
A Distributions of the mean number of isoforms detected per gene per cell for H9
hESCs sequenced at approximately 1 million reads per cell using the Weibull model
of isoform choice (Bacher et al., 2017; Hu et al., 2017). B shows the same distribu-
tions when the random model is used. C shows the distributions when the inferred
probabilities model is used. D shows the distributions when the cell variability model
is used. See the main text for a detailed description of each model.
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Figure 9.6: Different models of isoform choice alter our ability to detect isoforms.
a Distributions of overlap fraction with the ground truth for H9 hESCs sequenced
at approximately 1 million reads per cell using the Weibull model of isoform choice
(Bacher et al., 2017; Hu et al., 2017). b shows the same distributions when the
random model is used. c shows the distributions when the inferred probabilities
model is used. d shows the distributions when the cell variability model is used. See
the main text for a detailed description of each model.
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Figure 9.7: Some models of isoform choice are more plausible than others. I model
the probability of picking any given isoform as a Normal distribution, a Bernoulli
distribution and a constant probability, all with the same mean (0.25) (top row of
graphs). In the following rows, I show the distributions of the overlap fraction when
each model of isoform choice is used. The second row is H1 hESCs sequenced at 1
million reads per cell, the third row is H1 hESCs sequenced at 4 million reads, the
fourth row is H9 hESCs sequenced at 1 million reads, the fifth row is H9 hESCs
sequenced at 4 million reads.
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Figure 9.8: Mixture models. A and B Distributions of detected isoforms per gene
per cell (blue) and log normal fitted distributions (orange) for H1 cells sequenced
at 1 million reads per cell (A) or 4 million reads per cell (B) under the random
model (Bacher et al., 2017). C and D Mixing fractions vs iterations of expectation
maximisation for 1 million reads per cell (C) and 4 million reads per cell (D). Each
coloured line represents the distributions for one, two, three or four isoforms being
simulated as expressed per gene per cell.
Figure 9.9: Mixture models. A and B Distributions of detected isoforms per gene
per cell (blue) and log normal fitted distributions (orange) for H1 cells sequenced
at 1 million reads per cell (A) or 4 million reads per cell (B) under the inferred
model (Bacher et al., 2017). C and D Mixing fractions vs iterations of expectation
maximisation for 1 million reads per cell (C) and 4 million reads per cell (D). Each
coloured line represents the distributions for one, two, three or four isoforms being
simulated as expressed per gene per cell.
Figure 9.10: Mixture models. A and B Distributions of detected isoforms per gene
per cell (blue) and log normal fitted distributions (orange) for H1 cells sequenced at 1
million reads per cell (A) or 4 million reads per cell (B) under the cell variable model
(Bacher et al., 2017; Velten et al., 2015). C and D Mixing fractions vs iterations
of expectation maximisation for 1 million reads per cell (C) and 4 million reads per
cell (D). Each coloured line represents the distributions for one, two, three or four
isoforms being simulated as expressed per gene per cell.
Figure 9.11: Mixture models. A and B Distributions of detected isoforms per gene
per cell (blue) and log normal fitted distributions (orange) for H9 cells sequenced at
1 million reads per cell (A) or 4 million reads per cell (B) under the Weibull model
(Bacher et al., 2017; Hu et al., 2017). C and D Mixing fractions vs iterations of
expectation maximisation for 1 million reads per cell (C) and 4 million reads per
cell (D). Each coloured line represents the distributions for one, two, three or four
isoforms being simulated as expressed per gene per cell.
Figure 9.12: Mixture models. A and B Distributions of detected isoforms per gene
per cell (blue) and log normal fitted distributions (orange) for H9 cells sequenced
at 1 million reads per cell (A) or 4 million reads per cell (B) under the random
model (Bacher et al., 2017). C and D Mixing fractions vs iterations of expectation
maximisation for 1 million reads per cell (C) and 4 million reads per cell (D). Each
coloured line represents the distributions for one, two, three or four isoforms being
simulated as expressed per gene per cell.
Figure 9.13: Mixture models. A and B Distributions of detected isoforms per gene
per cell (blue) and log normal fitted distributions (orange) for H9 cells sequenced
at 1 million reads per cell (A) or 4 million reads per cell (B) under the inferred
model (Bacher et al., 2017). C and D Mixing fractions vs iterations of expectation
maximisation for 1 million reads per cell (C) and 4 million reads per cell (D). Each
coloured line represents the distributions for one, two, three or four isoforms being
simulated as expressed per gene per cell.
Figure 9.14: Mixture models. A and B Distributions of detected isoforms per gene
per cell (blue) and log normal fitted distributions (orange) for H9 cells sequenced at 1
million reads per cell (A) or 4 million reads per cell (B) under the cell variable model
(Bacher et al., 2017; Velten et al., 2015). C and D Mixing fractions vs iterations
of expectation maximisation for 1 million reads per cell (C) and 4 million reads per
cell (D). Each coloured line represents the distributions for one, two, three or four
isoforms being simulated as expressed per gene per cell.
9.1 Supplementary Tables
No. Isoforms Simulated p-Value
1 0.0
2 0.0
3 0.0
4 0.999999
Table 9.1: Results of K-sample Anderson–Darling test, which tests whether multiple
collections come from the same population. The test was applied to each row of
graphs in Figure 4.13, in other words testing whether the distributions generated by
different isoform choice models are significantly different.
No. Isoforms Simulated p-Value
1 0.835737
2 0.997938
3 0.998721
4 0.99074
Table 9.2: Results of K-sample Anderson–Darling test, which tests whether multiple
collections come from the same population. The test was applied to the simulation
results generated using the Inferred Probabilities vs the Cell Variable models of
isoform choice in Figure 4.13 to test whether the distributions generated by different
isoform choice models significantly differ.
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No. Isoforms Simulated p-Value
1 0.0
2 0.0
3 0.0
4 1.0
Table 9.3: Results of K-sample Anderson–Darling test, which tests whether multiple
collections come from the same population. The test was applied to each row of
graphs in Figure 4.12, in other words testing whether the distributions generated by
different isoform choice models are significantly different.
No. Isoforms Simulated p-Value
1 0.639939
2 0.959654
3 0.995236
4 0.999814
Table 9.4: Results of K-sample Anderson–Darling test, which tests whether multiple
collections come from the same population. The test was applied to the simulation
results generated using the Inferred Probabilities vs the Cell Variable models of
isoform choice in Figure 4.12 to test whether the distributions generated by different
isoform choice models significantly differ.
No. Isoforms Simulated p-Value
1 0.0
2 0.0
3 0.0
4 0.999999
Table 9.5: Results of K-sample Anderson–Darling test, which tests whether multiple
collections come from the same population. The test was applied to each row of
graphs in Supplementary Figure 9.3, in other words testing whether the distributions
generated by different isoform choice models are significantly different.
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No. Isoforms Simulated p-Value
1 0.98348
2 0.95075
3 0.999405
4 0.995485
Table 9.6: Results of K-sample Anderson–Darling test, which tests whether multiple
collections come from the same population. The test was applied to the simulation
results generated using the Inferred Probabilities vs the Cell Variable models of
isoform choice in Figure 9.3 to test whether the distributions generated by different
isoform choice models significantly differ.
No. Isoforms Simulated p-Value
1 0.0
2 0.0
3 0.0
4 1.0
Table 9.7: Results of K-sample Anderson–Darling test, which tests whether multiple
collections come from the same population. The test was applied to each row of
graphs in Supplementary Figure 9.5, in other words testing whether the distributions
generated by different isoform choice models are significantly different.
No. Isoforms Simulated p-Value
1 0.932755
2 0.969666
3 0.999973
4 0.999753
Table 9.8: Results of K-sample Anderson–Darling test, which tests whether multiple
collections come from the same population. The test was applied to the simulation
results generated using the Inferred Probabilities vs the Cell Variable models of iso-
form choice in Supplementary Figure 9.5 to test whether the distributions generated
by different isoform choice models significantly differ.
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Data source p-Value
H1 1 million reads 0.99808
H1 4 million reads 0.981612
H9 1 million reads 0.989299
H9 4 million reads 0.997866
Table 9.9: Results of K-sample Anderson–Darling test, which tests whether multiple
collections come from the same population. The test was applied to the simula-
tion results generated using the Normal, Bernoulli and p=0.25 models of isoform
choice to test whether the distributions generated by different isoform choice models
significantly differ.
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